"Centre.Name...Centre","Country...Centre","Register.ID...Record","Country.of.usual.residence...Record","Patient.follow.up.status...Record","First.contact.with.centre...Record","Date.of.birth...Birth","Sex.at.birth...Birth","Birth.weight..g....Birth","Birth.length..cm....Birth","Gestational.Age..weeks....Birth","Data.can.be.shared.for.research.purposes...Consent","Current.gender...Details.of.Condition","Karyotype...Details.of.Condition","Specify.the.karyotype...Details.of.Condition","Disorder.type...Details.of.Condition","Actual.diagnosis...Details.of.Condition","Specify.the.actual.diagnosis...Details.of.Condition","Date.of.diagnosis...Details.of.Condition","Mother.s.height..cm....Family","Father.s.height..cm....Family","Record...CAH.First.Presentation","Age.at.first.presentation...CAH.First.Presentation","Prenatal.diagnosis...CAH.First.Presentation","Prenatal.dexamethasone.therapy...CAH.First.Presentation","Additional.details...CAH.First.Presentation","Prader.stage.at.first.presentation...CAH.First.Presentation","Salt.wasting.crisis.at.presentation...CAH.First.Presentation","Adrenal.crisis.at.first.presentation...CAH.First.Presentation","Date...CAH.Longitudinal.Data","Weight..kg....CAH.Longitudinal.Data","Height..cm....CAH.Longitudinal.Data","Waist.circumference..cm....CAH.Longitudinal.Data","Hip.circumference..cm....CAH.Longitudinal.Data","BMI...CAH.Longitudinal.Data","BSA...CAH.Longitudinal.Data","Cushingoid...CAH.Longitudinal.Data","Virilisation...CAH.Longitudinal.Data","Systolic..mmHg....CAH.Longitudinal.Data","Diastolic..mmHg....CAH.Longitudinal.Data","Notes...CAH.Longitudinal.Data","Breast.stage...Puberty.Female","Pubic.hair.stage...Puberty.Female","Axillary.hair.stage...Puberty.Female","Menarche...Puberty.Female","Age.at.menarche...Puberty.Female","Regular.menstrual.cycle...Puberty.Female","Fertility.desired...Puberty.Female","Number.of.pregnancies.in.the.past...Puberty.Female","Number.of.live.births...Puberty.Female","History.of.assisted.conception...Puberty.Female","EUA..Examination.under.anaesthetic....Comorbid.Conditions.and.Surgery","EUA.note...Comorbid.Conditions.and.Surgery","Surgery...Comorbid.Conditions.and.Surgery","Surgery.note...Comorbid.Conditions.and.Surgery","Other.congenital.abnormalities...Comorbid.Conditions.and.Surgery","Other.congenital.abnormalities.note...Comorbid.Conditions.and.Surgery","Diabetes.mellitus.type.1...Comorbid.Conditions.and.Surgery","Diabetes.mellitus.type.1.note...Comorbid.Conditions.and.Surgery","Diabetes.mellitus.type.2...Comorbid.Conditions.and.Surgery","Diabetes.mellitus.type.2.note...Comorbid.Conditions.and.Surgery","Hypertension...Comorbid.Conditions.and.Surgery","Hypertension.note...Comorbid.Conditions.and.Surgery","Thyroid.disease...Comorbid.Conditions.and.Surgery","Thyroid.disease.note...Comorbid.Conditions.and.Surgery","Osteoporosis...Comorbid.Conditions.and.Surgery","Osteoporosis.note...Comorbid.Conditions.and.Surgery","Stroke...Comorbid.Conditions.and.Surgery","Stroke.note...Comorbid.Conditions.and.Surgery","Cardiovascular.disease...Comorbid.Conditions.and.Surgery","Cardiovascular.disease.note...Comorbid.Conditions.and.Surgery","Smoking...Comorbid.Conditions.and.Surgery","Smoking.note...Comorbid.Conditions.and.Surgery","Anaemia...Comorbid.Conditions.and.Surgery","Anaemia.note...Comorbid.Conditions.and.Surgery","Depression...Comorbid.Conditions.and.Surgery","Depression.note...Comorbid.Conditions.and.Surgery","Anxiety...Comorbid.Conditions.and.Surgery","Anxiety.note...Comorbid.Conditions.and.Surgery","Psychosis...Comorbid.Conditions.and.Surgery","Psychosis.note...Comorbid.Conditions.and.Surgery","Other.mental.health.problems...Comorbid.Conditions.and.Surgery","Other.mental.health.problems.note...Comorbid.Conditions.and.Surgery","Joint.hypermobility...Comorbid.Conditions.and.Surgery","Joint.hypermobility.note...Comorbid.Conditions.and.Surgery","Other...Comorbid.Conditions.and.Surgery","Other.note...Comorbid.Conditions.and.Surgery","Daily.adherence.to.therapy...Current.Medication","Has.treatment.changed.since.last.visit...Current.Medication","Why.was.treatment.changed...Current.Medication","Glucocorticoids...Current.Medication","Glucocorticoids.note...Current.Medication","Fludrocortisone...Current.Medication","Fludrocortisone.frequency...Current.Medication","Current.GC.replacement...Current.Medication","Salt.replacement...Current.Medication","Salt.replacement.note...Current.Medication","Oestrogen...Current.Medication","Oestrogen.note...Current.Medication","Testosterone...Current.Medication","Testosterone.note...Current.Medication","GnRH.analogues...Current.Medication","GnRH.analogues.note...Current.Medication","Antihypertensives...Current.Medication","Antihypertensives.note...Current.Medication","Antidiabetic...Current.Medication","Antidiabetic.note...Current.Medication","Antidepressants...Current.Medication","Antidepressants.note...Current.Medication","Other.drugs...Current.Medication","Other.drugs.note...Current.Medication","Date.of.test...Bone.health.and.maturation","Bone.age.result..years....Bone.health.and.maturation","Bone.age.method...Bone.health.and.maturation","Bone.mineral.density...Bone.health.and.maturation","Bone.mineral.density.test.date...Bone.health.and.maturation","Bone.mineral.density.test.result...Bone.health.and.maturation","Bone.mineral.density.test.result.note...Bone.health.and.maturation","Genital.stage...Puberty.Male","Pubic.hair.stage...Puberty.Male","Axillary.hair.stage...Puberty.Male","Testicular.volume.left..ml....Puberty.Male","Testicular.volume.right..ml....Puberty.Male","Testicular.texture...Puberty.Male","Evidence.of.TART...Puberty.Male","Fertility.desired...Puberty.Male","Fertility.attempted...Puberty.Male","Sperm.storage...Puberty.Male","Number.of.offspring...Puberty.Male","History.of.assisted.conception...Puberty.Male","Mid.Parental.Height","BMI","coid_asse_date"
"Birmingham - BCH - CAH","United Kingdom",1413,"United Kingdom",,,"22/06/2011","Male",3955,,"38 weeks",,"Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,,,1413,,,,,"Normal Male",,,"07/10/2016",25.8,113.7,,,19.96,0.9,"No","No",104,65,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Some Concerns","Not known",,"Yes",,"Yes","OD","HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"07/10/2016",8.2,"TW20","No",,,,"1","1","1",,,,,,,"Not Applicable",,,,,"1413 07/10/2016"
"Birmingham - BCH - CAH","United Kingdom",1413,"United Kingdom",,,"22/06/2011","Male",3955,,"38 weeks",,"Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,,,1413,,,,,"Normal Male",,,"17/08/2018",34,128.4,,,20.62,1.1,"No","No",95,47,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Some Concerns","Yes","Undertreatment","Yes",,"Yes","OD","HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"17/08/2018",12.7,"TW20","No",,,,"1","1","1",,,,,,,"Not Applicable",,,,,"1413 17/08/2018"
"Birmingham - BCH - CAH","United Kingdom",1413,"United Kingdom",,,"22/06/2011","Male",3955,,"38 weeks",,"Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,,,1413,,,,,"Normal Male",,,"09/04/2020",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Some Concerns","Yes","Undertreatment","Yes",,"Yes","OD","HC","No",,"No",,"No",,"Yes","started 09/04/2020","No",,"No",,"No",,"Yes","Anastrazole 1mg/day started 09/04/2020","17/08/2018",12.7,"TW20","No",,,,"1","1","1",,,,,,,"Not Applicable",,,,,"1413 09/04/2020"
"Birmingham - BCH - CAH","United Kingdom",1413,"United Kingdom",,,"22/06/2011","Male",3955,,"38 weeks",,"Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,,,1413,,,,,"Normal Male",,,"10/11/2022",63.05,154.2,,,26.52,1.64,"No","No",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Some Concerns","Yes","Undertreatment","Yes",,"Yes","OD","HC","No",,"No",,"No",,"Yes","started 09/04/2020","No",,"No",,"No",,"Yes","Anastrazole 1mg/day started 09/04/2020","10/11/2022",15,"TW20","No",,,,"1","1","1",,,,,,,"Not Applicable",,,,,"1413 10/11/2022"
"Birmingham - BCH - CAH","United Kingdom",1413,"United Kingdom",,,"22/06/2011","Male",3955,,"38 weeks",,"Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,,,1413,,,,,"Normal Male",,,"05/10/2022",61.7,152.1,,,26.67,1.61,"No","No",91,63,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Some Concerns","Yes","Undertreatment","Yes",,"Yes","OD","HC","No",,"No",,"No",,"Yes","started 09/04/2020","No",,"No",,"No",,"Yes","Anastrazole 1mg/day started 09/04/2020","05/10/2022",15,"TW20","Yes","05/10/2020","Normal","Above average lumbar spine bone density for his age and size. Total body less head and distalradius bone density
are within normal limits for his age. No evidence of vertebral compression fractures.","1","1","1",,,,,,,"Not Applicable",,,,,"1413 05/10/2022"
"Birmingham - BCH - CAH","United Kingdom",1413,"United Kingdom",,,"22/06/2011","Male",3955,,"38 weeks",,"Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,,,1413,,,,,"Normal Male",,,"26/05/2023",65,155.4,,,26.92,1.68,"No","Not Applicable",104,65,,,,,,,,,,,,,,,,,,,,"No",,"No",,,,,,,,,,,,,,,,,,,,,,,,,,"Some Concerns","No","Undertreatment","Yes",,"Yes","OD","HC","No",,"No",,"No",,"Yes","started 09/04/2020
stopped 26/05/2022. last dose 27/04/2023
","No",,"No",,"No",,"Yes","Anastrazole 1mg/day started 09/04/2020","10/11/2022",15,"TW20","No",,,,"1","3","1",3,3,"Normal","Not known","not_applicable","Not Applicable","Not Applicable",,"no",,,"1413 26/05/2023"
"Birmingham - BCH - CAH","United Kingdom",1568,"United Kingdom","Active",,"01/01/2006","Female",3370,,"39 weeks","Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,,,1568,,,,,"IV",,,"27/01/2023",79.4,157.9,,,31.85,1.87,,,101,75,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No",,"Yes",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"1568 27/01/2023"
"Birmingham - BCH - CAH","United Kingdom",1767,"United Kingdom",,"15/01/2008","01/01/2008","Male",,,,,"Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,,,1767,"< 1 month",,"No",,"Normal Male",,,"26/05/2023",58.45,181.5,,,17.74,1.72,"No","Not Applicable",106,69,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No Concerns","No",,"Yes",,"Yes","OD","HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"17/12/2021",14.6,"TW20","No",,,,"4","4","3",15,15,"Normal","No","not_applicable","Not Applicable",,,"no",,,"1767 26/05/2023"
"Birmingham - BCH - CAH","United Kingdom",1796,"United Kingdom",,,"01/01/2015","Female",2630,,"36 weeks",,"Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,,,1796,,,,,"IV",,,"10/02/2016",8.14,71.6,,,15.88,0.4,"No","Yes",90,45,,"1","1","1","Not known",,,,,,,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,"No","Not Applicable","Yes",,"Yes","OD","HC","Yes",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,,,,,,,,,,,,,,,"1796 10/02/2016"
"Birmingham - BCH - CAH","United Kingdom",2671,"United Kingdom",,"15/01/2008","01/01/2008","Male",,,,,"Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,,,2671,,,,,,,,"27/01/2023",71.35,169.5,,,24.83,1.83,"No","No",120,70,,,,,,,,,,,,"No",,"No",,"No",,"No",,"No",,"No",,"Not known",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,,,"Some Concerns","No",,"Yes",,"Yes",,"HC","Not known",,"No",,"No",,"Not known",,"Not known",,"Not known",,"Not known",,"No",,"22/12/2020",16.4,"TW20",,,,,,,,,,,,,,,,,,,"2671 27/01/2023"
"Birmingham - BCH - CAH","United Kingdom",2985,"United Kingdom","Active","05/06/2015","08/05/2015","Male",3480,,"40 weeks","Yes","Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"05/06/2015",165.6,173.6,2985,"1 - 3 months",,"No",,"Normal Male",,,"10/02/2017",11.43,81.7,,,17.12,0.51,"No","No",85,58,,,,,,,,,,,,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"No Concerns","No","Not Applicable","Not known",,,"OD","HC","Yes","5mmol QDS","No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,"Not Known",,,,,,,,,,"Not known",,,,,,"176.1",,"2985 10/02/2017"
"Birmingham - BCH - CAH","United Kingdom",2985,"United Kingdom","Active","05/06/2015","08/05/2015","Male",3480,,"40 weeks","Yes","Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"05/06/2015",165.6,173.6,2985,"1 - 3 months",,"No",,"Normal Male",,,"26/03/2021",19.85,109.7,,,16.49,0.78,"Not known","No",99,60,"bone age and bloods requested
",,,,,,,,,,,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"No Concerns","No","Not Applicable","Yes",,"Yes","OD","HC","No","5mmol QDS","No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,"Not Known",,,,,,,,,,"Not known",,,,,,"176.1",,"2985 26/03/2021"
"Birmingham - BCH - CAH","United Kingdom",2985,"United Kingdom","Active","05/06/2015","08/05/2015","Male",3480,,"40 weeks","Yes","Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"05/06/2015",165.6,173.6,2985,"1 - 3 months",,"No",,"Normal Male",,,"27/01/2023",24.5,122.2,,,16.41,0.91,"No","No",97,70,,,,,,,,,,,,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"No Concerns","No","Not Applicable","Yes",,"Yes",,"HC","No","5mmol QDS","No",,"No",,"No",,"No",,"No",,"No",,"No",,"22/04/2022",7.1,"TW20","Not Known",,,,,,,,,,"Not known",,,,,,"176.1",,"2985 27/01/2023"
"Birmingham - BCH - CAH","United Kingdom",3235,"United Kingdom",,"15/01/2008","01/01/2008","Female",,,,,"Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,,,3235,"< 1 month",,"No",,"Not Known",,,"09/11/2020",,,,,,,,,,,,,,,,,,,,,,"Yes","2009","Yes","Nov-09","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Some Concerns","No",,"Yes",,"Yes","OD","HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,"Not Known",,,,,,,,,,,,,,,,,,"3235 09/11/2020"
"Birmingham - BCH - CAH","United Kingdom",3837,"United Kingdom",,"15/01/2008","01/01/2008","Male",,,,,"Male","Presumed XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,,,3837,,,,,,,,"26/05/2023",68,174.4,,,22.36,1.81,"No","Not Applicable",134,67,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Some Concerns","No",,"Yes",,"Yes","OD","HC","No",,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No",,,,,,,,"3837 26/05/2023"
"Birmingham - BCH - CAH","United Kingdom",3852,"United Kingdom",,"01/07/2012","26/11/2007","Female",,,,"Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"02/08/2012",,,3852,"4",,"No","investigated by liver team for prolonged jaundice as baby; 
no endocrine input at the time. 
Presented to GP with clitoromegaly aged 4 years. Referred to endocrine via gen paeds. ","III",,,"23/04/2021",53.2,149.4,,,23.83,1.49,"No","No",119,63,,"5","5",,,6,"Yes","Not known",,,"No","Yes","2014","Yes","2014",,,"No",,"No",,"No",,"Not known",,,,"No",,"No",,"Never",,,,,,,,,,,,,,,,"Not Known","No",,"Yes",,"Yes","OD","HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,,,,,,,,,,,,,,,"3852 23/04/2021"
"Birmingham - BCH - CAH","United Kingdom",4444,"United Kingdom","Active","30/09/2018","29/09/2018","Female",,,"37 weeks","Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"04/10/2018",,,4444,"< 1 month",,"Yes",,"Normal Female",,,"26/10/2018",3.25,,,,,,,"No",,,,"1","1","1",,,,,,,,"No",,"No",,"No",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No Concerns","No",,"Yes",,"Yes",,,"Yes",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,,,,,,,,,,,,,,,"4444 26/10/2018"
"Birmingham - BCH - CAH","United Kingdom",4444,"United Kingdom","Active","30/09/2018","29/09/2018","Female",,,"37 weeks","Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"04/10/2018",,,4444,"< 1 month",,"Yes",,"Normal Female",,,"25/01/2019",5.05,59,,,14.51,0.29,"No","No",78,61,,"1","1","1",,,,,,,,"No",,"No",,"No",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No Concerns","No",,"Yes",,"Yes",,,"Yes",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,,,,,,,,,,,,,,,"4444 25/01/2019"
"Birmingham - BCH - CAH","United Kingdom",8073,"United Kingdom","Active","24/05/2019","10/07/2012","Male",,,,"Yes","Male","Not known",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"31/05/2019",150,175,8073,"6",,"No","referred for precocious puberty","Normal Male",,,"31/05/2019",29.85,130.2,,,17.61,1.04,"No","Yes",108,64,"SHORT SYNACTHEN TEST - PEAK cORTISOL 138 NMOL/L",,,,,,,,,,,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"Not known",,"No",,"No",,"No",,"Yes","/autism","No",,"No",,"Not Known","No",,"Yes",,"No",,"HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"30/05/2019",14.3,"TW20","Not Known",,,,"2","3",,2,2,"Normal",,,,,,,"169",,"8073 31/05/2019"
"Cambridge - CUH","United Kingdom",2324,"United Kingdom",,"15/01/2008","01/01/2008","Female",3875,,"40 weeks",,"Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,162.8,186.3,2324,"< 1 month",,,,"III",,,"13/11/2018",29.7,142.3,,,14.67,1.08,"No","No",83,57,"sick day may not accurate. note states rarely needed""""","1","1",,,,,,,,,"Not known",,"Yes","feminizing genitoplasty 2008","Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Yes","juvenile idiopathic arthritis since sep 2015","No Concerns","No","Not Applicable","Yes",,"Yes","OD","HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"Yes","methotrexate, NSAID, folic acid, omeplazole, multi vit",,,,,,,,,,,,,,"Not known",,,,,,"168.05",,"2324 13/11/2018"
"Cambridge - CUH","United Kingdom",2324,"United Kingdom",,"15/01/2008","01/01/2008","Female",3875,,"40 weeks",,"Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,162.8,186.3,2324,"< 1 month",,,,"III",,,"02/05/2018",27.8,138,,,14.6,1.03,"No","No",100,59,"sick day may not be accurate, note states rarely needed""""","1","1",,,,,,,,,"Not known",,"Yes","feminizing genitoplasty 2008","Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Yes","juvenile idiopathic arthritis since sep 2015","No Concerns","No","Not Applicable","Yes",,"Yes","OD","HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"Yes","methotrexate, NSAID, folic acid, omeplazole, multi vit",,,,,,,,,,,,,,"Not known",,,,,,"168.05",,"2324 02/05/2018"
"Cambridge - CUH","United Kingdom",2324,"United Kingdom",,"15/01/2008","01/01/2008","Female",3875,,"40 weeks",,"Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,162.8,186.3,2324,"< 1 month",,,,"III",,,"03/05/2017",24.3,131.5,,,14.05,0.94,"No","No",95,57,"sick day not mentioned in the notes","1","1",,,,,,,,,"Not known",,"Yes","feminizing genitoplasty 2008","Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Yes","juvenile idiopathic arthritis since sep 2015","No Concerns","No","Not Applicable","Yes",,"Yes","OD","HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"Yes","methotrexate, NSAID, folic acid, omeplazole, multi vit",,,,,,,,,,,,,,"Not known",,,,,,"168.05",,"2324 03/05/2017"
"Cambridge - CUH","United Kingdom",2324,"United Kingdom",,"15/01/2008","01/01/2008","Female",3875,,"40 weeks",,"Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,162.8,186.3,2324,"< 1 month",,,,"III",,,"25/01/2017",23.3,130.3,,,13.72,0.92,"No","No",87,61,,"1","1",,,,,,,,,"Not known",,"Yes","feminizing genitoplasty 2008","Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Yes","juvenile idiopathic arthritis since sep 2015","No Concerns","No","Not Applicable","Yes",,"Yes","OD","HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"Yes","methotrexate, NSAID, folic acid, omeplazole, multi vit",,,,,,,,,,,,,,"Not known",,,,,,"168.05",,"2324 25/01/2017"
"Cambridge - CUH","United Kingdom",2324,"United Kingdom",,"15/01/2008","01/01/2008","Female",3875,,"40 weeks",,"Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,162.8,186.3,2324,"< 1 month",,,,"III",,,"20/07/2016",22.6,126,,,14.24,0.89,"No","No",90,51,,"1","1",,,,,,,,,"Not known",,"Yes","feminizing genitoplasty 2008","Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Yes","juvenile idiopathic arthritis since sep 2015","No Concerns","No","Not Applicable","Yes",,"Yes","OD","HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"Yes","methotrexate, NSAID, folic acid, omeplazole, multi vit",,,,,,,,,,,,,,"Not known",,,,,,"168.05",,"2324 20/07/2016"
"Cambridge - CUH","United Kingdom",2325,"United Kingdom",,"15/01/2005","01/01/2005","Male",,,,,"Male","Presumed XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,,,2325,"< 1 month",,,,"Normal Male",,,"16/03/2016",30.2,128.8,,,18.2,1.04,"No","No",98,60,,,,,,,,,,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,"No","Not Applicable","Yes",,"Yes","OD","HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,"Not Known",,,,"1","1",,,,,"Not known",,,,,,,,"2325 16/03/2016"
"Cambridge - CUH","United Kingdom",2325,"United Kingdom",,"15/01/2005","01/01/2005","Male",,,,,"Male","Presumed XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,,,2325,"< 1 month",,,,"Normal Male",,,"05/09/2018",39.8,138.2,,,20.84,1.24,"No","No",105,66,,,,,,,,,,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"No Concerns","Yes","Dose adjustment for size","Yes",,"Yes","OD","HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,"2","1",,6,6,,"Not known",,,,,,,,"2325 05/09/2018"
"Cambridge - CUH","United Kingdom",2325,"United Kingdom",,"15/01/2005","01/01/2005","Male",,,,,"Male","Presumed XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,,,2325,"< 1 month",,,,"Normal Male",,,"07/03/2018",39.8,138.2,,,,,"No","No",110,73,,,,,,,,,,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"No Concerns","No","Not Applicable","Yes",,"Yes","OD","HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"07/03/2018",10,,,,,,,,,,,,"Not known",,,,,,,,"2325 07/03/2018"
"Cambridge - CUH","United Kingdom",2325,"United Kingdom",,"15/01/2005","01/01/2005","Male",,,,,"Male","Presumed XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,,,2325,"< 1 month",,,,"Normal Male",,,"06/09/2017",35.6,134.7,,,19.62,1.15,"No","No",98,64,,,,,,,,,,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"No Concerns","No","Not Applicable","Yes",,"Yes","OD","HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,"1","1",,4,4,,"Not known",,,,,,,,"2325 06/09/2017"
"Cambridge - CUH","United Kingdom",2325,"United Kingdom",,"15/01/2005","01/01/2005","Male",,,,,"Male","Presumed XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,,,2325,"< 1 month",,,,"Normal Male",,,"01/03/2017",34.7,132.3,,,19.82,1.13,"No","No",97,62,,,,,,,,,,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"No Concerns","No","Not Applicable","Yes",,"Yes","OD","HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,"2","1",,2,2,,"Not known",,,,,,,,"2325 01/03/2017"
"Cambridge - CUH","United Kingdom",2325,"United Kingdom",,"15/01/2005","01/01/2005","Male",,,,,"Male","Presumed XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,,,2325,"< 1 month",,,,"Normal Male",,,"21/09/2016",30.6,130,,,18.11,1.05,"No","No",103,59,,,,,,,,,,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,"No","Not Applicable","Yes",,"Yes","OD","HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,"2","1",,2,2,,"Not known",,,,,,,,"2325 21/09/2016"
"Cambridge - CUH","United Kingdom",2358,"United Kingdom",,"01/01/2011","01/01/2007","Female",3900,,"41 weeks",,"Female","Presumed XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,,,2358,"4",,,"presented PH, tall stature, insertion of foreign objects into vagina",,,,"12/04/2016",24.7,126.8,,,15.36,0.93,"Not known","Not known",86,52,,,,,,,,,,,,"Yes","2011 prominent labial folds no scrotisation","No",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,"No","Not Applicable","Yes",,"Yes","OD","HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"12/04/2016",8,,"Not Known",,,,,,,,,,"Not known",,,,,,,,"2358 12/04/2016"
"Cambridge - CUH","United Kingdom",2358,"United Kingdom",,"01/01/2011","01/01/2007","Female",3900,,"41 weeks",,"Female","Presumed XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,,,2358,"4",,,"presented PH, tall stature, insertion of foreign objects into vagina",,,,"03/04/2019",24.7,126.8,,,,,"Not known","Not known",92,45,,"1","3","2",,,,,,,,"Yes","2011 prominent labial folds no scrotisation","No",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,"Yes","Not Applicable","Yes",,"Yes","OD","HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,,,,,,,"Not known",,,,,,,,"2358 03/04/2019"
"Cambridge - CUH","United Kingdom",2358,"United Kingdom",,"01/01/2011","01/01/2007","Female",3900,,"41 weeks",,"Female","Presumed XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,,,2358,"4",,,"presented PH, tall stature, insertion of foreign objects into vagina",,,,"17/10/2018",31.3,141.2,,,15.7,1.11,"Not known","Not known",,,,,,,,,,,,,,"Yes","2011 prominent labial folds no scrotisation","No",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,"No","Not Applicable","Yes",,"Yes","OD","HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"17/10/2018",10,,,,,,,,,,,,"Not known",,,,,,,,"2358 17/10/2018"
"Cambridge - CUH","United Kingdom",2358,"United Kingdom",,"01/01/2011","01/01/2007","Female",3900,,"41 weeks",,"Female","Presumed XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,,,2358,"4",,,"presented PH, tall stature, insertion of foreign objects into vagina",,,,"07/03/2018",29.3,136.8,,,15.66,1.06,"Not known","Not known",98,52,,"2","1","2",,,,,,,,"Yes","2011 prominent labial folds no scrotisation","No",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,"No","Not Applicable","Yes",,"Yes","OD","HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,,,,,,,"Not known",,,,,,,,"2358 07/03/2018"
"Cambridge - CUH","United Kingdom",2358,"United Kingdom",,"01/01/2011","01/01/2007","Female",3900,,"41 weeks",,"Female","Presumed XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,,,2358,"4",,,"presented PH, tall stature, insertion of foreign objects into vagina",,,,"05/07/2017",26.6,132.4,,,15.17,0.99,"Not known","Not known",96,54,,,,,,,,,,,,"Yes","2011 prominent labial folds no scrotisation","No",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,"No","Not Applicable","Yes",,"Yes","OD","HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,,,,,,,"Not known",,,,,,,,"2358 05/07/2017"
"Cambridge - CUH","United Kingdom",2358,"United Kingdom",,"01/01/2011","01/01/2007","Female",3900,,"41 weeks",,"Female","Presumed XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,,,2358,"4",,,"presented PH, tall stature, insertion of foreign objects into vagina",,,,"16/11/2016",25.8,130.2,,,15.22,0.97,"Not known","Not known",91,49,,,,,,,,,,,,"Yes","2011 prominent labial folds no scrotisation","No",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,"No","Not Applicable","Yes",,"Yes","OD","HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,,,,,,,"Not known",,,,,,,,"2358 16/11/2016"
"Cambridge - CUH","United Kingdom",2426,"United Kingdom",,,"01/01/2007","Male",,,,,"Male","Presumed XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,,,2426,,,,,,,,"18/05/2016",36.5,144.8,,,17.41,1.21,"No","No",109,56,,,,,,,,,,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,"No","Not Applicable","Yes",,,"OD","HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"18/05/2016",,,"Not Known",,,,"1","1",,1,1,,"Not known",,,,,,,,"2426 18/05/2016"
"Cambridge - CUH","United Kingdom",2426,"United Kingdom",,,"01/01/2007","Male",,,,,"Male","Presumed XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,,,2426,,,,,,,,"02/05/2018",46,155.3,,,19.07,1.41,"No","No",97,58,"number of sick day not sure, note states occasional sick day rule""""",,,,,,,,,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,"Yes","Dose adjustment for size","Yes",,,"OD","HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,"1","1",,1,1,,"Not known",,,,,,,,"2426 02/05/2018"
"Cambridge - CUH","United Kingdom",2426,"United Kingdom",,,"01/01/2007","Male",,,,,"Male","Presumed XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,,,2426,,,,,,,,"16/10/2017",42.6,151.4,,,18.58,1.34,"No","No",118,74,"fainted during game of hockey",,,,,,,,,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"No Concerns","No","Not Applicable","Yes",,,"OD","HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,,"1",,,,,"Not known",,,,,,,,"2426 16/10/2017"
"Cambridge - CUH","United Kingdom",2426,"United Kingdom",,,"01/01/2007","Male",,,,,"Male","Presumed XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,,,2426,,,,,,,,"03/05/2017",41.4,149.9,,,18.42,1.31,"No","No",,,"sick day not accurate. notes states infrequent""""",,,,,,,,,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"No Concerns","No","Not Applicable","Yes",,,"OD","HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,"1","1",,1,1,,"Not known",,,,,,,,"2426 03/05/2017"
"Cambridge - CUH","United Kingdom",2494,"United Kingdom",,"15/01/2016","01/01/2016","Female",3250,,"38 weeks",,"Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,,,2494,"< 1 month",,"No",,"IV",,,"08/03/2016",3.12,49.7,,,12.63,0.21,"No","Yes",,,,,,,,,,,,,,"No",,"No",,"No",,"No",,"No",,"Not known",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No Concerns","No","Not Applicable","Yes",,"Yes","OD","HC","Yes","1.8 mmol",,,,,,,,,,,,,,,,,,"Not Known",,,,,,,,,,"Not known",,,,,,,,"2494 08/03/2016"
"Cambridge - CUH","United Kingdom",2494,"United Kingdom",,"15/01/2016","01/01/2016","Female",3250,,"38 weeks",,"Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,,,2494,"< 1 month",,"No",,"IV",,,"12/07/2016",6.56,61.7,,,17.23,0.34,"No","Yes",,,,,,,,,,,,,,"No",,"No",,"No",,"No",,"No",,"Not known",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No Concerns","No","Not Applicable","Yes",,"Yes","OD","HC","Yes","1.8 mmol bd",,,,,,,,,,,,,,,,,,,,,,,,,,,,"Not known",,,,,,,,"2494 12/07/2016"
"Cambridge - CUH","United Kingdom",2494,"United Kingdom",,"15/01/2016","01/01/2016","Female",3250,,"38 weeks",,"Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,,,2494,"< 1 month",,"No",,"IV",,,"25/10/2016",7.58,66,,,17.4,0.37,"No","Yes",,,,,,,,,,,,,,"No",,"No",,"No",,"No",,"No",,"Not known",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No Concerns","No","Not Applicable","Yes",,"Yes","OD","HC","Yes","1.8 mmol bd",,,,,,,,,,,,,,,,,,,,,,,,,,,,"Not known",,,,,,,,"2494 25/10/2016"
"Cambridge - CUH","United Kingdom",2494,"United Kingdom",,"15/01/2016","01/01/2016","Female",3250,,"38 weeks",,"Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,,,2494,"< 1 month",,"No",,"IV",,,"02/11/2016",7.58,68,,,16.39,0.38,"No","Yes",,,,,,,,,,,,,,"Yes","02/11/2016","No",,"No",,"No",,"No",,"Not known",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No Concerns","No","Not Applicable","Yes",,"Yes","OD","HC","Yes","1.8 mmol bd",,,,,,,,,,,,,"Yes","propranorol for haemangiona in eye",,,,,,,,,,,,,,"Not known",,,,,,,,"2494 02/11/2016"
"Cambridge - CUH","United Kingdom",2494,"United Kingdom",,"15/01/2016","01/01/2016","Female",3250,,"38 weeks",,"Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,,,2494,"< 1 month",,"No",,"IV",,,"14/02/2017",8.26,69.5,,,17.1,0.4,"No","Yes",108,67,"not sure about number of sick days, no mention in notes",,,,,,,,,,,"Yes","02/11/2016","No",,"No",,"No",,"No",,"Not known",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No Concerns","No","Not Applicable","Yes",,"Yes","OD","HC","No","1.8 mmol bd",,,,,,,,,,,,,"Yes","propranorol for haemangiona in eye",,,,,,,,,,,,,,"Not known",,,,,,,,"2494 14/02/2017"
"Cambridge - CUH","United Kingdom",2494,"United Kingdom",,"15/01/2016","01/01/2016","Female",3250,,"38 weeks",,"Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,,,2494,"< 1 month",,"No",,"IV",,,"08/05/2018",12.4,83,,,18,0.53,"No","Yes",106,54,"number of sick day not accurate. notes states doubled HC several occasion during winter due to URI""""",,,,,,,,,,,"Yes","02/11/2016","No",,"No",,"No",,"No",,"Not known",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No Concerns","Yes","Dose adjustment for size","Yes",,"Yes","OD","HC","No","1.8 mmol bd",,,,,,,,,,,,,"Yes","propranorol for haemangiona in eye",,,,,,,,,,,,,,"Not known",,,,,,,,"2494 08/05/2018"
"Cambridge - CUH","United Kingdom",2494,"United Kingdom",,"15/01/2016","01/01/2016","Female",3250,,"38 weeks",,"Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,,,2494,"< 1 month",,"No",,"IV",,,"11/11/2016",7.75,67.6,,,16.96,0.38,"No","Yes",108,69,"sick day doubled HC on a couple of occasion over the last 3 months""""",,,,,,,,,,,"Yes","02/11/2016","No",,"No",,"No",,"No",,"Not known",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No Concerns","No","Not Applicable","Yes",,"Yes","OD","HC","Yes","2ml x3/day",,,,,,,,,,,,,"Yes","propranorol for haemangiona in eye",,,,,,,,,,,,,,"Not known",,,,,,,,"2494 11/11/2016"
"Cambridge - CUH","United Kingdom",2494,"United Kingdom",,"15/01/2016","01/01/2016","Female",3250,,"38 weeks",,"Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,,,2494,"< 1 month",,"No",,"IV",,,"14/12/2018",14.5,88.7,,,18.43,0.6,"No","Yes",,,"doubled up HC 1-2/month for last 6 months""""",,,,,,,,,,,"Yes","02/11/2016","No",,"No",,"No",,"No",,"Not known",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No Concerns","No","Not Applicable","Yes",,"Yes","OD","HC","No","1.8 mmol bd",,,,,,,,,,,,,"Yes","propranorol for haemangiona in eye",,,,,,,,,,,,,,"Not known",,,,,,,,"2494 14/12/2018"
"Cambridge - CUH","United Kingdom",2762,"United Kingdom",,"15/01/2006","01/01/2006","Male",,,,,"Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,,,2762,"< 1 month",,"No",,,,,"16/11/2016",36,135.3,,,19.67,1.16,"Not known","Not known",108,73,"prepubertal on 2/9/15",,,,,,,,,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,"Not known",,"Not known",,"Not known",,"Not known",,"Yes","autism","Not known",,"Not known",,"No Concerns","No","Not Applicable","Yes",,"Yes","OD","HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"16/11/2016",10,"Greulich & Pyle","Not Known",,,,,,,,,,"Not known",,,,,,,,"2762 16/11/2016"
"Cambridge - CUH","United Kingdom",2762,"United Kingdom",,"15/01/2006","01/01/2006","Male",,,,,"Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,,,2762,"< 1 month",,"No",,,,,"20/03/2019",51.2,153.2,,,21.81,1.48,"Not known","Not known",112,60,,,,,,,,,,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,"Not known",,"Not known",,"Not known",,"Not known",,"Yes","autism","Not known",,"Not known",,"No Concerns","No","Not Applicable","Yes",,"Yes","OD","HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"20/03/2019",15,,,,,,"4","4",,15,15,,"Not known",,"Not Applicable",,,,,,"2762 20/03/2019"
"Cambridge - CUH","United Kingdom",2762,"United Kingdom",,"15/01/2006","01/01/2006","Male",,,,,"Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,,,2762,"< 1 month",,"No",,,,,"04/09/2018",,,,,,,"Not known","Not known",,,,,,,,,,,,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,"Not known",,"Not known",,"Not known",,"Not known",,"Yes","autism","Not known",,"Not known",,"No Concerns","No","Not Applicable","Yes",,"Yes","OD","HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,,,,,,,"Not known",,"Not Applicable",,,,,,"2762 04/09/2018"
"Cambridge - CUH","United Kingdom",2762,"United Kingdom",,"15/01/2006","01/01/2006","Male",,,,,"Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,,,2762,"< 1 month",,"No",,,,,"01/11/2017",51.2,153.2,,,,,"Not known","Not known",118,62,,,,,,,,,,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,"Not known",,"Not known",,"Not known",,"Not known",,"Yes","autism","Not known",,"Not known",,"No Concerns","No","Not Applicable","Yes",,"Yes","OD","HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,"3","3",,4,4,,"Not known",,"Not Applicable",,,,,,"2762 01/11/2017"
"Cambridge - CUH","United Kingdom",2762,"United Kingdom",,"15/01/2006","01/01/2006","Male",,,,,"Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,,,2762,"< 1 month",,"No",,,,,"17/07/2017",51.2,153.2,,,,,"Not known","Not known",,,,,,,,,,,,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,"Not known",,"Not known",,"Not known",,"Not known",,"Yes","autism","Not known",,"Not known",,,"No","Not Applicable","Yes",,"Yes","OD","HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,,,,,,,"Not known",,"Not Applicable",,,,,,"2762 17/07/2017"
"Cambridge - CUH","United Kingdom",2762,"United Kingdom",,"15/01/2006","01/01/2006","Male",,,,,"Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,,,2762,"< 1 month",,"No",,,,,"02/06/2016",39.2,132.5,,,22.33,1.2,"Not known","Not known",123,79,,,,,,,,,,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,"Not known",,"Not known",,"Not known",,"Not known",,"Yes","autism","Not known",,"Not known",,,"No","Not Applicable","Yes",,"Yes","OD","HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,,,,,,,"Not known",,"Not Applicable",,,,,,"2762 02/06/2016"
"Cambridge - CUH","United Kingdom",2763,"United Kingdom",,"15/01/2007","01/01/2007","Male",4300,,"40 weeks",,"Male","Presumed XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,,,2763,"< 1 month",,"No",,,,,"16/11/2016",36.9,142.8,,,18.1,1.21,"No","No",113,61,"sick day a couple of occasions""""",,,,,,,,,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"No Concerns","No","Not Applicable","Yes",,"Yes","OD","HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"16/11/2016",11,,"Not Known",,,,,,,,,,"Not known",,,,,,,,"2763 16/11/2016"
"Cambridge - CUH","United Kingdom",2763,"United Kingdom",,"15/01/2007","01/01/2007","Male",4300,,"40 weeks",,"Male","Presumed XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,,,2763,"< 1 month",,"No",,,,,"20/03/2019",45.6,153.2,,,19.43,1.39,"No","No",111,65,"a run of URI last few weeks and months",,,,,,,,,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,"Yes","Not Applicable","Yes",,"Yes","OD","HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,"2","1",,2,2,,"Not known",,,,,,,,"2763 20/03/2019"
"Cambridge - CUH","United Kingdom",2763,"United Kingdom",,"15/01/2007","01/01/2007","Male",4300,,"40 weeks",,"Male","Presumed XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,,,2763,"< 1 month",,"No",,,,,"31/10/2018",47.8,152,,,20.69,1.42,"No","No",108,69,,,,,,,,,,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known","increased due to renin results",,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,"Yes","Dose adjustment for size","Yes",,"Yes","OD","HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"31/10/2018",11,"Greulich & Pyle",,,,,,,,,,,"Not known",,,,,,,,"2763 31/10/2018"
"Cambridge - CUH","United Kingdom",2763,"United Kingdom",,"15/01/2007","01/01/2007","Male",4300,,"40 weeks",,"Male","Presumed XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,,,2763,"< 1 month",,"No",,,,,"02/05/2018",44.4,150,,,19.73,1.36,"No","No",106,58,,,,,,,,,,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known","increased due to renin results",,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,"No","Not Applicable","Yes",,"Yes","OD","HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,"2","1",,1,1,,"Not known",,,,,,,,"2763 02/05/2018"
"Cambridge - CUH","United Kingdom",2763,"United Kingdom",,"15/01/2007","01/01/2007","Male",4300,,"40 weeks",,"Male","Presumed XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,,,2763,"< 1 month",,"No",,,,,"15/11/2017",44,148.8,,,19.87,1.35,"No","No",110,66,,,,,,,,,,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known","increased due to renin results",,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,"No","Not Applicable","Yes",,"Yes","OD","HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"15/11/2017",12,,,,,,"1","1",,1,1,,"Not known",,,,,,,,"2763 15/11/2017"
"Cambridge - CUH","United Kingdom",2763,"United Kingdom",,"15/01/2007","01/01/2007","Male",4300,,"40 weeks",,"Male","Presumed XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,,,2763,"< 1 month",,"No",,,,,"21/06/2017",40.4,145.2,,,19.16,1.28,"No","No",111,65,,,,,,,,,,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known","increased due to renin results",,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,"No","Not Applicable","Yes",,"Yes","OD","HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,"1","1",,2,2,,"Not known",,,,,,,,"2763 21/06/2017"
"Cambridge - CUH","United Kingdom",2763,"United Kingdom",,"15/01/2007","01/01/2007","Male",4300,,"40 weeks",,"Male","Presumed XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,,,2763,"< 1 month",,"No",,,,,"18/05/2016",33.3,139.7,,,17.06,1.14,"No","No",117,64,"no mention sick days though gastritis",,,,,,,,,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known","increased due to renin results",,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,"No","Not Applicable","Yes",,"Yes","OD","HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,,,,,,,"Not known",,,,,,,,"2763 18/05/2016"
"Cambridge - CUH","United Kingdom",2778,"United Kingdom",,"15/01/2016","01/01/2016","Female",4000,,"40 weeks",,"Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,,,2778,"< 1 month",,"No",,"IV",,,"31/08/2016",4.39,55.8,,,14.1,0.26,"No","Yes",,,"sick day not mentioned in the notes",,,,,,,,,,,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No Concerns","No","Not Applicable","Yes",,"Yes","OD","HC","Yes","1 ml TDS","No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,"Not Known",,,,,,,,,,"Not known",,,,,,,,"2778 31/08/2016"
"Cambridge - CUH","United Kingdom",2778,"United Kingdom",,"15/01/2016","01/01/2016","Female",4000,,"40 weeks",,"Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,,,2778,"< 1 month",,"No",,"IV",,,"12/09/2016",4.6,,,,14.77,0.27,"No","Yes",94,53,,,,,,,,,,,,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No Concerns","No","Not Applicable","Yes",,"Yes","OD","HC","Yes","30% NaCl 1 ml TDS","No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,,,,,,,"Not known",,,,,,,,"2778 12/09/2016"
"Cambridge - CUH","United Kingdom",2778,"United Kingdom",,"15/01/2016","01/01/2016","Female",4000,,"40 weeks",,"Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,,,2778,"< 1 month",,"No",,"IV",,,"18/11/2016",,,,,,,"No","Yes",,,,,,,,,,,,,,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No Concerns","No","Not Applicable","Yes",,"Yes","OD","HC","Yes","30% NaCl 1 ml twice daily","No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,,,,,,,"Not known",,,,,,,,"2778 18/11/2016"
"Cambridge - CUH","United Kingdom",2778,"United Kingdom",,"15/01/2016","01/01/2016","Female",4000,,"40 weeks",,"Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,,,2778,"< 1 month",,"No",,"IV",,,"13/12/2016",7.02,65.5,,,16.36,0.36,"No","Yes",76,39,"sick day not mentioned in the notes",,,,,,,,,,,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No Concerns","No","Other","Yes",,"Yes","OD","HC","No","30% NaCl 1 ml TDS","No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,,,,,,,"Not known",,,,,,,,"2778 13/12/2016"
"Cambridge - CUH","United Kingdom",2778,"United Kingdom",,"15/01/2016","01/01/2016","Female",4000,,"40 weeks",,"Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,,,2778,"< 1 month",,"No",,"IV",,,"08/05/2018",13,87,,,17.18,0.56,"No","Yes",101,66,,,,,,,,,,,,"Yes",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,,"Yes","Dose adjustment for size","Yes",,"Yes","OD","HC","Yes","30% NaCl 1 ml TDS","No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,,,,,,,"Not known",,,,,,,,"2778 08/05/2018"
"Cambridge - CUH","United Kingdom",2778,"United Kingdom",,"15/01/2016","01/01/2016","Female",4000,,"40 weeks",,"Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,,,2778,"< 1 month",,"No",,"IV",,,"13/06/2017",11.09,74.9,,,19.77,0.48,"No","Yes",,,"sick day not mentioned in the notes",,,,,,,,,,,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,,"No","Not Applicable","Yes",,"Yes","OD","HC","Yes","30% NaCl 1 ml TDS","No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,,,,,,,"Not known",,,,,,,,"2778 13/06/2017"
"Cambridge - CUH","United Kingdom",3092,"United Kingdom",,"01/01/2009","01/01/2006","Male",,,,,"Male","Presumed XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,160.4,185.8,3092,"3",,"No",,"Normal Male",,,"21/03/2017",38.1,148.2,,,17.35,1.25,"No","Not known",113,57,"testicular volume patient report. admitted to hospital several occasions"" (may be more than 2)""",,,,,,,,,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not Known","No","Not Applicable","Yes",,,"OD","HC","No",,"No",,"No",,"Yes",,"No",,"No",,"No",,"No",,"21/03/2017",14,"Greulich & Pyle","No",,,,,,,,,,"Not known",,,,,,"179.6",,"3092 21/03/2017"
"Cambridge - CUH","United Kingdom",3092,"United Kingdom",,"01/01/2009","01/01/2006","Male",,,,,"Male","Presumed XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,160.4,185.8,3092,"3",,"No",,"Normal Male",,,"19/03/2019",48.5,159.5,,,19.06,1.47,"No","Not known",124,60,"sick day rules not mentioned in the notes",,,,,,,,,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,"No","Not Applicable","Yes",,,"OD","HC","No",,"No",,"No",,"Yes",,"No",,"No",,"No",,"No",,"19/03/2019",14,,,,,,,,,,,,"Not known",,,,,,"179.6",,"3092 19/03/2019"
"Cambridge - CUH","United Kingdom",3092,"United Kingdom",,"01/01/2009","01/01/2006","Male",,,,,"Male","Presumed XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,160.4,185.8,3092,"3",,"No",,"Normal Male",,,"20/03/2018",43.6,153.8,,,18.43,1.36,"No","Not known",118,51,"no admissions over 12 months. sick day rules not mentioned in the notes",,,,,,,,,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,"No","Not Applicable","Yes",,,"OD","HC","No",,"No",,"No",,"Yes",,"No",,"No",,"No",,"No",,"20/03/2018",14,,,,,,"3","3",,3,3,,"Not known",,,,,,"179.6",,"3092 20/03/2018"
"Cambridge - CUH","United Kingdom",3092,"United Kingdom",,"01/01/2009","01/01/2006","Male",,,,,"Male","Presumed XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,160.4,185.8,3092,"3",,"No",,"Normal Male",,,"15/03/2016",34.6,141.3,,,17.33,1.17,"No","Not known",105,64,"sick day rules not mentioned in the notes",,,,,,,,,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,"No","Not Applicable","Yes",,,"OD","HC","No",,"No",,"No",,"Yes",,"No",,"No",,"No",,"No",,,,,,,,,,,,,,,"Not known",,,,,,"179.6",,"3092 15/03/2016"
"Cambridge - CUH","United Kingdom",3092,"United Kingdom",,"01/01/2009","01/01/2006","Male",,,,,"Male","Presumed XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,160.4,185.8,3092,"3",,"No",,"Normal Male",,,"20/10/2016",37.5,145.5,,,17.71,1.23,"No","Not known",116,64,"sick day rules not mentioned in the clinic letter",,,,,,,,,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,"No","Not Applicable","Yes",,,"OD","HC","No",,"No",,"No",,"Yes",,"No",,"No",,"No",,"No",,,,,,,,,"1","2",,3,3,,"Not known",,,,,,"179.6",,"3092 20/10/2016"
"Cambridge - CUH","United Kingdom",3220,"United Kingdom",,"15/01/2011","01/01/2011","Male",3490,,"40 weeks",,"Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,,,3220,"< 1 month",,"No",,"Normal Male",,,"05/07/2017",21.2,113,,,16.6,0.82,"Not known","Not known",97,68,"sick day rules at least 1/month 5-6 days""""",,,,,,,,,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"No Concerns","No","Not Applicable","Yes",,,"OD","HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"05/07/2017",4,"Greulich & Pyle","Not Known",,,,,,,,,,"Not known",,,,,,,,"3220 05/07/2017"
"Cambridge - CUH","United Kingdom",3220,"United Kingdom",,"15/01/2011","01/01/2011","Male",3490,,"40 weeks",,"Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,,,3220,"< 1 month",,"No",,"Normal Male",,,"23/01/2019",27.5,124.2,,,17.83,0.97,"Not known","Not known",102,53,"a few episodes of UTRI"," sick day rules applied""""",,,,,,,,,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,"Yes","Not Applicable","Yes",,,"OD","HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,,,,,,,"Not known",,,,,,,"3220 23/01/2019"
"Cambridge - CUH","United Kingdom",3220,"United Kingdom",,"15/01/2011","01/01/2011","Male",3490,,"40 weeks",,"Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,,,3220,"< 1 month",,"No",,"Normal Male",,,"04/07/2018",23.7,121,,,16.19,0.89,"Not known","Not known",93,58,,,,,,,,,,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,"No","Not Applicable","Yes",,,"OD","HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"04/07/2018",5,"Greulich & Pyle",,,,,,,,,,,"Not known",,,,,,,,"3220 04/07/2018"
"Cambridge - CUH","United Kingdom",3220,"United Kingdom",,"15/01/2011","01/01/2011","Male",3490,,"40 weeks",,"Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,,,3220,"< 1 month",,"No",,"Normal Male",,,"10/01/2018",22.8,117.3,,,16.57,0.86,"Not known","Not known",94,71,,,,,,,,,,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,"No","Not Applicable","Yes",,,"OD","HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,,,,,,,"Not known",,,,,,,,"3220 10/01/2018"
"Cambridge - CUH","United Kingdom",3220,"United Kingdom",,"15/01/2011","01/01/2011","Male",3490,,"40 weeks",,"Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,,,3220,"< 1 month",,"No",,"Normal Male",,,"04/01/2017",19.6,110,,,16.2,0.77,"Not known","Not known",112,62,"sick day rules quite frequentlyseveral cold throughout winter""""",,,,,,,,,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,"No","Not Applicable","Yes",,,"OD","HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,,,,,,,"Not known",,,,,,,,"3220 04/01/2017"
"Cambridge - CUH","United Kingdom",3220,"United Kingdom",,"15/01/2011","01/01/2011","Male",3490,,"40 weeks",,"Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,,,3220,"< 1 month",,"No",,"Normal Male",,,"31/08/2016",17.9,107.9,,,15.37,0.73,"Not known","Not known",95,61,"has had coughs and colds""""",,,,,,,,,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,"No","Not Applicable","Yes",,,"OD","HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"31/08/2016",4,"Greulich & Pyle",,,,,,,,,,,"Not known",,,,,,,,"3220 31/08/2016"
"Cambridge - CUH","United Kingdom",3220,"United Kingdom",,"15/01/2011","01/01/2011","Male",3490,,"40 weeks",,"Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,,,3220,"< 1 month",,"No",,"Normal Male",,,"16/03/2016",16.7,104.6,,,15.26,0.7,"Not known","Not known",114,64,,,,,,,,,,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,"No","Not Applicable","Yes",,,"OD","HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,,,,,,,"Not known",,,,,,,,"3220 16/03/2016"
"Cambridge - CUH","United Kingdom",3587,"United Kingdom",,"15/01/2017","01/01/2017","Male",,,"38 weeks",,"Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,,,3587,"< 1 month",,"No",,"Not Known",,,"08/05/2018",7.72,65.6,,,17.94,0.38,"Not known","Not known",98,56,"cough and sniffles mentioned in the notes but not sure if sick day rules applied",,,,,,,,,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"No Concerns","No","Not Applicable","Yes",,"Yes","OD","HC","Yes","2ml 3 doses","No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,"Not Known",,,,,,,,,,"Not known",,,,,,,,"3587 08/05/2018"
"Cambridge - CUH","United Kingdom",4499,"United Kingdom",,"01/09/2005","22/08/2005","Female",,,,,"Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"01/09/2005",,,4499,"< 1 month",,,,,,,"11/09/2019",48.8,151.9,,,21.15,1.43,"No","No",114,67,,"3","Not known","Not known",,,,,,,,"Yes","10/09/2019","No",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Yes","enuresis","Some Concerns","No","Not Applicable","Yes",,"Yes","OD","HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"10/09/2019",,,"No",,,,,,,,,,"Not known",,,,,,,,"4499 11/09/2019"
"Doncaster - DBTH","United Kingdom",8633,"United Kingdom","Active","15/11/2015","29/10/2015","Male",4105,,"42 weeks","Yes","Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"15/11/2015",167.5,175.2,8633,"< 1 month",,"No",,"Normal Male",,,"25/02/2016",7.93,61.1,,,21.24,0.37,"Not known","No",,,,,,,,,,,,,,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Not Known","No",,"Yes",,"Yes","BD","HC","Yes","6mmol TDS","No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,"1",,"1",,,,,,,,,,"177.85",,"8633 25/02/2016"
"Doncaster - DBTH","United Kingdom",8633,"United Kingdom","Active","15/11/2015","29/10/2015","Male",4105,,"42 weeks","Yes","Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"15/11/2015",167.5,175.2,8633,"< 1 month",,"No",,"Normal Male",,,"30/06/2016",9.78,67.7,,,21.34,0.43,"Not known","No",,,,,,,,,,,,,,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Not Known","Yes","Overtreatment","Yes",,"Yes","OD","HC","No","6mmol TDS","No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,"1",,"1",,,,,,,,,,"177.85",,"8633 30/06/2016"
"Doncaster - DBTH","United Kingdom",8633,"United Kingdom","Active","15/11/2015","29/10/2015","Male",4105,,"42 weeks","Yes","Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"15/11/2015",167.5,175.2,8633,"< 1 month",,"No",,"Normal Male",,,"04/08/2022",6.76,116.3,,,5,0.47,"Not known","No",91,52,,,,,,,,,,,,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Not Known","Yes","Dose adjustment for size","Yes",,"Yes","OD","HC","No","6mmol TDS","No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,"1",,"1",,,,,,,,,,"177.85",,"8633 04/08/2022"
"Doncaster - DBTH","United Kingdom",8633,"United Kingdom","Active","15/11/2015","29/10/2015","Male",4105,,"42 weeks","Yes","Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"15/11/2015",167.5,175.2,8633,"< 1 month",,"No",,"Normal Male",,,"15/12/2022",24.85,117.5,,,18,0.9,"Not known","No",94,63,,,,,,,,,,,,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Not Known","No","Dose adjustment for size","Yes",,"Yes","OD","HC","No","6mmol TDS","No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,"1",,"1",,,,,,,,,,"177.85",,"8633 15/12/2022"
"Doncaster - DBTH","United Kingdom",8633,"United Kingdom","Active","15/11/2015","29/10/2015","Male",4105,,"42 weeks","Yes","Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"15/11/2015",167.5,175.2,8633,"< 1 month",,"No",,"Normal Male",,,"25/05/2023",27.35,120.9,,,18.71,0.96,"Not known","No",96,59,,,,,,,,,,,,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Not Known","No","Dose adjustment for size","Yes",,"Yes","OD","HC","No","6mmol TDS","No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,"1",,"1",,,,,,,,,,"177.85",,"8633 25/05/2023"
"Doncaster - DBTH","United Kingdom",8633,"United Kingdom","Active","15/11/2015","29/10/2015","Male",4105,,"42 weeks","Yes","Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"15/11/2015",167.5,175.2,8633,"< 1 month",,"No",,"Normal Male",,,"29/09/2016",9.88,70,,,20.16,0.44,"No","No",,,,,,,,,,,,,,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Not Known","No","Dose adjustment for size","Yes",,"Yes","OD","HC","No","6mmol TDS","No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,"1",,"1",,,,,,,,,,"177.85",,"8633 29/09/2016"
"Doncaster - DBTH","United Kingdom",8633,"United Kingdom","Active","15/11/2015","29/10/2015","Male",4105,,"42 weeks","Yes","Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"15/11/2015",167.5,175.2,8633,"< 1 month",,"No",,"Normal Male",,,"12/01/2017",10.6,74.2,,,19.25,0.47,"No","No",,,,,,,,,,,,,,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Not Known","Yes","Dose adjustment for size","Yes",,"Yes","OD","HC","No","6mmol TDS","No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,"1",,"1",,,,,,,,,,"177.85",,"8633 12/01/2017"
"Doncaster - DBTH","United Kingdom",8633,"United Kingdom","Active","15/11/2015","29/10/2015","Male",4105,,"42 weeks","Yes","Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"15/11/2015",167.5,175.2,8633,"< 1 month",,"No",,"Normal Male",,,"11/05/2017",10.89,76.4,,,18.66,0.48,"No","No",,,,,,,,,,,,,,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Not Known","No","Dose adjustment for size","Yes",,"Yes","OD","HC","No","6mmol TDS","No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,"1",,"1",,,,,,,,,,"177.85",,"8633 11/05/2017"
"Doncaster - DBTH","United Kingdom",8633,"United Kingdom","Active","15/11/2015","29/10/2015","Male",4105,,"42 weeks","Yes","Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"15/11/2015",167.5,175.2,8633,"< 1 month",,"No",,"Normal Male",,,"01/02/2018",13.08,84,,,18.54,0.55,"No","No",,,,,,,,,,,,,,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Not Known","No","Dose adjustment for size","Yes",,"Yes","OD","HC","No","6mmol TDS","No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,"1",,"1",,,,,,,,,,"177.85",,"8633 01/02/2018"
"Doncaster - DBTH","United Kingdom",8633,"United Kingdom","Active","15/11/2015","29/10/2015","Male",4105,,"42 weeks","Yes","Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"15/11/2015",167.5,175.2,8633,"< 1 month",,"No",,"Normal Male",,,"01/11/2018",15.3,91.5,,,18.27,0.62,"No","No",,,,,,,,,,,,,,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Not Known","Yes","Dose adjustment for size","Yes",,"Yes","OD","HC","No","6mmol TDS","No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,"1",,"1",,,,,,,,,,"177.85",,"8633 01/11/2018"
"Doncaster - DBTH","United Kingdom",8633,"United Kingdom","Active","15/11/2015","29/10/2015","Male",4105,,"42 weeks","Yes","Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"15/11/2015",167.5,175.2,8633,"< 1 month",,"No",,"Normal Male",,,"20/06/2019",15.85,94.2,,,17.86,0.64,"No","No",,,,,,,,,,,,,,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Not Known","Yes","Dose adjustment for size","Yes",,"Yes","OD","HC","No","6mmol TDS","No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,"1",,"1",,,,,,,,,,"177.85",,"8633 20/06/2019"
"Doncaster - DBTH","United Kingdom",8633,"United Kingdom","Active","15/11/2015","29/10/2015","Male",4105,,"42 weeks","Yes","Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"15/11/2015",167.5,175.2,8633,"< 1 month",,"No",,"Normal Male",,,"05/12/2019",16.7,98,,,17.39,0.67,"No","No",,,,,,,,,,,,,,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Not Known","No","Dose adjustment for size","Yes",,"Yes","OD","HC","No","6mmol TDS","No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,"1",,"1",,,,,,,,,,"177.85",,"8633 05/12/2019"
"Doncaster - DBTH","United Kingdom",8633,"United Kingdom","Active","15/11/2015","29/10/2015","Male",4105,,"42 weeks","Yes","Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"15/11/2015",167.5,175.2,8633,"< 1 month",,"No",,"Normal Male",,,"20/05/2021",21.15,108,,,18.13,0.8,"No","No",,,,,,,,,,,,,,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Not Known","Yes","Dose adjustment for size","Yes",,"Yes","OD","HC","No","6mmol TDS","No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,"1",,"1",,,,,,,,,,"177.85",,"8633 20/05/2021"
"Doncaster - DBTH","United Kingdom",8633,"United Kingdom","Active","15/11/2015","29/10/2015","Male",4105,,"42 weeks","Yes","Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"15/11/2015",167.5,175.2,8633,"< 1 month",,"No",,"Normal Male",,,"03/02/2022",23.3,111.9,,,18.61,0.85,"No","No",,,,,,,,,,,,,,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Not Known","No","Dose adjustment for size","Yes",,"Yes","OD","HC","No","6mmol TDS","No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,"1",,"1",,,,,,,,,,"177.85",,"8633 03/02/2022"
"Doncaster - DBTH","United Kingdom",8633,"United Kingdom","Active","15/11/2015","29/10/2015","Male",4105,,"42 weeks","Yes","Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"15/11/2015",167.5,175.2,8633,"< 1 month",,"No",,"Normal Male",,,"14/12/2023",30.75,123.8,,,20.06,1.03,,,,,,,,,,,,,,,,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Not Known","No","Dose adjustment for size","Yes",,"Yes","OD","HC","No","6mmol TDS","No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,"1",,"1",,,,,,,,,,"177.85",,"8633 14/12/2023"
"Doncaster - DBTH","United Kingdom",8942,"United Kingdom","Active","06/03/2014","19/01/2012","Female",,,,"Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"04/09/2014",163,172.9,8942,"2",,"No",,"Normal Female",,,"18/08/2022",10.5,149.7,,,4.69,0.66,"No","No",122,76,,"1","1","1",,,,,,,"No","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Not Known","Yes","Undertreatment","Yes",,"No",,,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"29/10/2015",3.43,"TW20","Not Known",,,,,,,,,,,,,,,,"161.45",,"8942 18/08/2022"
"Doncaster - DBTH","United Kingdom",8942,"United Kingdom","Active","06/03/2014","19/01/2012","Female",,,,"Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"04/09/2014",163,172.9,8942,"2",,"No",,"Normal Female",,,"01/12/2022",38.83,150.5,,,17.14,1.27,"No","No",117,80,,"1","1","1",,,,,,,"No","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Not Known","No","Undertreatment","Yes",,"No",,,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"29/10/2015",3.43,"TW20","Not Known",,,,,,,,,,,,,,,,"161.45",,"8942 01/12/2022"
"Doncaster - DBTH","United Kingdom",8942,"United Kingdom","Active","06/03/2014","19/01/2012","Female",,,,"Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"04/09/2014",163,172.9,8942,"2",,"No",,"Normal Female",,,"17/08/2023",43.15,153.2,,,18.38,1.36,"No","No",112,69,,"1","1","1",,,,,,,"No","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Not Known","No","Undertreatment","Yes",,"No",,,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"29/10/2015",3.43,"TW20","Not Known",,,,,,,,,,,,,,,,"161.45",,"8942 17/08/2023"
"Doncaster - DBTH","United Kingdom",9203,"United Kingdom","Active","05/10/2017","12/12/2016","Female",,,,"Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,164.3,174.3,9203,,,,,"II",,,"05/10/2017",9.58,73.5,,,17.73,0.44,,"Yes",,,,,,,,,,,,,,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Not Known","No","Dose adjustment for size","Yes",,"Yes","OD","HC","Yes","5mmol QDS","No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,,,,,,,,,,,,,"162.8",,"9203 05/10/2017"
"Doncaster - DBTH","United Kingdom",9203,"United Kingdom","Active","05/10/2017","12/12/2016","Female",,,,"Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,164.3,174.3,9203,,,,,"II",,,"26/04/2018",11.05,81.1,,,16.8,0.5,,,,,,,,,,,,,,,,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Not Known","Yes","Dose adjustment for size","Yes",,"Yes","OD","HC","No","5mmol QDS","No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,,,,,,,,,,,,,"162.8",,"9203 26/04/2018"
"Doncaster - DBTH","United Kingdom",9203,"United Kingdom","Active","05/10/2017","12/12/2016","Female",,,,"Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,164.3,174.3,9203,,,,,"II",,,"02/08/2018",11.2,83.2,,,16.18,0.51,,,94,73,,,,,,,,,,,,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Not Known","No","Dose adjustment for size","Yes",,"Yes","OD","HC","No","5mmol QDS","No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,,,,,,,,,,,,,"162.8",,"9203 02/08/2018"
"Doncaster - DBTH","United Kingdom",9203,"United Kingdom","Active","05/10/2017","12/12/2016","Female",,,,"Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,164.3,174.3,9203,,,,,"II",,,"07/03/2019",11.8,85.8,,,16.03,0.53,,,106,69,,,,,,,,,,,,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Not Known","Yes","Dose adjustment for size","Yes",,"Yes","OD","HC","No","5mmol QDS","No",,"No",,"No",,"No",,"No",,"No",,"No",,"07/03/2019",2.76,,,,,,,,,,,,,,,,,,"162.8",,"9203 07/03/2019"
"Doncaster - DBTH","United Kingdom",9203,"United Kingdom","Active","05/10/2017","12/12/2016","Female",,,,"Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,164.3,174.3,9203,,,,,"II",,,"23/01/2020",14.4,94.4,,,16.16,0.61,,,99,40,,,,,,,,,,,,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Some Concerns","Yes","Dose adjustment for size","Yes",,"Yes","OD","HC","No","5mmol QDS","No",,"No",,"No",,"No",,"No",,"No",,"No",,"07/03/2019",2.76,,,,,,,,,,,,,,,,,,"162.8",,"9203 23/01/2020"
"Doncaster - DBTH","United Kingdom",9203,"United Kingdom","Active","05/10/2017","12/12/2016","Female",,,,"Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,164.3,174.3,9203,,,,,"II",,,"18/06/2020",15,97.5,,,15.78,0.64,,,100,64,,,,,,,,,,,,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Some Concerns","Yes","Dose adjustment for size","Yes",,"Yes","OD","HC","No","5mmol QDS","No",,"No",,"No",,"No",,"No",,"No",,"No",,"07/03/2019",2.76,,,,,,,,,,,,,,,,,,"162.8",,"9203 18/06/2020"
"Doncaster - DBTH","United Kingdom",9203,"United Kingdom","Active","05/10/2017","12/12/2016","Female",,,,"Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,164.3,174.3,9203,,,,,"II",,,"04/03/2021",17.3,105,,,15.69,0.71,,,108,54,,,,,,,,,,,,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Some Concerns","Yes","Dose adjustment for size","Yes",,"Yes","OD","HC","No","5mmol QDS","No",,"No",,"No",,"No",,"No",,"No",,"No",,"07/03/2019",2.76,,,,,,,,,,,,,,,,,,"162.8",,"9203 04/03/2021"
"Doncaster - DBTH","United Kingdom",9203,"United Kingdom","Active","05/10/2017","12/12/2016","Female",,,,"Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,164.3,174.3,9203,,,,,"II",,,"27/01/2022",19.35,113.7,,,14.97,0.78,,,116,49,,,"4",,,,,,,,,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Some Concerns","Yes","Dose adjustment for size","Yes",,"Yes","OD","HC","No","5mmol QDS","No",,"No",,"No",,"No",,"No",,"No",,"No",,"27/01/2022",7.16,,,,,,,,,,,,,,,,,,"162.8",,"9203 27/01/2022"
"Doncaster - DBTH","United Kingdom",9203,"United Kingdom","Active","05/10/2017","12/12/2016","Female",,,,"Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,164.3,174.3,9203,,,,,"II",,,"29/09/2022",22.15,118.7,,,15.72,0.85,,,109,63,,,,,,,,,,,,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Some Concerns","No","Dose adjustment for size","Yes",,"Yes","OD","HC","No","5mmol QDS","No",,"No",,"No",,"No",,"No",,"No",,"No",,"27/01/2022",7.16,,,,,,,,,,,,,,,,,,"162.8",,"9203 29/09/2022"
"Doncaster - DBTH","United Kingdom",9203,"United Kingdom","Active","05/10/2017","12/12/2016","Female",,,,"Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,164.3,174.3,9203,,,,,"II",,,"18/05/2023",24.65,124.3,,,15.95,0.92,,,107,58,,,,,,,,,,,,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Some Concerns","Yes","Dose adjustment for size","Yes",,"Yes","OD","HC","No","5mmol QDS","No",,"No",,"No",,"No",,"No",,"No",,"No",,"18/05/2023",8.91,,,,,,,,,,,,,,,,,,"162.8",,"9203 18/05/2023"
"Doncaster - DBTH","United Kingdom",9203,"United Kingdom","Active","05/10/2017","12/12/2016","Female",,,,"Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,164.3,174.3,9203,,,,,"II",,,"26/10/2023",25.25,130.1,,,14.92,0.96,,,114,73,,,,,,,,,,,,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Some Concerns","Yes","Dose adjustment for size","Yes",,"Yes","OD","HC","No","5mmol QDS","No",,"No",,"No",,"No",,"No",,"No",,"No",,"18/05/2023",8.91,,,,,,,,,,,,,,,,,,"162.8",,"9203 26/10/2023"
"Doncaster - DBTH","United Kingdom",9203,"United Kingdom","Active","05/10/2017","12/12/2016","Female",,,,"Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,164.3,174.3,9203,,,,,"II",,,"21/12/2023",25.7,131.8,,,14.79,0.97,"No",,96,56,,,,,,,,,,,,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Some Concerns","Yes","Other","Yes",,"Yes","OD","HC","No","5mmol QDS","No",,"No",,"No",,"No",,"No",,"No",,"No",,"18/05/2023",8.91,,,,,,,,,,,,,,,,,,"162.8",,"9203 21/12/2023"
"Doncaster - DBTH","United Kingdom",9269,"United Kingdom","Active","29/06/2017","09/06/2017","Male",3320,,,"Yes","Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"19/06/2017",154.5,173.8,9269,"< 1 month",,,,,,,"29/06/2017",3.21,51,,,12.34,0.21,,,,,,,,,,,,,,,,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No Concerns","Yes","Not Applicable","Yes",,"Yes","BD","HC","Yes","5mmol TDS","No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,,,,,,,,,,,,,"170.65",,"9269 29/06/2017"
"Doncaster - DBTH","United Kingdom",9269,"United Kingdom","Active","29/06/2017","09/06/2017","Male",3320,,,"Yes","Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"19/06/2017",154.5,173.8,9269,"< 1 month",,,,,,,"24/08/2017",5.67,58,,,16.85,0.3,,,99,40,,,,,,,,,,,,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No Concerns","Yes","Dose adjustment for size","Yes",,"Yes","BD","HC","Yes","5mmol TDS","No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,,,,,,,,,,,,,"170.65",,"9269 24/08/2017"
"Doncaster - DBTH","United Kingdom",9269,"United Kingdom","Active","29/06/2017","09/06/2017","Male",3320,,,"Yes","Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"19/06/2017",154.5,173.8,9269,"< 1 month",,,,,,,"04/01/2018",6.98,66,,,16.02,0.36,,,110,64,,,,,,,,,,,,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No Concerns","No","Dose adjustment for size","Yes",,"Yes","BD","HC","Yes","5mmol TDS","No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,,,,,,,,,,,,,"170.65",,"9269 04/01/2018"
"Doncaster - DBTH","United Kingdom",9269,"United Kingdom","Active","29/06/2017","09/06/2017","Male",3320,,,"Yes","Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"19/06/2017",154.5,173.8,9269,"< 1 month",,,,,,,"30/08/2018",10.18,75,,,18.1,0.46,,,,,,,,,,,,,,,,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No Concerns","Yes","Dose adjustment for size","Yes",,"Yes","BD","HC","No","5mmol TDS","No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,,,,,,,,,,,,,"170.65",,"9269 30/08/2018"
"Doncaster - DBTH","United Kingdom",9269,"United Kingdom","Active","29/06/2017","09/06/2017","Male",3320,,,"Yes","Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"19/06/2017",154.5,173.8,9269,"< 1 month",,,,,,,"11/04/2019",11.9,85.5,,,16.28,0.53,,,,,,,,,,,,,,,,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No Concerns","Yes","Dose adjustment for size","Yes",,"Yes","OD","HC","No","5mmol TDS","No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,,,,,,,,,,,,,"170.65",,"9269 11/04/2019"
"Doncaster - DBTH","United Kingdom",9269,"United Kingdom","Active","29/06/2017","09/06/2017","Male",3320,,,"Yes","Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"19/06/2017",154.5,173.8,9269,"< 1 month",,,,,,,"14/11/2019",12.7,89,,,16.03,0.56,,,102,81,,,,,,,,,,,,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No Concerns","Yes","Dose adjustment for size","Yes",,"Yes","OD","HC","No","5mmol TDS","No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,,,,,,,,,,,,,"170.65",,"9269 14/11/2019"
"Doncaster - DBTH","United Kingdom",9269,"United Kingdom","Active","29/06/2017","09/06/2017","Male",3320,,,"Yes","Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"19/06/2017",154.5,173.8,9269,"< 1 month",,,,,,,"03/07/2020",13.9,94.3,,,15.63,0.6,,,,,,,,,,,,,,,,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No Concerns","Yes","Dose adjustment for size","Yes",,"Yes","OD","HC","No","5mmol TDS","No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,,,,,,,,,,,,,"170.65",,"9269 03/07/2020"
"Doncaster - DBTH","United Kingdom",9269,"United Kingdom","Active","29/06/2017","09/06/2017","Male",3320,,,"Yes","Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"19/06/2017",154.5,173.8,9269,"< 1 month",,,,,,,"11/03/2021",15.6,99.7,,,15.69,0.66,,,,,,,,,,,,,,,,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No Concerns","Yes","Dose adjustment for size","Yes",,"Yes","OD","HC","No","5mmol TDS","No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,,,,,,,,,,,,,"170.65",,"9269 11/03/2021"
"Doncaster - DBTH","United Kingdom",9269,"United Kingdom","Active","29/06/2017","09/06/2017","Male",3320,,,"Yes","Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"19/06/2017",154.5,173.8,9269,"< 1 month",,,,,,,"19/05/2022",17,108.8,,,14.36,0.72,,,88,58,,,,,,,,,,,,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No Concerns","Yes","Dose adjustment for size","Yes",,"Yes","OD","HC","No","5mmol TDS","No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,,,,,,,,,,,,,"170.65",,"9269 19/05/2022"
"Doncaster - DBTH","United Kingdom",9269,"United Kingdom","Active","29/06/2017","09/06/2017","Male",3320,,,"Yes","Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"19/06/2017",154.5,173.8,9269,"< 1 month",,,,,,,"01/03/2023",18.25,114.3,,,13.97,0.76,,,87,54,,,,,,,,,,,,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No Concerns","Yes","Dose adjustment for size","Yes",,"Yes","OD","HC","No","5mmol TDS","No",,"No",,"No",,"No",,"No",,"No",,"No",,"13/07/2023",8.21,,,,,,,,,,,,,,,,,,"170.65",,"9269 01/03/2023"
"Doncaster - DBTH","United Kingdom",9269,"United Kingdom","Active","29/06/2017","09/06/2017","Male",3320,,,"Yes","Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"19/06/2017",154.5,173.8,9269,"< 1 month",,,,,,,"16/11/2023",19.3,119.8,,,13.45,0.8,,,92,60,,,,,,,,,,,,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No Concerns","Yes","Dose adjustment for size","Yes",,"Yes","TDS","HC","No","5mmol TDS","No",,"No",,"No",,"No",,"No",,"No",,"No",,"13/07/2023",8.21,,,,,,,,,,,,,,,,,,"170.65",,"9269 16/11/2023"
"Edinburgh - RHC","United Kingdom",8499,"United Kingdom","Active","01/06/2014","21/05/2014","Male",2400,,"41 weeks","Yes","Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"01/06/2014",151.8,,8499,"< 1 month",,"No",,"Normal Male",,,"02/05/2023",27.8,116.6,,,20.45,0.95,"No","No",106,67,,,,,,,,,,,,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,,,,,"Yes",,,,,,,,"Yes","Sensory issues
1:1 help at school
Limited diet","No Concerns","Yes","Not Applicable","Yes","13.68 mg/m2/day","Yes","OD","HC","No","NaCL 5 mmol 4 times a day","No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,,,,,,,,,,,,,,,"8499 02/05/2023"
"Edinburgh - RHC","United Kingdom",8499,"United Kingdom","Active","01/06/2014","21/05/2014","Male",2400,,"41 weeks","Yes","Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"01/06/2014",151.8,,8499,"< 1 month",,"No",,"Normal Male",,,"25/01/2022",20.8,111.9,,,16.61,0.8,"No","No",,,,,,,,,,,,,,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,,,,,"Yes",,,,,,,,"Yes","Sensory issues
1:1 help at school
Limited diet","No Concerns","Yes","Dose adjustment for size","Yes","12.8 mg/m2/day","Yes","BD","HC","No","NaCL 5 mmol 4 times a day","No",,"No",,"No",,"No",,"No",,"No",,"No",,"25/01/2022",6.1,"TW20","Not Known",,,,,,,,,,,,,,,,,,"8499 25/01/2022"
"Edinburgh - RHC","United Kingdom",8499,"United Kingdom","Active","01/06/2014","21/05/2014","Male",2400,,"41 weeks","Yes","Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"01/06/2014",151.8,,8499,"< 1 month",,"No",,"Normal Male",,,"16/10/2020",19.1,106.3,,,16.9,0.75,"No","No",,,,,,,,,,,,,,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,,,,,"Yes",,,,,,,,"Yes","Sensory issues
1:1 help at school
Limited diet","No Concerns","Yes","Dose adjustment for size","Yes","12.8 mg/m2/day","Yes","OD","HC","No","NaCL 5 mmol 4 times a day","No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,,,,,,,,,,,,,,,"8499 16/10/2020"
"Edinburgh - RHC","United Kingdom",8499,"United Kingdom","Active","01/06/2014","21/05/2014","Male",2400,,"41 weeks","Yes","Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"01/06/2014",151.8,,8499,"< 1 month",,"No",,"Normal Male",,,"26/07/2017",14.2,86.3,,,19.07,0.58,"No","No",72,37,,,,,,,,,,,,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,,,,,"Yes",,,,,,,,"Yes","Sensory issues
1:1 help at school
Limited diet","No Concerns","No","Not Applicable","Yes","13.68 mg/m2/day","Yes","OD","HC","No","NaCL 5 mmol 4 times a day","No",,"No",,"No",,"No",,"No",,"No",,"No",,"25/07/2017",3.13,"TW20",,,,,,,,,,,,,,,,,,,"8499 26/07/2017"
"Edinburgh - RHC","United Kingdom",8499,"United Kingdom","Active","01/06/2014","21/05/2014","Male",2400,,"41 weeks","Yes","Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"01/06/2014",151.8,,8499,"< 1 month",,"No",,"Normal Male",,,"29/08/2023",27.6,117.5,,,19.99,0.95,"Yes","No",105,80,"Mum has short stature 
No skeletal disproportion 
For genetic review
Previous low IGF 1 latest IGF 1 in normal range.",,,,,,,,,,,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,,,,,"Yes",,,,,,,,"Yes","Sensory issues
1:1 help at school
Limited diet","No Concerns","No","Not Applicable","Yes","13.68 mg/m2/day","Yes","OD","HC","No","NaCL 5 mmol 4 times a day","No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,"1","1","1",,,,,,,,,,,,"8499 29/08/2023"
"Edinburgh - RHC","United Kingdom",8500,"United Kingdom","Active","10/12/2014","10/12/2014","Not assigned",3220,,"38 weeks","Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"03/12/2014",164,180,8500,"< 1 month",,"No",,"III",,,"07/03/2023",32.2,134.8,,,17.72,1.1,,"No",107,63,,"1","1","1",,,,,,,,"Yes",,"No",,"No",,"No",,"No",,"No",,"No",,"Not known",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No Concerns","Yes","Dose adjustment for size","Yes",,"Yes","BD","HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"01/11/2022",9.8,"TW20","Not Known",,,,,,,,,,,,,,,,"(Male) 178.5 (Female) 165.5",,"8500 07/03/2023"
"Edinburgh - RHC","United Kingdom",8500,"United Kingdom","Active","10/12/2014","10/12/2014","Not assigned",3220,,"38 weeks","Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"03/12/2014",164,180,8500,"< 1 month",,"No",,"III",,,"05/07/2022",29.1,130.2,,,17.17,1.03,"No","No",109,63,"GnRH test 24/11/21 no CPP","1","1","1",,,,,,,,"Yes",,"No",,"No",,"No",,"No",,"No",,"No",,"Not known",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No Concerns","No",,"Yes",,"Yes","BD","HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"01/11/2022",9.8,"TW20","Not Known",,,,,,,,,,,,,,,,"(Male) 178.5 (Female) 165.5",,"8500 05/07/2022"
"Edinburgh - RHC","United Kingdom",8500,"United Kingdom","Active","10/12/2014","10/12/2014","Not assigned",3220,,"38 weeks","Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"03/12/2014",164,180,8500,"< 1 month",,"No",,"III",,,"26/10/2021",25.5,125,,,16.32,0.94,"No","No",107,71,"Increased height velocity and breast buds - GnRH test FSH response only - premature thelarche","2","1","1",,,,,,,,"Yes",,"No",,"No",,"No",,"No",,"No",,"No",,"Not known",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No Concerns","Yes","Undertreatment","Yes",,"Yes","BD","HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"26/10/2022",8.92,"TW20","Not Known",,,,,,,,,,,,,,,,"(Male) 178.5 (Female) 165.5",,"8500 26/10/2021"
"Edinburgh - RHC","United Kingdom",8500,"United Kingdom","Active","10/12/2014","10/12/2014","Not assigned",3220,,"38 weeks","Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"03/12/2014",164,180,8500,"< 1 month",,"No",,"III",,,"24/11/2020",21.2,117.6,,,15.33,0.83,"No","No",,,,"1","1","1",,,,,,,,"Yes",,"No",,"No",,"No",,"No",,"No",,"No",,"Not known",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No Concerns","No","Dose adjustment for size","Yes",,"Yes","BD","HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"24/11/2020",7.3,"TW20","Not Known",,,,,,,,,,,,,,,,"(Male) 178.5 (Female) 165.5",,"8500 24/11/2020"
"Edinburgh - RHC","United Kingdom",8500,"United Kingdom","Active","10/12/2014","10/12/2014","Not assigned",3220,,"38 weeks","Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"03/12/2014",164,180,8500,"< 1 month",,"No",,"III",,,"25/07/2023",31,136.5,,,16.64,1.08,"No","No",102,69,"Premature thelarche several GnRh tests FSH response only.
Normal prepubertal ht vel 4.4 cm/yr","2","1","1",,,"No",,,,,"Yes",,"No",,"No",,"No",,"No",,"No",,"No",,"Not known",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No Concerns","Yes","Other","Yes","changed form liquid to tablets/ dissolved tablets","Yes","BD","HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"01/11/2022",9.8,"TW20","Not Known",,,,,,,,,,,,,,,,"(Male) 178.5 (Female) 165.5",,"8500 25/07/2023"
"Glasgow - RHC","United Kingdom",1442,"United Kingdom",,,"25/11/2005","Male",,,,,"Male","Presumed XY",,"Disorder of androgen excess","21-hydroxylase def (CYP21A)",,,,,1442,,,,"- Not convinced that he is a salt loser
- Presented with virilisation; renin at upper end of normal at presentation
- Compound heterozygous for mutations that may be associated with salt losing CAH
- Now has prec puberty; on triptorelin

","Normal Male",,,"08/02/2016",58.05,165.2,,,21.27,1.63,"Not known","Not known",,,,,,,,,,,,,,"Not known",,"Not known",,"Not known",,"No",,"Not known",,"Not known",,"No",,"Not known",,"Not known",,"Not known",,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"No Concerns","No","Not Applicable","Yes",,"Yes","OD","HC","Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,,,,,,,,,,,,"Not known",,,,,,,,"1442 08/02/2016"
"Glasgow - RHC","United Kingdom",1442,"United Kingdom",,,"25/11/2005","Male",,,,,"Male","Presumed XY",,"Disorder of androgen excess","21-hydroxylase def (CYP21A)",,,,,1442,,,,"- Not convinced that he is a salt loser
- Presented with virilisation; renin at upper end of normal at presentation
- Compound heterozygous for mutations that may be associated with salt losing CAH
- Now has prec puberty; on triptorelin

","Normal Male",,,"08/08/2016",53.65,167.7,,,19.08,1.58,"Not known","Not known",,,,,,,,,,,,,,"Not known",,"Not known",,"Not known",,"No",,"Not known",,"Not known",,"No",,"Not known",,"Not known",,"Not known",,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"No Concerns","No","Not Applicable","Yes",,"Yes","OD","HC","Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,,,,,,,,,,,,"Not known",,,,,,,,"1442 08/08/2016"
"Glasgow - RHC","United Kingdom",1442,"United Kingdom",,,"25/11/2005","Male",,,,,"Male","Presumed XY",,"Disorder of androgen excess","21-hydroxylase def (CYP21A)",,,,,1442,,,,"- Not convinced that he is a salt loser
- Presented with virilisation; renin at upper end of normal at presentation
- Compound heterozygous for mutations that may be associated with salt losing CAH
- Now has prec puberty; on triptorelin

","Normal Male",,,"12/06/2017",58.4,170.4,,,20.11,1.66,"Not known","Not known",,,,,,,,,,,,,,"Not known",,"Not known",,"Not known",,"No",,"Not known",,"Not known",,"No",,"Not known",,"Not known",,"Not known",,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"No Concerns","Yes","Dose adjustment for size","Yes",,"Yes","OD","HC","Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,,,,,,,,,,,,"Not known",,,,,,,,"1442 12/06/2017"
"Glasgow - RHC","United Kingdom",1442,"United Kingdom",,,"25/11/2005","Male",,,,,"Male","Presumed XY",,"Disorder of androgen excess","21-hydroxylase def (CYP21A)",,,,,1442,,,,"- Not convinced that he is a salt loser
- Presented with virilisation; renin at upper end of normal at presentation
- Compound heterozygous for mutations that may be associated with salt losing CAH
- Now has prec puberty; on triptorelin

","Normal Male",,,"09/10/2018",62.15,171.4,,,21.16,1.72,"Not known","Not known",,,,,,,,,,,,,,"Not known",,"Not known",,"Not known",,"No",,"Not known",,"Not known",,"No",,"Not known",,"Not known",,"Not known",,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"No Concerns","Yes","Other","Yes",,"Yes","OD","HC","Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,,,,,,,,,,,,"Not known",,,,,,,,"1442 09/10/2018"
"Glasgow - RHC","United Kingdom",1442,"United Kingdom",,,"25/11/2005","Male",,,,,"Male","Presumed XY",,"Disorder of androgen excess","21-hydroxylase def (CYP21A)",,,,,1442,,,,"- Not convinced that he is a salt loser
- Presented with virilisation; renin at upper end of normal at presentation
- Compound heterozygous for mutations that may be associated with salt losing CAH
- Now has prec puberty; on triptorelin

","Normal Male",,,"09/09/2019",64.4,172.5,,,21.64,1.76,,,117,76,,,,,,,,,,,,"Not known",,"Not known",,"Not known",,"No",,"Not known",,"Not known",,"No",,"Not known",,"Not known",,"Not known",,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"No Concerns","Yes","Undertreatment","Yes","7.5 mg/ 2.5 mg/ 5 mg","Yes","OD","HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,,,,,,,"Not known",,,,,,,,"1442 09/09/2019"
"Glasgow - RHC","United Kingdom",1442,"United Kingdom",,,"25/11/2005","Male",,,,,"Male","Presumed XY",,"Disorder of androgen excess","21-hydroxylase def (CYP21A)",,,,,1442,,,,"- Not convinced that he is a salt loser
- Presented with virilisation; renin at upper end of normal at presentation
- Compound heterozygous for mutations that may be associated with salt losing CAH
- Now has prec puberty; on triptorelin

","Normal Male",,,"03/03/2020",67.7,174.5,,,22.23,1.81,,,121,56,,,,,,,,,,,,"Not known",,"Not known",,"Not known",,"No",,"Not known",,"Not known",,"No",,"Not known",,"Not known",,"Not known",,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"No Concerns","No","Undertreatment","Yes","7.5 mg/ 2.5 mg/ 5 mg","Yes","OD","HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,,,,,,,"Not known",,,,,,,,"1442 03/03/2020"
"Glasgow - RHC","United Kingdom",1442,"United Kingdom",,,"25/11/2005","Male",,,,,"Male","Presumed XY",,"Disorder of androgen excess","21-hydroxylase def (CYP21A)",,,,,1442,,,,"- Not convinced that he is a salt loser
- Presented with virilisation; renin at upper end of normal at presentation
- Compound heterozygous for mutations that may be associated with salt losing CAH
- Now has prec puberty; on triptorelin

","Normal Male",,,"18/02/2021",,,,,,,,,,,,,,,,,,,,,,"Not known",,"Not known",,"Not known",,"No",,"Not known",,"Not known",,"No",,"Not known",,"Not known",,"Not known",,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"No Concerns","No","Undertreatment","Yes","7.5 mg/ 2.5 mg/ 5 mg","Yes","OD","HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,,,,,,,"Not known",,,,,,,,"1442 18/02/2021"
"Glasgow - RHC","United Kingdom",1442,"United Kingdom",,,"25/11/2005","Male",,,,,"Male","Presumed XY",,"Disorder of androgen excess","21-hydroxylase def (CYP21A)",,,,,1442,,,,"- Not convinced that he is a salt loser
- Presented with virilisation; renin at upper end of normal at presentation
- Compound heterozygous for mutations that may be associated with salt losing CAH
- Now has prec puberty; on triptorelin

","Normal Male",,,"17/05/2021",66.85,171.4,,,22.76,1.78,,,,,,,,,,,,,,,,"Not known",,"Not known",,"Not known",,"No",,"Not known",,"Not known",,"No",,"Not known",,"Not known",,"Not known",,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"No Concerns","Yes","Other","Yes","5mg TDS","Yes","OD","HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,,,,,,,"Not known",,,,,,,,"1442 17/05/2021"
"Glasgow - RHC","United Kingdom",1443,"United Kingdom",,"04/03/2014","18/02/2014","Male",,,"38 weeks",,"Male","Presumed XY",,"Disorder of androgen excess","21-hydroxylase def (CYP21A)",,,,,1443,"< 1 month",,,"Confirmed mutation
Affected older sister","Normal Male",,,"11/01/2016",8.31,78.2,,,13.59,0.42,"No","No",,,,,,,,,,,,,,"No",,"No","CIRCUMCISION FOR RELIGION
","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No","introduced because salt losing form suspected because poor gain weight","Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No Concerns","No","Not Applicable","Yes",,"No","OD","HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,"1","1","1",,,,"Not known",,,,,,,,"1443 11/01/2016"
"Glasgow - RHC","United Kingdom",1443,"United Kingdom",,"04/03/2014","18/02/2014","Male",,,"38 weeks",,"Male","Presumed XY",,"Disorder of androgen excess","21-hydroxylase def (CYP21A)",,,,,1443,"< 1 month",,,"Confirmed mutation
Affected older sister","Normal Male",,,"11/04/2016",8.92,79.9,,,13.97,0.44,"No","No",106,66,,,,,,,,,,,,"No",,"No","CIRCUMCISION FOR RELIGION
","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No","introduced because salt losing form suspected because poor gain weight","Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No Concerns","Yes","Not Applicable","Yes",,"No","OD","HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,"1","1","1",,,,"Not known",,,,,,,,"1443 11/04/2016"
"Glasgow - RHC","United Kingdom",1443,"United Kingdom",,"04/03/2014","18/02/2014","Male",,,"38 weeks",,"Male","Presumed XY",,"Disorder of androgen excess","21-hydroxylase def (CYP21A)",,,,,1443,"< 1 month",,,"Confirmed mutation
Affected older sister","Normal Male",,,"10/04/2017",12.1,89.8,,,15,0.55,"No","No",,,,,,,,,,,,,,"No",,"No","CIRCUMCISION FOR RELIGION
","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No","introduced because salt losing form suspected because poor gain weight","Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No Concerns","No","Not Applicable","Yes",,"No","OD","HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,"1","1","1",,,,"Not known",,,,,,,,"1443 10/04/2017"
"Glasgow - RHC","United Kingdom",1443,"United Kingdom",,"04/03/2014","18/02/2014","Male",,,"38 weeks",,"Male","Presumed XY",,"Disorder of androgen excess","21-hydroxylase def (CYP21A)",,,,,1443,"< 1 month",,,"Confirmed mutation
Affected older sister","Normal Male",,,"11/09/2017",13.2,94.5,,,14.78,0.59,"No","No",,,,,,,,,,,,,,"No",,"No","CIRCUMCISION FOR RELIGION
","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No","introduced because salt losing form suspected because poor gain weight","Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No Concerns","Yes","Other","Yes",,"No","OD","HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,"1","1","1",,,,"Not known",,,,,,,,"1443 11/09/2017"
"Glasgow - RHC","United Kingdom",1443,"United Kingdom",,"04/03/2014","18/02/2014","Male",,,"38 weeks",,"Male","Presumed XY",,"Disorder of androgen excess","21-hydroxylase def (CYP21A)",,,,,1443,"< 1 month",,,"Confirmed mutation
Affected older sister","Normal Male",,,"11/06/2018",,,,,,,"No","No",,,,,,,,,,,,,,"No",,"No","CIRCUMCISION FOR RELIGION
","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No","introduced because salt losing form suspected because poor gain weight","Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No Concerns","No","Not Applicable","Yes",,"No","OD","HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,"1","1","1",,,,"Not known",,,,,,,,"1443 11/06/2018"
"Glasgow - RHC","United Kingdom",1443,"United Kingdom",,"04/03/2014","18/02/2014","Male",,,"38 weeks",,"Male","Presumed XY",,"Disorder of androgen excess","21-hydroxylase def (CYP21A)",,,,,1443,"< 1 month",,,"Confirmed mutation
Affected older sister","Normal Male",,,"11/11/2019",19.8,117,,,14.46,0.8,"No","No",,,,,,,,,,,,,,"No",,"No","CIRCUMCISION FOR RELIGION
","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No","introduced because salt losing form suspected because poor gain weight","Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No Concerns","Yes","Undertreatment","Yes",,"No","OD","HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,"1","1","1",,,,"Not known",,,,,,,,"1443 11/11/2019"
"Glasgow - RHC","United Kingdom",1443,"United Kingdom",,"04/03/2014","18/02/2014","Male",,,"38 weeks",,"Male","Presumed XY",,"Disorder of androgen excess","21-hydroxylase def (CYP21A)",,,,,1443,"< 1 month",,,"Confirmed mutation
Affected older sister","Normal Male",,,"10/06/2020",,,,,,,"No","No",,,,,,,,,,,,,,"No",,"No","CIRCUMCISION FOR RELIGION
","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No","introduced because salt losing form suspected because poor gain weight","Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No Concerns","No","Undertreatment","Yes",,"No","OD","HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,"1","1","1",,,,"Not known",,,,,,,,"1443 10/06/2020"
"Glasgow - RHC","United Kingdom",1443,"United Kingdom",,"04/03/2014","18/02/2014","Male",,,"38 weeks",,"Male","Presumed XY",,"Disorder of androgen excess","21-hydroxylase def (CYP21A)",,,,,1443,"< 1 month",,,"Confirmed mutation
Affected older sister","Normal Male",,,"07/06/2021",,,,,,,"No","No",,,,,,,,,,,,,,"No",,"No","CIRCUMCISION FOR RELIGION
","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No","introduced because salt losing form suspected because poor gain weight","Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No Concerns","No","Undertreatment","Yes",,"No","OD","HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,"1","1","1",,,,"Not known",,,,,,,,"1443 07/06/2021"
"Glasgow - RHC","United Kingdom",1443,"United Kingdom",,"04/03/2014","18/02/2014","Male",,,"38 weeks",,"Male","Presumed XY",,"Disorder of androgen excess","21-hydroxylase def (CYP21A)",,,,,1443,"< 1 month",,,"Confirmed mutation
Affected older sister","Normal Male",,,"06/12/2021",27.7,137.1,,,14.74,1.03,"No","No",,,,,,,,,,,,,,"No",,"No","CIRCUMCISION FOR RELIGION
","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No","introduced because salt losing form suspected because poor gain weight","Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No Concerns","Yes","Undertreatment","Yes",,"No","OD","HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,"1","1","1",,,,"Not known",,,,,,,,"1443 06/12/2021"
"Glasgow - RHC","United Kingdom",1443,"United Kingdom",,"04/03/2014","18/02/2014","Male",,,"38 weeks",,"Male","Presumed XY",,"Disorder of androgen excess","21-hydroxylase def (CYP21A)",,,,,1443,"< 1 month",,,"Confirmed mutation
Affected older sister","Normal Male",,,"14/03/2022",29.2,139.4,,,15.03,1.06,"No","No",,,,,,,,,,,,,,"No",,"No","CIRCUMCISION FOR RELIGION
","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No","introduced because salt losing form suspected because poor gain weight","Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No Concerns","No","Undertreatment","Yes",,"No","OD","HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,"1","1","1",,,,"Not known",,,,,,,,"1443 14/03/2022"
"Glasgow - RHC","United Kingdom",1443,"United Kingdom",,"04/03/2014","18/02/2014","Male",,,"38 weeks",,"Male","Presumed XY",,"Disorder of androgen excess","21-hydroxylase def (CYP21A)",,,,,1443,"< 1 month",,,"Confirmed mutation
Affected older sister","Normal Male",,,"14/01/2019",17.3,109.2,,,14.51,0.72,"No","No",,,,,,,,,,,,,,"No",,"No","CIRCUMCISION FOR RELIGION
","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No","introduced because salt losing form suspected because poor gain weight","Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No Concerns","No","Undertreatment","Yes",,"No","OD","HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"14/01/2019",8.65,"Radius-ulna-short bone","Not Known",,,,"1","1","1",,,,"Not known",,,,,,,,"1443 14/01/2019"
"Glasgow - RHC","United Kingdom",1443,"United Kingdom",,"04/03/2014","18/02/2014","Male",,,"38 weeks",,"Male","Presumed XY",,"Disorder of androgen excess","21-hydroxylase def (CYP21A)",,,,,1443,"< 1 month",,,"Confirmed mutation
Affected older sister","Normal Male",,,"31/01/2020",,,,,,,"No","No",,,,,,,,,,,,,,"No",,"No","CIRCUMCISION FOR RELIGION
","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No","introduced because salt losing form suspected because poor gain weight","Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No Concerns","Yes","Undertreatment","Yes",,"No","OD","HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,,,,,,,"Not known",,,,,,,,"1443 31/01/2020"
"Glasgow - RHC","United Kingdom",1444,"United Kingdom",,,"26/07/2011","Female",,,,,"Female","46 XX",,"Disorder of androgen excess","21-hydroxylase def (CYP21A)",,,,,1444,,,,"Genetic confirmation
Results not available just now
Jointly managed with London GOS (Brain)","IV",,,"14/03/2016",27.25,114.3,,,20.86,0.93,"Not known","Not known",113,58,,,,,,,,,,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"No Concerns","Yes","Not Applicable","Yes",,"Yes","OD","HC","Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,,,,,,,,,,,,"Not known",,,,,,,,"1444 14/03/2016"
"Glasgow - RHC","United Kingdom",1444,"United Kingdom",,,"26/07/2011","Female",,,,,"Female","46 XX",,"Disorder of androgen excess","21-hydroxylase def (CYP21A)",,,,,1444,,,,"Genetic confirmation
Results not available just now
Jointly managed with London GOS (Brain)","IV",,,"13/11/2016",29.85,120.9,,,20.42,1,"Not known","Not known",,,,,,,,,,,,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known","was previously increased to 115mg but reduced on visit to London due to ?hypertension",,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"No Concerns","Yes","Not Applicable","Yes",,"Yes","OD","HC","Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,,,,,,,,,,,,"Not known",,,,,,,,"1444 13/11/2016"
"Glasgow - RHC","United Kingdom",1444,"United Kingdom",,,"26/07/2011","Female",,,,,"Female","46 XX",,"Disorder of androgen excess","21-hydroxylase def (CYP21A)",,,,,1444,,,,"Genetic confirmation
Results not available just now
Jointly managed with London GOS (Brain)","IV",,,"18/07/2017",32.7,124.3,,,21.16,1.06,"Not known","Not known",97,79,,,,,,,,,,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"No Concerns","Yes","Other","Yes",,"Yes","OD","HC","Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,,,,,,,,,,,,"Not known",,,,,,,,"1444 18/07/2017"
"Glasgow - RHC","United Kingdom",1444,"United Kingdom",,,"26/07/2011","Female",,,,,"Female","46 XX",,"Disorder of androgen excess","21-hydroxylase def (CYP21A)",,,,,1444,,,,"Genetic confirmation
Results not available just now
Jointly managed with London GOS (Brain)","IV",,,"08/01/2018",34.4,128.1,,,20.96,1.11,"Not known","Not known",,,,,,,,,,,,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"No Concerns","Yes","Not Applicable","Yes",,"Yes","OD","HC","Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,,,,,,,,,,,,"Not known",,,,,,,,"1444 08/01/2018"
"Glasgow - RHC","United Kingdom",1444,"United Kingdom",,,"26/07/2011","Female",,,,,"Female","46 XX",,"Disorder of androgen excess","21-hydroxylase def (CYP21A)",,,,,1444,,,,"Genetic confirmation
Results not available just now
Jointly managed with London GOS (Brain)","IV",,,"12/07/2018",38.2,132.4,,,21.79,1.19,"Not known","Not known",101,60,,,,,,,,,,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"No Concerns","No","Not Applicable","Yes",,"Yes","OD","HC","Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,,,,,,,,,,,,"Not known",,,,,,,,"1444 12/07/2018"
"Glasgow - RHC","United Kingdom",1444,"United Kingdom",,,"26/07/2011","Female",,,,,"Female","46 XX",,"Disorder of androgen excess","21-hydroxylase def (CYP21A)",,,,,1444,,,,"Genetic confirmation
Results not available just now
Jointly managed with London GOS (Brain)","IV",,,"06/03/2019",,,,,,,"Not known","Not known",,,,,,,,,,,,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"No Concerns","Yes","Not Applicable","Yes",,"Yes","OD","HC","Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,,,,,,,,,,,,"Not known",,,,,,,,"1444 06/03/2019"
"Glasgow - RHC","United Kingdom",1444,"United Kingdom",,,"26/07/2011","Female",,,,,"Female","46 XX",,"Disorder of androgen excess","21-hydroxylase def (CYP21A)",,,,,1444,,,,"Genetic confirmation
Results not available just now
Jointly managed with London GOS (Brain)","IV",,,"16/11/2020",41.6,139.9,,,21.25,1.27,"Not known","Not known",102,67,,,,,,,,,,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"No Concerns","Yes","Undertreatment","Yes",,"Yes","OD","HC","Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,,,,,,,,,,,,"Not known",,,,,,,,"1444 16/11/2020"
"Glasgow - RHC","United Kingdom",1444,"United Kingdom",,,"26/07/2011","Female",,,,,"Female","46 XX",,"Disorder of androgen excess","21-hydroxylase def (CYP21A)",,,,,1444,,,,"Genetic confirmation
Results not available just now
Jointly managed with London GOS (Brain)","IV",,,"11/04/2021",46.6,143.7,,,22.57,1.36,,,,,,"1","2",,,,,,,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"No Concerns","Not known","Undertreatment","Yes",,"Yes","OD","HC","Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,,,,,,,,,,,,"Not known",,,,,,,,"1444 11/04/2021"
"Glasgow - RHC","United Kingdom",1444,"United Kingdom",,,"26/07/2011","Female",,,,,"Female","46 XX",,"Disorder of androgen excess","21-hydroxylase def (CYP21A)",,,,,1444,,,,"Genetic confirmation
Results not available just now
Jointly managed with London GOS (Brain)","IV",,,"08/11/2021",51,146.4,,,23.8,1.44,"No","No",110,72,,"1","2",,,,,,,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"No Concerns","Yes","Other","Yes",,"Yes","OD","HC","Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,,,,,,,,,,,,"Not known",,,,,,,,"1444 08/11/2021"
"Glasgow - RHC","United Kingdom",1450,"United Kingdom",,,"18/02/2014","Male",,,,,"Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,,,1450,,,,"NaCl supps 0.2mls TDS (May 2014)","Normal Male",,,"17/06/2016",,,,,,,"No","No",,,,,,,,,,,,,,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No","Constipation resolved","No Concerns","Yes","Dose adjustment for size","Yes",,"Yes","OD","HC","No","NaCl 0.4 mls bd","No",,"No",,"No",,"No",,"No",,"No",,"No","Salt stopped 6 weeks ago. Movicol stopped too",,,,,,,,,,,,,,"Not known",,,,,,,,"1450 17/06/2016"
"Glasgow - RHC","United Kingdom",1450,"United Kingdom",,,"18/02/2014","Male",,,,,"Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,,,1450,,,,"NaCl supps 0.2mls TDS (May 2014)","Normal Male",,,"10/10/2016",14.6,91.4,,,17.48,0.61,"No","No",,,,,,,,,,,,,,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No","Constipation resolved","No Concerns","Yes","Undertreatment","Yes","1.6 mg  3 times ","Yes","OD","HC","No","NaCl 0.4 mls bd","No",,"No",,"No",,"No",,"No",,"No",,"No","Salt stopped 6 weeks ago. Movicol stopped too",,,,,,,,,,,,,,"Not known",,,,,,,,"1450 10/10/2016"
"Glasgow - RHC","United Kingdom",1450,"United Kingdom",,,"18/02/2014","Male",,,,,"Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,,,1450,,,,"NaCl supps 0.2mls TDS (May 2014)","Normal Male",,,"01/06/2017",16.15,97,,,17.16,0.66,"No","No",101,44,,,,,,,,,,,,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No","Constipation resolved","No Concerns","No","Not Applicable","Yes",,"Yes","OD","HC","No","NaCl 0.4 mls bd","No",,"No",,"No",,"No",,"No",,"No",,"No","Salt stopped 6 weeks ago. Movicol stopped too",,,,,,,,,,,,,,"Not known",,,,,,,,"1450 01/06/2017"
"Glasgow - RHC","United Kingdom",1450,"United Kingdom",,,"18/02/2014","Male",,,,,"Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,,,1450,,,,"NaCl supps 0.2mls TDS (May 2014)","Normal Male",,,"13/11/2017",16.9,100,,,16.9,0.69,"No","No",92,54,,,,,,,,,,,,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No","Constipation resolved","No Concerns","No","Not Applicable","Yes",,"Yes","OD","HC","No","NaCl 0.4 mls bd","No",,"No",,"No",,"No",,"No",,"No",,"No","Salt stopped 6 weeks ago. Movicol stopped too",,,,,,,,,,,,,,"Not known",,,,,,,,"1450 13/11/2017"
"Glasgow - RHC","United Kingdom",1450,"United Kingdom",,,"18/02/2014","Male",,,,,"Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,,,1450,,,,"NaCl supps 0.2mls TDS (May 2014)","Normal Male",,,"12/11/2018",18.1,107,,,15.81,0.73,"No","No",100,62,,,,,,,,,,,,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No","Constipation resolved","No Concerns","No","Not Applicable","Yes",,"Yes","OD","HC","No","NaCl 0.4 mls bd","No",,"No",,"No",,"No",,"No",,"No",,"No","Salt stopped 6 weeks ago. Movicol stopped too",,,,,,,,,,,,,,"Not known",,,,,,,,"1450 12/11/2018"
"Glasgow - RHC","United Kingdom",1450,"United Kingdom",,,"18/02/2014","Male",,,,,"Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,,,1450,,,,"NaCl supps 0.2mls TDS (May 2014)","Normal Male",,,"23/03/2020",,,,,,,"No","No",,,,,,,,,,,,,,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No","Constipation resolved","No Concerns","No","Not Applicable","Yes",,"Yes","OD","HC","No","NaCl 0.4 mls bd","No",,"No",,"No",,"No",,"No",,"No",,"No","Salt stopped 6 weeks ago. Movicol stopped too",,,,,,,,,,,,,,"Not known",,,,,,,,"1450 23/03/2020"
"Glasgow - RHC","United Kingdom",1450,"United Kingdom",,,"18/02/2014","Male",,,,,"Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,,,1450,,,,"NaCl supps 0.2mls TDS (May 2014)","Normal Male",,,"08/02/2021",26.3,124.2,,,17.05,0.95,,,,,,,,,,,,,,,,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No","Constipation resolved","No Concerns","No","Not Applicable","Yes",,"Yes","OD","HC","No","NaCl 0.4 mls bd","No",,"No",,"No",,"No",,"No",,"No",,"No","Salt stopped 6 weeks ago. Movicol stopped too",,,,,,,,,,,,,,"Not known",,,,,,,,"1450 08/02/2021"
"Glasgow - RHC","United Kingdom",1450,"United Kingdom",,,"18/02/2014","Male",,,,,"Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,,,1450,,,,"NaCl supps 0.2mls TDS (May 2014)","Normal Male",,,"15/11/2021",28.3,127.5,,,17.41,1,,,,,,,,,,,,,,,,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No","Constipation resolved","No Concerns","No","Not Applicable","Yes",,"Yes","OD","HC","No","NaCl 0.4 mls bd","No",,"No",,"No",,"No",,"No",,"No",,"No","Salt stopped 6 weeks ago. Movicol stopped too",,,,,,,,,,,,,,"Not known",,,,,,,,"1450 15/11/2021"
"Glasgow - RHC","United Kingdom",1450,"United Kingdom",,,"18/02/2014","Male",,,,,"Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,,,1450,,,,"NaCl supps 0.2mls TDS (May 2014)","Normal Male",,,"13/09/2022",,,,,,,,,,,,,,,,,,,,,,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No","Constipation resolved","No Concerns","No","Not Applicable","Yes",,"Yes","OD","HC","No","NaCl 0.4 mls bd","No",,"No",,"No",,"No",,"No",,"No",,"No","Salt stopped 6 weeks ago. Movicol stopped too",,,,,,,,,,,,,,"Not known",,,,,,,,"1450 13/09/2022"
"Glasgow - RHC","United Kingdom",1450,"United Kingdom",,,"18/02/2014","Male",,,,,"Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,,,1450,,,,"NaCl supps 0.2mls TDS (May 2014)","Normal Male",,,"16/01/2023",33.25,135,,,18.24,1.12,,,,,,,,,,,,,,,,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No","Constipation resolved","No Concerns","No","Not Applicable","Yes",,"Yes","OD","HC","No","NaCl 0.4 mls bd","No",,"No",,"No",,"No",,"No",,"No",,"No","Salt stopped 6 weeks ago. Movicol stopped too",,,,,,,,,,,,,,"Not known",,,,,,,,"1450 16/01/2023"
"Glasgow - RHC","United Kingdom",1450,"United Kingdom",,,"18/02/2014","Male",,,,,"Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,,,1450,,,,"NaCl supps 0.2mls TDS (May 2014)","Normal Male",,,"17/07/2023",34.4,138.5,,,17.93,1.15,,,,,,,,,,,,,,,,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No","Constipation resolved","No Concerns","No","Not Applicable","Yes",,"Yes","OD","HC","No","NaCl 0.4 mls bd","No",,"No",,"No",,"No",,"No",,"No",,"No","Salt stopped 6 weeks ago. Movicol stopped too",,,,,,,,,,,,,,"Not known",,,,,,,,"1450 17/07/2023"
"Glasgow - RHC","United Kingdom",2043,"United Kingdom",,"23/06/2013","23/03/2013","Female",,,"37 weeks",,"Female","46 XX",,"Disorder of androgen excess","21-hydroxylase def (CYP21A)",,,,,2043,"1 - 3 months",,,,"I",,,"08/02/2016",15.24,92.4,,,17.85,0.63,"No","Not known",,,,,,,,,,,,,,"Yes",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,,"No","Not Applicable",,,"Yes","OD","HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"08/02/2016",3,"Radius-ulna-short bone","Not Known",,,,,,,,,,,,,,,,,,"2043 08/02/2016"
"Glasgow - RHC","United Kingdom",2043,"United Kingdom",,"23/06/2013","23/03/2013","Female",,,"37 weeks",,"Female","46 XX",,"Disorder of androgen excess","21-hydroxylase def (CYP21A)",,,,,2043,"1 - 3 months",,,,"I",,,"08/08/2016",16.04,96.6,,,17.19,0.66,"No","Not known",,,,,,,,,,,,,,"Yes",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No Concerns","No","Not Applicable","Yes",,"Yes","OD","HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,,,,,,,,,,,,,,,"2043 08/08/2016"
"Glasgow - RHC","United Kingdom",2043,"United Kingdom",,"23/06/2013","23/03/2013","Female",,,"37 weeks",,"Female","46 XX",,"Disorder of androgen excess","21-hydroxylase def (CYP21A)",,,,,2043,"1 - 3 months",,,,"I",,,"10/04/2017",18.44,101.7,,,17.83,0.72,"No","Not known",114,73,,,,,,,,,,,,"Yes",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No Concerns","No","Not Applicable","Yes",,"Yes","OD","HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,,,,,,,,,,,,,,,"2043 10/04/2017"
"Glasgow - RHC","United Kingdom",2043,"United Kingdom",,"23/06/2013","23/03/2013","Female",,,"37 weeks",,"Female","46 XX",,"Disorder of androgen excess","21-hydroxylase def (CYP21A)",,,,,2043,"1 - 3 months",,,,"I",,,"27/07/2017",,,,,,,"No","Not known",,,,,,,,,,,,,,"Yes",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No Concerns","No","Not Applicable","Yes",,"Yes","OD","HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,,,,,,,,,,,,,,,"2043 27/07/2017"
"Glasgow - RHC","United Kingdom",2043,"United Kingdom",,"23/06/2013","23/03/2013","Female",,,"37 weeks",,"Female","46 XX",,"Disorder of androgen excess","21-hydroxylase def (CYP21A)",,,,,2043,"1 - 3 months",,,,"I",,,"30/10/2017",19.7,105.6,,,17.67,0.76,"No","Not known",,,,,,,,,,,,,,"Yes",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No Concerns","Yes","Not Applicable","Yes",,"Yes","OD","HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,,,,,,,,,,,,,,,"2043 30/10/2017"
"Glasgow - RHC","United Kingdom",2043,"United Kingdom",,"23/06/2013","23/03/2013","Female",,,"37 weeks",,"Female","46 XX",,"Disorder of androgen excess","21-hydroxylase def (CYP21A)",,,,,2043,"1 - 3 months",,,,"I",,,"30/07/2018",19.7,105.6,,,17.67,0.76,"No","Not known",,,,,,,,,,,,,,"Yes",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No Concerns","Yes","Other","Yes",,"Yes","OD","HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,,,,,,,,,,,,,,,"2043 30/07/2018"
"Glasgow - RHC","United Kingdom",2043,"United Kingdom",,"23/06/2013","23/03/2013","Female",,,"37 weeks",,"Female","46 XX",,"Disorder of androgen excess","21-hydroxylase def (CYP21A)",,,,,2043,"1 - 3 months",,,,"I",,,"11/02/2019",23.9,117.3,,,17.37,0.88,"No","Not known",103,60,,,,,,,,,,,,"Yes",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No Concerns","Yes","Other","Yes",,"Yes","OD","HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,,,,,,,,,,,,,,,"2043 11/02/2019"
"Glasgow - RHC","United Kingdom",2043,"United Kingdom",,"23/06/2013","23/03/2013","Female",,,"37 weeks",,"Female","46 XX",,"Disorder of androgen excess","21-hydroxylase def (CYP21A)",,,,,2043,"1 - 3 months",,,,"I",,,"26/08/2019",26.5,121.3,,,18.01,0.94,"No","Not known",118,63,,,,,,,,,,,,"Yes",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No Concerns","Yes","Other","Yes",,"Yes","OD","HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,,,,,,,,,,,,,,,"2043 26/08/2019"
"Glasgow - RHC","United Kingdom",2043,"United Kingdom",,"23/06/2013","23/03/2013","Female",,,"37 weeks",,"Female","46 XX",,"Disorder of androgen excess","21-hydroxylase def (CYP21A)",,,,,2043,"1 - 3 months",,,,"I",,,"10/02/2020",27.35,125.4,,,17.39,0.98,"No","Not known",106,51,,,,,,,,,,,,"Yes",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No Concerns","Yes","Undertreatment","Yes",,"Yes","OD","HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,,,,,,,,,,,,,,,"2043 10/02/2020"
"Glasgow - RHC","United Kingdom",2043,"United Kingdom",,"23/06/2013","23/03/2013","Female",,,"37 weeks",,"Female","46 XX",,"Disorder of androgen excess","21-hydroxylase def (CYP21A)",,,,,2043,"1 - 3 months",,,,"I",,,"10/08/2020",30.95,129,,,18.6,1.05,"No","Not known",111,39,,,,,,,,,,,,"Yes",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No Concerns","Yes","Undertreatment","Yes",,"Yes","OD","HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,,,,,,,,,,,,,,,"2043 10/08/2020"
"Glasgow - RHC","United Kingdom",2043,"United Kingdom",,"23/06/2013","23/03/2013","Female",,,"37 weeks",,"Female","46 XX",,"Disorder of androgen excess","21-hydroxylase def (CYP21A)",,,,,2043,"1 - 3 months",,,,"I",,,"22/02/2021",34.1,132.4,,,19.45,1.12,"No","Not known",,,,,,,,,,,,,,"Yes",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No Concerns","Yes","Undertreatment","Yes",,"Yes","OD","HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,,,,,,,,,,,,,,,"2043 22/02/2021"
"Glasgow - RHC","United Kingdom",2043,"United Kingdom",,"23/06/2013","23/03/2013","Female",,,"37 weeks",,"Female","46 XX",,"Disorder of androgen excess","21-hydroxylase def (CYP21A)",,,,,2043,"1 - 3 months",,,,"I",,,"13/09/2021",37.8,135.3,,,20.65,1.19,"No","Not known",,,,,,,,,,,,,,"Yes",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No Concerns","Yes","Undertreatment","Yes",,"Yes","OD","HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,,,,,,,,,,,,,,,"2043 13/09/2021"
"Glasgow - RHC","United Kingdom",2043,"United Kingdom",,"23/06/2013","23/03/2013","Female",,,"37 weeks",,"Female","46 XX",,"Disorder of androgen excess","21-hydroxylase def (CYP21A)",,,,,2043,"1 - 3 months",,,,"I",,,"21/03/2022",40.6,137.3,,,21.54,1.24,"No","Not known",104,71,,,,,,,,,,,,"Yes",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No Concerns","No","Undertreatment","Yes",,"Yes","OD","HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,,,,,,,,,,,,,,,"2043 21/03/2022"
"Glasgow - RHC","United Kingdom",2043,"United Kingdom",,"23/06/2013","23/03/2013","Female",,,"37 weeks",,"Female","46 XX",,"Disorder of androgen excess","21-hydroxylase def (CYP21A)",,,,,2043,"1 - 3 months",,,,"I",,,"03/10/2022",40.05,139.7,,,20.52,1.25,"No","Not known",,,,,,,,,,,,,,"Yes",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No Concerns","No","Undertreatment","Yes",,"Yes","OD","HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,,,,,,,,,,,,,,,"2043 03/10/2022"
"Glasgow - RHC","United Kingdom",2043,"United Kingdom",,"23/06/2013","23/03/2013","Female",,,"37 weeks",,"Female","46 XX",,"Disorder of androgen excess","21-hydroxylase def (CYP21A)",,,,,2043,"1 - 3 months",,,,"I",,,"17/04/2023",45.85,141.8,,,22.8,1.34,"No","Not known",116,56,,"3","3","1",,,,,,,,"Yes",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No Concerns","Yes","Other","Yes",,"Yes","OD","HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,,,,,,,,,,,,,,,"2043 17/04/2023"
"Glasgow - RHC","United Kingdom",2044,"United Kingdom",,"04/06/2013","04/06/2010","Male",,,,,"Male","46 XY",,"Disorder of androgen excess","21-hydroxylase def (CYP21A)",,"30/05/2013",,,2044,"3",,,,,,,"08/02/2016",23.3,119,,,16.45,0.88,"Not known","Not known",,,,,,,,,,,,,,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"Not known",,"No",,"No",,"Yes","poorly controlled congenital
adrenal hyperplasia",,"No","Not Applicable",,,"Yes","OD","HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"08/02/2016",9,"Radius-ulna-short bone","Not Known",,,,"2","1","1",2,2,,"Not known",,,,,,,,"2044 08/02/2016"
"Glasgow - RHC","United Kingdom",2044,"United Kingdom",,"04/06/2013","04/06/2010","Male",,,,,"Male","46 XY",,"Disorder of androgen excess","21-hydroxylase def (CYP21A)",,"30/05/2013",,,2044,"3",,,,,,,"08/08/2016",24.5,122.9,,,16.22,0.91,"Not known","Not known",,,,,,,,,,,,,,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"Not known",,"No",,"No",,"Not known","poorly controlled congenital
adrenal hyperplasia","No Concerns","No","Not Applicable","Yes",,"Yes","OD","HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,"Not known","not_known","not_known",,,,"Not known",,,,,,,,"2044 08/08/2016"
"Glasgow - RHC","United Kingdom",2044,"United Kingdom",,"04/06/2013","04/06/2010","Male",,,,,"Male","46 XY",,"Disorder of androgen excess","21-hydroxylase def (CYP21A)",,"30/05/2013",,,2044,"3",,,,,,,"10/04/2017",27.05,126,,,17.04,0.97,"Not known","Not known",110,68,,,,,,,,,,,,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"Not known",,"No",,"No",,"Not known","poorly controlled congenital
adrenal hyperplasia","No Concerns","No","Not Applicable","Yes",,"Yes","OD","HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,"Not known","not_known","not_known",,,,"Not known",,,,,,,,"2044 10/04/2017"
"Glasgow - RHC","United Kingdom",2044,"United Kingdom",,"04/06/2013","04/06/2010","Male",,,,,"Male","46 XY",,"Disorder of androgen excess","21-hydroxylase def (CYP21A)",,"30/05/2013",,,2044,"3",,,,,,,"30/10/2017",28.5,129.1,,,17.1,1.01,"Not known","Not known",,,,,,,,,,,,,,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"Not known",,"No",,"No",,"Not known","poorly controlled congenital
adrenal hyperplasia","No Concerns","No","Not Applicable","Yes",,"Yes","OD","HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,"Not known","not_known","not_known",,,,"Not known",,,,,,,,"2044 30/10/2017"
"Glasgow - RHC","United Kingdom",2044,"United Kingdom",,"04/06/2013","04/06/2010","Male",,,,,"Male","46 XY",,"Disorder of androgen excess","21-hydroxylase def (CYP21A)",,"30/05/2013",,,2044,"3",,,,,,,"30/07/2018",31.15,133.7,,,17.43,1.08,"Not known","Not known",,,,,,,,,,,,,,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"Not known",,"No",,"No",,"Not known","poorly controlled congenital
adrenal hyperplasia","No Concerns","No","Not Applicable","Yes",,"Yes","OD","HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,"Not known","not_known","not_known",,,,"Not known",,,,,,,,"2044 30/07/2018"
"Glasgow - RHC","United Kingdom",2044,"United Kingdom",,"04/06/2013","04/06/2010","Male",,,,,"Male","46 XY",,"Disorder of androgen excess","21-hydroxylase def (CYP21A)",,"30/05/2013",,,2044,"3",,,,,,,"11/02/2019",33.25,137.1,,,17.69,1.13,"Not known","Not known",101,56,,,,,,,,,,,,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"Not known",,"No",,"No",,"Not known","poorly controlled congenital
adrenal hyperplasia","No Concerns","Yes","Other","Yes",,"Yes","OD","HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,"Not known","not_known","not_known",,,,"Not known",,,,,,,,"2044 11/02/2019"
"Glasgow - RHC","United Kingdom",2044,"United Kingdom",,"04/06/2013","04/06/2010","Male",,,,,"Male","46 XY",,"Disorder of androgen excess","21-hydroxylase def (CYP21A)",,"30/05/2013",,,2044,"3",,,,,,,"26/08/2019",36.3,76.4,,,62.19,0.88,"Not known","Not known",,,,,,,,,,,,,,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"Not known",,"No",,"No",,"Not known","poorly controlled congenital
adrenal hyperplasia","No Concerns","Yes","Undertreatment","Yes",,"Yes","OD","HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,"Not known","not_known","not_known",,,,"Not known",,,,,,,,"2044 26/08/2019"
"Glasgow - RHC","United Kingdom",2044,"United Kingdom",,"04/06/2013","04/06/2010","Male",,,,,"Male","46 XY",,"Disorder of androgen excess","21-hydroxylase def (CYP21A)",,"30/05/2013",,,2044,"3",,,,,,,"10/02/2020",36.5,144.7,,,17.43,1.21,"Not known","Not known",,,,,,,,,,,,,,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"Not known",,"No",,"No",,"Not known","poorly controlled congenital
adrenal hyperplasia","No Concerns","Yes","Undertreatment","Yes",,"Yes","OD","HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,"Not known","not_known","not_known",,,,"Not known",,,,,,,,"2044 10/02/2020"
"Glasgow - RHC","United Kingdom",2044,"United Kingdom",,"04/06/2013","04/06/2010","Male",,,,,"Male","46 XY",,"Disorder of androgen excess","21-hydroxylase def (CYP21A)",,"30/05/2013",,,2044,"3",,,,,,,"10/08/2020",40.4,148.2,,,18.39,1.29,"Not known","Not known",,,,,,,,,,,,,,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"Not known",,"No",,"No",,"Not known","poorly controlled congenital
adrenal hyperplasia","No Concerns","Yes","Undertreatment","Yes",,"Yes","OD","HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,"Not known","not_known","not_known",,,,"Not known",,,,,,,,"2044 10/08/2020"
"Glasgow - RHC","United Kingdom",2044,"United Kingdom",,"04/06/2013","04/06/2010","Male",,,,,"Male","46 XY",,"Disorder of androgen excess","21-hydroxylase def (CYP21A)",,"30/05/2013",,,2044,"3",,,,,,,"22/02/2021",42.8,152.4,,,18.43,1.35,"Not known","Not known",,,,,,,,,,,,,,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"Not known",,"No",,"No",,"Not known","poorly controlled congenital
adrenal hyperplasia","No Concerns","Yes","Undertreatment","Yes",,"Yes","OD","HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,"Not known","not_known","not_known",,,,"Not known",,,,,,,,"2044 22/02/2021"
"Glasgow - RHC","United Kingdom",2044,"United Kingdom",,"04/06/2013","04/06/2010","Male",,,,,"Male","46 XY",,"Disorder of androgen excess","21-hydroxylase def (CYP21A)",,"30/05/2013",,,2044,"3",,,,,,,"13/09/2021",41.15,155,,,17.13,1.33,"Not known","Not known",,,,,,,,,,,,,,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"Not known",,"No",,"No",,"Not known","poorly controlled congenital
adrenal hyperplasia","No Concerns","Yes","Undertreatment","Yes",,"Yes","OD","HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,"Not known","not_known","not_known",,,,"Not known",,,,,,,,"2044 13/09/2021"
"Glasgow - RHC","United Kingdom",2044,"United Kingdom",,"04/06/2013","04/06/2010","Male",,,,,"Male","46 XY",,"Disorder of androgen excess","21-hydroxylase def (CYP21A)",,"30/05/2013",,,2044,"3",,,,,,,"21/03/2022",47.9,158.5,,,19.07,1.45,"Not known","Not known",,,,,,,,,,,,,,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"Not known",,"No",,"No",,"Not known","poorly controlled congenital
adrenal hyperplasia","No Concerns","Yes","Undertreatment","Yes",,"Yes","OD","HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,"Not known","not_known","not_known",,,,"Not known",,,,,,,,"2044 21/03/2022"
"Glasgow - RHC","United Kingdom",2768,"United Kingdom",,"25/07/2013","11/07/2013","Female",,,"39 weeks",,"Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,,,2768,"< 1 month",,"No",,"III",,,"17/06/2016",11.34,84.3,,,15.96,0.52,"Not known","Not known",,,,,,,,,,,,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"No Concerns","No","Not Applicable","Yes",,"Yes","OD","HC","Not known","5mmol/L oral bd","Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,,,,,,,,,,,,"Not known",,,,,,,,"2768 17/06/2016"
"Glasgow - RHC","United Kingdom",2768,"United Kingdom",,"25/07/2013","11/07/2013","Female",,,"39 weeks",,"Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,,,2768,"< 1 month",,"No",,"III",,,"08/12/2016",12.1,85.5,,,16.55,0.54,"Not known","Not known",,,,,,,,,,,,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"No Concerns","No","Not Applicable","Yes",,"Yes","OD","HC","Not known","5mmol/L oral bd","Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,,,,,,,,,,,,"Not known",,,,,,,,"2768 08/12/2016"
"Glasgow - RHC","United Kingdom",2768,"United Kingdom",,"25/07/2013","11/07/2013","Female",,,"39 weeks",,"Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,,,2768,"< 1 month",,"No",,"III",,,"08/05/2017",13.05,89.7,,,16.22,0.57,"Not known","Not known",,,,,,,,,,,,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"No Concerns","No","Not Applicable","Yes",,"Yes","OD","HC","Not known","5mmol/L oral bd","Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"08/05/2017",2.63,,,,,,,,,,,,"Not known",,,,,,,,"2768 08/05/2017"
"Glasgow - RHC","United Kingdom",2768,"United Kingdom",,"25/07/2013","11/07/2013","Female",,,"39 weeks",,"Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,,,2768,"< 1 month",,"No",,"III",,,"08/01/2018",14.35,92.2,,,16.88,0.61,"Not known","Not known",,,,,,,,,,,,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"No Concerns","No","Not Applicable","Yes",,"Yes","OD","HC","Not known","5mmol/L oral bd","Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,,,,,,,,,,,,"Not known",,,,,,,,"2768 08/01/2018"
"Glasgow - RHC","United Kingdom",2768,"United Kingdom",,"25/07/2013","11/07/2013","Female",,,"39 weeks",,"Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,,,2768,"< 1 month",,"No",,"III",,,"09/10/2018",15.55,98.5,,,16.03,0.65,"Not known","Not known",97,58,,,,,,,,,,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"No Concerns","No","Not Applicable","Yes",,"Yes","OD","HC","Not known","5mmol/L oral bd","Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,,,,,,,,,,,,"Not known",,,,,,,,"2768 09/10/2018"
"Glasgow - RHC","United Kingdom",2768,"United Kingdom",,"25/07/2013","11/07/2013","Female",,,"39 weeks",,"Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,,,2768,"< 1 month",,"No",,"III",,,"19/09/2022",27.55,122.4,,,18.39,0.97,"Not known","Not known",,,,,,,,,,,,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"No Concerns","No","Not Applicable","Yes",,"Yes","OD","HC","No","5mmol/L oral bd","Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,,,,,,,,,,,,"Not known",,,,,,,,"2768 19/09/2022"
"Glasgow - RHC","United Kingdom",2768,"United Kingdom",,"25/07/2013","11/07/2013","Female",,,"39 weeks",,"Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,,,2768,"< 1 month",,"No",,"III",,,"13/01/2020",17.84,106,,,15.88,0.72,"Not known","Not known",97,55,,,,,,,,,,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"No Concerns","No","Not Applicable","Yes",,"Yes","OD","HC","No","5mmol/L oral bd","Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,,,,,,,,,,,,"Not known",,,,,,,,"2768 13/01/2020"
"Glasgow - RHC","United Kingdom",2768,"United Kingdom",,"25/07/2013","11/07/2013","Female",,,"39 weeks",,"Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,,,2768,"< 1 month",,"No",,"III",,,"07/07/2020",18.7,108.5,,,15.88,0.75,"Not known","Not known",94,54,,,,,,,,,,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"No Concerns","Yes","Undertreatment","Yes",,"Yes","OD","HC","No","5mmol/L oral bd","Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,,,,,,,,,,,,"Not known",,,,,,,,"2768 07/07/2020"
"Glasgow - RHC","United Kingdom",2768,"United Kingdom",,"25/07/2013","11/07/2013","Female",,,"39 weeks",,"Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,,,2768,"< 1 month",,"No",,"III",,,"15/02/2021",20.6,111.8,,,16.48,0.8,"Not known","Not known",,,,,,,,,,,,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"No Concerns","Yes","Undertreatment","Yes",,"Yes","OD","HC","No","5mmol/L oral bd","Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,,,,,,,,,,,,"Not known",,,,,,,,"2768 15/02/2021"
"Glasgow - RHC","United Kingdom",2768,"United Kingdom",,"25/07/2013","11/07/2013","Female",,,"39 weeks",,"Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,,,2768,"< 1 month",,"No",,"III",,,"30/08/2021",24.85,116.6,,,18.28,0.9,"Not known","Not known",,,,,,,,,,,,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"No Concerns","No","Not Applicable","Yes",,"Yes","OD","HC","No","5mmol/L oral bd","Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,,,,,,,,,,,,"Not known",,,,,,,,"2768 30/08/2021"
"Glasgow - RHC","United Kingdom",2768,"United Kingdom",,"25/07/2013","11/07/2013","Female",,,"39 weeks",,"Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,,,2768,"< 1 month",,"No",,"III",,,"07/03/2022",26.05,119,,,18.4,0.93,"Not known","Not known",,,,,,,,,,,,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"No Concerns","Yes","Not Applicable","Yes",,"Yes","OD","HC","No","5mmol/L oral bd","Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,,,,,,,,,,,,"Not known",,,,,,,,"2768 07/03/2022"
"Glasgow - RHC","United Kingdom",2768,"United Kingdom",,"25/07/2013","11/07/2013","Female",,,"39 weeks",,"Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,,,2768,"< 1 month",,"No",,"III",,,"22/07/2019",16.85,104,,,15.58,0.7,"Not known","Not known",97,56,,,,,,,,,,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"No Concerns","No","Not Applicable","Yes",,"Yes","OD","HC","No","5mmol/L oral bd","Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"22/07/2019",4.1,,,,,,,,,,,,"Not known",,,,,,,,"2768 22/07/2019"
"Glasgow - RHC","United Kingdom",2768,"United Kingdom",,"25/07/2013","11/07/2013","Female",,,"39 weeks",,"Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,,,2768,"< 1 month",,"No",,"III",,,"20/03/2023",28.6,125.5,,,18.16,1,"No","Not known",,,,,,,,,,,,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"No Concerns","Yes","Undertreatment","Yes","2.5 mg in the morning and at lunchtime and 3.75 mg at night","Yes","OD","HC","No","5mmol/L oral bd","Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,,,,,,,,,,,,"Not known",,,,,,,,"2768 20/03/2023"
"Glasgow - RHC","United Kingdom",3120,"United Kingdom",,"25/07/2013","11/07/2013","Female",,,,,"Female","46 XX",,"Disorder of androgen excess","21-hydroxylase def (CYP21A)",,,,,3120,"< 1 month",,"No",,"Normal Female",,,"09/10/2018",,,,,,,"Not known","Not known",,,,,,,,,,,,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"No Concerns","No","Not Applicable","Not known",,"Yes","OD","HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"Not known",,,,,"Not Known",,,,,,,,,,"Not known",,,,,,,,"3120 09/10/2018"
"Glasgow - RHC","United Kingdom",3120,"United Kingdom",,"25/07/2013","11/07/2013","Female",,,,,"Female","46 XX",,"Disorder of androgen excess","21-hydroxylase def (CYP21A)",,,,,3120,"< 1 month",,"No",,"Normal Female",,,"22/07/2019",16.85,104,,,15.58,0.7,"Not known","Not known",97,56,,,,,,,,,,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"No Concerns","No","Not Applicable","Yes",,"Yes","OD","HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"Not known",,,,,"Not Known",,,,,,,,,,"Not known",,,,,,,,"3120 22/07/2019"
"Glasgow - RHC","United Kingdom",3120,"United Kingdom",,"25/07/2013","11/07/2013","Female",,,,,"Female","46 XX",,"Disorder of androgen excess","21-hydroxylase def (CYP21A)",,,,,3120,"< 1 month",,"No",,"Normal Female",,,"13/01/2020",,,,,,,"Not known","Not known",97,55,,,,,,,,,,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"No Concerns","No","Not Applicable","Yes",,"Yes","OD","HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"Not known",,,,,"Not Known",,,,,,,,,,"Not known",,,,,,,,"3120 13/01/2020"
"Glasgow - RHC","United Kingdom",3120,"United Kingdom",,"25/07/2013","11/07/2013","Female",,,,,"Female","46 XX",,"Disorder of androgen excess","21-hydroxylase def (CYP21A)",,,,,3120,"< 1 month",,"No",,"Normal Female",,,"07/07/2020",18.7,108.5,,,15.88,0.75,"Not known","Not known",,,,,,,,,,,,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"No Concerns","Yes","Undertreatment","Yes",,"Yes","OD","HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"Not known",,,,,"Not Known",,,,,,,,,,"Not known",,,,,,,,"3120 07/07/2020"
"Glasgow - RHC","United Kingdom",3120,"United Kingdom",,"25/07/2013","11/07/2013","Female",,,,,"Female","46 XX",,"Disorder of androgen excess","21-hydroxylase def (CYP21A)",,,,,3120,"< 1 month",,"No",,"Normal Female",,,"15/02/2021",20.6,111.8,,,16.48,0.8,"Not known","Not known",,,,,,,,,,,,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"No Concerns","Yes","Undertreatment","Yes",,"Yes","OD","HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"Not known",,,,,"Not Known",,,,,,,,,,"Not known",,,,,,,,"3120 15/02/2021"
"Glasgow - RHC","United Kingdom",3120,"United Kingdom",,"25/07/2013","11/07/2013","Female",,,,,"Female","46 XX",,"Disorder of androgen excess","21-hydroxylase def (CYP21A)",,,,,3120,"< 1 month",,"No",,"Normal Female",,,"30/08/2021",24.85,116.6,,,18.28,0.9,"Not known","Not known",,,,,,,,,,,,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"No Concerns","No","Undertreatment","Yes",,"Yes","OD","HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"Not known",,,,,"Not Known",,,,,,,,,,"Not known",,,,,,,,"3120 30/08/2021"
"Glasgow - RHC","United Kingdom",3120,"United Kingdom",,"25/07/2013","11/07/2013","Female",,,,,"Female","46 XX",,"Disorder of androgen excess","21-hydroxylase def (CYP21A)",,,,,3120,"< 1 month",,"No",,"Normal Female",,,"07/03/2022",26.05,119,,,18.4,0.93,"Not known","Not known",,,,,,,,,,,,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"No Concerns","No","Undertreatment","Yes",,"Yes","OD","HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"Not known",,,,,"Not Known",,,,,,,,,,"Not known",,,,,,,,"3120 07/03/2022"
"Glasgow - RHC","United Kingdom",3560,"United Kingdom",,"20/07/2017","06/07/2017","Female",,,"40 weeks",,"Female","46 XX",,"Disorder of androgen excess","21-hydroxylase def (CYP21A)",,,,,3560,"< 1 month",,"No",,"II",,,"14/08/2017",4.79,56.5,,,15.01,0.27,"Not known","Not known",,,,,,,,,,,,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"No Concerns","Yes","Not Applicable","Yes",,"Yes","OD","HC","Yes","0.4mls four times/day","Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,,"Not Known",,,,,,,,,,"Not known",,,,,,,,"3560 14/08/2017"
"Glasgow - RHC","United Kingdom",3560,"United Kingdom",,"20/07/2017","06/07/2017","Female",,,"40 weeks",,"Female","46 XX",,"Disorder of androgen excess","21-hydroxylase def (CYP21A)",,,,,3560,"< 1 month",,"No",,"II",,,"29/01/2018",8.4,70,,,17.14,0.4,"Not known","Not known",,,,,,,,,,,,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"No Concerns","Yes","Not Applicable","Yes",,"Yes","OD","HC","Yes","0.4mls four times/day","Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,,,,,,,,,,,,"Not known",,,,,,,,"3560 29/01/2018"
"Glasgow - RHC","United Kingdom",3560,"United Kingdom",,"20/07/2017","06/07/2017","Female",,,"40 weeks",,"Female","46 XX",,"Disorder of androgen excess","21-hydroxylase def (CYP21A)",,,,,3560,"< 1 month",,"No",,"II",,,"12/03/2018",8.98,71.6,,,17.52,0.42,"Not known","Not known",114,66,,,,,,,,,,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"No Concerns","No","Not Applicable","Yes",,"Yes","OD","HC","Yes","0.4mls four times/day","Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,,,,,,,,,,,,"Not known",,,,,,,,"3560 12/03/2018"
"Glasgow - RHC","United Kingdom",3560,"United Kingdom",,"20/07/2017","06/07/2017","Female",,,"40 weeks",,"Female","46 XX",,"Disorder of androgen excess","21-hydroxylase def (CYP21A)",,,,,3560,"< 1 month",,"No",,"II",,,"11/06/2018",10.39,77.5,,,17.3,0.47,"Not known","Not known",,,,,,,,,,,,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"No Concerns","No","Not Applicable","Yes",,"Yes","OD","HC","Yes","0.4mls four times/day","Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,,,,,,,,,,,,"Not known",,,,,,,,"3560 11/06/2018"
"Glasgow - RHC","United Kingdom",3560,"United Kingdom",,"20/07/2017","06/07/2017","Female",,,"40 weeks",,"Female","46 XX",,"Disorder of androgen excess","21-hydroxylase def (CYP21A)",,,,,3560,"< 1 month",,"No",,"II",,,"13/11/2018",12.1,81.5,,,18.22,0.52,"Not known","Not known",,,,,,,,,,,,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"No Concerns","Yes","Dose adjustment for size","Yes",,"Yes","OD","HC","Yes","0.4mls four times/day","Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,,,,,,,,,,,,"Not known",,,,,,,,"3560 13/11/2018"
"Glasgow - RHC","United Kingdom",3560,"United Kingdom",,"20/07/2017","06/07/2017","Female",,,"40 weeks",,"Female","46 XX",,"Disorder of androgen excess","21-hydroxylase def (CYP21A)",,,,,3560,"< 1 month",,"No",,"II",,,"13/05/2019",16.45,87.3,,,21.58,0.63,"Not known","Not known",107,58,,,,,,,,,,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"No Concerns","Yes","Dose adjustment for size","Yes",,"Yes","OD","HC","No","0.4mls four times/day","Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,,,,,,,,,,,,"Not known",,,,,,,,"3560 13/05/2019"
"Glasgow - RHC","United Kingdom",3560,"United Kingdom",,"20/07/2017","06/07/2017","Female",,,"40 weeks",,"Female","46 XX",,"Disorder of androgen excess","21-hydroxylase def (CYP21A)",,,,,3560,"< 1 month",,"No",,"II",,,"27/07/2020",,,,,,,"Not known","Not known",,,,,,,,,,,,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Yes","Asthma","No Concerns","No","Dose adjustment for size","Yes",,"Yes","OD","HC","No","0.4mls four times/day","Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,,,,,,,,,,,,"Not known",,,,,,,,"3560 27/07/2020"
"Glasgow - RHC","United Kingdom",3560,"United Kingdom",,"20/07/2017","06/07/2017","Female",,,"40 weeks",,"Female","46 XX",,"Disorder of androgen excess","21-hydroxylase def (CYP21A)",,,,,3560,"< 1 month",,"No",,"II",,,"12/11/2020",30.1,105.8,,,26.89,0.94,"Not known","Not known",,,,,,,,,,,,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Yes","Asthma","No Concerns","No","Dose adjustment for size","Yes",,"Yes","OD","HC","No","0.4mls four times/day","Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,,,,,,,,,,,,"Not known",,,,,,,,"3560 12/11/2020"
"Glasgow - RHC","United Kingdom",3560,"United Kingdom",,"20/07/2017","06/07/2017","Female",,,"40 weeks",,"Female","46 XX",,"Disorder of androgen excess","21-hydroxylase def (CYP21A)",,,,,3560,"< 1 month",,"No",,"II",,,"02/10/2017",6.4,61.4,,,16.98,0.33,"Not known","Not known",,,,,,,,,,,,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"No Concerns","No","Dose adjustment for size","Yes",,"Yes","OD","HC","No","0.4mls four times/day","Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,,,,,,,,,,,,"Not known",,,,,,,,"3560 02/10/2017"
"Glasgow - RHC","United Kingdom",3691,"United Kingdom",,"10/12/2006","26/11/2006","Female",,,"40 weeks",,"Female","46 XX",,"Disorder of androgen excess","21-hydroxylase def (CYP21A)",,,,,3691,"< 1 month",,"No",,"IV",,,"15/02/2016",,,,,,,"Not known","Not known",,,,,,,,,,,,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"No Concerns","No","Not Applicable","Yes",,"Yes","BD","HC","Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,,"Not Known",,,,,,,,,,"Not known",,,,,,,,"3691 15/02/2016"
"Glasgow - RHC","United Kingdom",3691,"United Kingdom",,"10/12/2006","26/11/2006","Female",,,"40 weeks",,"Female","46 XX",,"Disorder of androgen excess","21-hydroxylase def (CYP21A)",,,,,3691,"< 1 month",,"No",,"IV",,,"15/11/2016",27,134.1,,,15.01,1,"Not known","Not known",118,81,,,,,,,,,,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"No Concerns","No","Not Applicable","Yes",,"Yes","BD","HC","Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,,,,,,,,,,,,"Not known",,,,,,,,"3691 15/11/2016"
"Glasgow - RHC","United Kingdom",3691,"United Kingdom",,"10/12/2006","26/11/2006","Female",,,"40 weeks",,"Female","46 XX",,"Disorder of androgen excess","21-hydroxylase def (CYP21A)",,,,,3691,"< 1 month",,"No",,"IV",,,"12/02/2018",33.3,145.4,,,15.75,1.16,"Not known","Not known",,,,,,,,,,,,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"No Concerns","No","Not Applicable","Yes",,"Yes","BD","HC","Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,,,,,,,,,,,,"Not known",,,,,,,,"3691 12/02/2018"
"Glasgow - RHC","United Kingdom",3691,"United Kingdom",,"10/12/2006","26/11/2006","Female",,,"40 weeks",,"Female","46 XX",,"Disorder of androgen excess","21-hydroxylase def (CYP21A)",,,,,3691,"< 1 month",,"No",,"IV",,,"13/08/2018",34.1,149.1,,,15.34,1.19,"Not known","Not known",,,,,,,,,,,,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"No Concerns","Yes","Other","Yes",,"Yes","OD","HC","Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,,,,,,,,,,,,"Not known",,,,,,,,"3691 13/08/2018"
"Glasgow - RHC","United Kingdom",3691,"United Kingdom",,"10/12/2006","26/11/2006","Female",,,"40 weeks",,"Female","46 XX",,"Disorder of androgen excess","21-hydroxylase def (CYP21A)",,,,,3691,"< 1 month",,"No",,"IV",,,"29/01/2019",36.95,153.8,,,15.62,1.26,"Not known","Not known",109,64,,,,,,,,,,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"No Concerns","No","Not Applicable","Yes",,"Yes","OD","HC","Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,,,,,,,,,,,,"Not known",,,,,,,,"3691 29/01/2019"
"Glasgow - RHC","United Kingdom",3691,"United Kingdom",,"10/12/2006","26/11/2006","Female",,,"40 weeks",,"Female","46 XX",,"Disorder of androgen excess","21-hydroxylase def (CYP21A)",,,,,3691,"< 1 month",,"No",,"IV",,,"09/12/2019",42.3,160.2,,,16.48,1.37,"No","No",110,60,"ACTH mU/L (<20)
Testosterone nmol/l
Adione nmol/l
17OHP nmol/l
Renin mIU/L (<125)",,,,"Spontaneous",13,,,,,,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"Yes","ankles","No Concerns","No","Not Applicable","Yes",,"Yes","OD","HC","Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,,,,,,,,,,,,"Not known",,,,,,,,"3691 09/12/2019"
"Glasgow - RHC","United Kingdom",3691,"United Kingdom",,"10/12/2006","26/11/2006","Female",,,"40 weeks",,"Female","46 XX",,"Disorder of androgen excess","21-hydroxylase def (CYP21A)",,,,,3691,"< 1 month",,"No",,"IV",,,"11/05/2020",40.1,161.1,,,15.45,1.34,"No","No",,,"no adverse events",,,,"Spontaneous",13,"Yes",,,,,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"Yes","ankles","No Concerns","No","Not Applicable","Yes",,"Yes","OD","HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,"No",,,,,,,,,,"Not known",,,,,,,,"3691 11/05/2020"
"Glasgow - RHC","United Kingdom",3691,"United Kingdom",,"10/12/2006","26/11/2006","Female",,,"40 weeks",,"Female","46 XX",,"Disorder of androgen excess","21-hydroxylase def (CYP21A)",,,,,3691,"< 1 month",,"No",,"IV",,,"23/11/2020",,,,,,,,,,,"no adverse events",,,,"Spontaneous",13,"Yes",,,,,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"Yes","ankles","No Concerns","No","Not Applicable","Yes",,"Yes","OD","HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,"No",,,,,,,,,,"Not known",,,,,,,,"3691 23/11/2020"
"Glasgow - RHC","United Kingdom",3691,"United Kingdom",,"10/12/2006","26/11/2006","Female",,,"40 weeks",,"Female","46 XX",,"Disorder of androgen excess","21-hydroxylase def (CYP21A)",,,,,3691,"< 1 month",,"No",,"IV",,,"02/11/2020",,,,,,,,,,,,,,,"Spontaneous",13,"Yes",,,,,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"Yes","ankles","No Concerns","Yes","Not Applicable","Yes",,"Yes","OD","HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,"No",,,,,,,,,,"Not known",,,,,,,,"3691 02/11/2020"
"Glasgow - RHC","United Kingdom",3691,"United Kingdom",,"10/12/2006","26/11/2006","Female",,,"40 weeks",,"Female","46 XX",,"Disorder of androgen excess","21-hydroxylase def (CYP21A)",,,,,3691,"< 1 month",,"No",,"IV",,,"10/05/2021",44.5,163.5,,,16.65,1.42,,,111,64,,,,,"Spontaneous",13,"Yes",,,,,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"Yes","ankles","No Concerns","Yes","Not Applicable","Yes",,"Yes","OD","HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,"No",,,,,,,,,,"Not known",,,,,,,,"3691 10/05/2021"
"Glasgow - RHC","United Kingdom",3691,"United Kingdom",,"10/12/2006","26/11/2006","Female",,,"40 weeks",,"Female","46 XX",,"Disorder of androgen excess","21-hydroxylase def (CYP21A)",,,,,3691,"< 1 month",,"No",,"IV",,,"15/11/2021",45,164.2,,,16.69,1.43,,,,,,,,,"Spontaneous",13,"Yes",,,,,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"Yes","ankles","No Concerns","No","Not Applicable","Yes",,"Yes","OD","HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,"No",,,,,,,,,,"Not known",,,,,,,,"3691 15/11/2021"
"Glasgow - RHC","United Kingdom",3691,"United Kingdom",,"10/12/2006","26/11/2006","Female",,,"40 weeks",,"Female","46 XX",,"Disorder of androgen excess","21-hydroxylase def (CYP21A)",,,,,3691,"< 1 month",,"No",,"IV",,,"25/07/2022",46.8,164.5,,,17.29,1.46,,,,,,,,,"Spontaneous",13,"Yes",,,,,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"Yes","ankles","No Concerns","Yes","Not Applicable","Yes",,"Yes","OD","HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,"No",,,,,,,,,,"Not known",,,,,,,,"3691 25/07/2022"
"Glasgow - RHC","United Kingdom",3692,"United Kingdom",,"17/03/2016","17/03/2009","Male",3402,,,,"Male","46 XY",,"Disorder of androgen excess","21-hydroxylase def (CYP21A)",,"25/02/2016",,,3692,"7",,,,,,,"25/02/2016",,,,,,,"Not known","Not known",,,,,,,,,,,,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not Known","No","Not Applicable","Yes",,"No",,"HC","Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,,"Not Known",,,,,,,,,,"Not known",,,,,,,,"3692 25/02/2016"
"Glasgow - RHC","United Kingdom",3692,"United Kingdom",,"17/03/2016","17/03/2009","Male",3402,,,,"Male","46 XY",,"Disorder of androgen excess","21-hydroxylase def (CYP21A)",,"25/02/2016",,,3692,"7",,,,,,,"09/05/2016",28.4,136.6,,,15.22,1.04,"Not known","Not known",,,,,,,,,,,,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"No Concerns","No","Not Applicable","Yes",,"No",,"HC","Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,,,,,,,,,,,,"Not known",,,,,,,,"3692 09/05/2016"
"Glasgow - RHC","United Kingdom",3692,"United Kingdom",,"17/03/2016","17/03/2009","Male",3402,,,,"Male","46 XY",,"Disorder of androgen excess","21-hydroxylase def (CYP21A)",,"25/02/2016",,,3692,"7",,,,,,,"08/08/2016",28.85,138.3,,,15.08,1.05,"Not known","Not known",,,,,,,,,,,,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"No Concerns","No","Not Applicable","Yes",,"No",,"HC","Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,,,,,,,,,,,,"Not known",,,,,,,,"3692 08/08/2016"
"Glasgow - RHC","United Kingdom",3692,"United Kingdom",,"17/03/2016","17/03/2009","Male",3402,,,,"Male","46 XY",,"Disorder of androgen excess","21-hydroxylase def (CYP21A)",,"25/02/2016",,,3692,"7",,,,,,,"13/03/2017",31.8,142,,,15.77,1.12,"Not known","Not known",,,,,,,,,,,,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"No Concerns","No","Not Applicable","Yes",,"No",,"HC","Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,,,,,,,,,,,,"Not known",,,,,,,,"3692 13/03/2017"
"Glasgow - RHC","United Kingdom",3692,"United Kingdom",,"17/03/2016","17/03/2009","Male",3402,,,,"Male","46 XY",,"Disorder of androgen excess","21-hydroxylase def (CYP21A)",,"25/02/2016",,,3692,"7",,,,,,,"14/08/2017",34.15,144.7,,,16.31,1.17,"Not known","Not known",,,,,,,,,,,,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"No Concerns","No","Not Applicable","Yes",,"No",,"HC","Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,,,,,,,,,,,,"Not known",,,,,,,,"3692 14/08/2017"
"Glasgow - RHC","United Kingdom",3692,"United Kingdom",,"17/03/2016","17/03/2009","Male",3402,,,,"Male","46 XY",,"Disorder of androgen excess","21-hydroxylase def (CYP21A)",,"25/02/2016",,,3692,"7",,,,,,,"12/02/2018",37.8,148.6,,,17.12,1.25,"Not known","Not known",106,55,,,,,,,,,,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"No Concerns","No","Not Applicable","Yes",,"No",,"HC","Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,,,,,,,,,,,,"Not known",,,,,,,,"3692 12/02/2018"
"Glasgow - RHC","United Kingdom",3692,"United Kingdom",,"17/03/2016","17/03/2009","Male",3402,,,,"Male","46 XY",,"Disorder of androgen excess","21-hydroxylase def (CYP21A)",,"25/02/2016",,,3692,"7",,,,,,,"13/08/2018",40.75,151.7,,,17.71,1.31,"Not known","Not known",128,65,,,,,,,,,,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"No Concerns","No","Not Applicable","Yes",,"No",,"HC","Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,,,,,,,,,,,,"Not known",,,,,,,,"3692 13/08/2018"
"Glasgow - RHC","United Kingdom",3692,"United Kingdom",,"17/03/2016","17/03/2009","Male",3402,,,,"Male","46 XY",,"Disorder of androgen excess","21-hydroxylase def (CYP21A)",,"25/02/2016",,,3692,"7",,,,,,,"14/10/2019",43.05,159.9,,,16.84,1.38,"Not known","Not known",,,,,,,,,,,,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"No Concerns","Yes","Not Applicable","Yes",,"No",,"HC","Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,,,,,,,,,,,,"Not known",,,,,,,,"3692 14/10/2019"
"Glasgow - RHC","United Kingdom",3692,"United Kingdom",,"17/03/2016","17/03/2009","Male",3402,,,,"Male","46 XY",,"Disorder of androgen excess","21-hydroxylase def (CYP21A)",,"25/02/2016",,,3692,"7",,,,,,,"29/04/2020",45,161,,,17.36,1.42,"Not known","Not known",,,,,,,,,,,,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"No Concerns","No","Not Applicable","Yes",,"No",,"HC","Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,,,,,,,,,,,,"Not known",,,,,,,,"3692 29/04/2020"
"Glasgow - RHC","United Kingdom",3692,"United Kingdom",,"17/03/2016","17/03/2009","Male",3402,,,,"Male","46 XY",,"Disorder of androgen excess","21-hydroxylase def (CYP21A)",,"25/02/2016",,,3692,"7",,,,,,,"21/12/2020",51.5,165,,,18.92,1.54,"Not known","Not known",,,,,,,,,,,,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"No Concerns","No","Not Applicable","Yes",,"No",,"HC","Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,,,,,,,,,,,,"Not known",,,,,,,,"3692 21/12/2020"
"Glasgow - RHC","United Kingdom",3692,"United Kingdom",,"17/03/2016","17/03/2009","Male",3402,,,,"Male","46 XY",,"Disorder of androgen excess","21-hydroxylase def (CYP21A)",,"25/02/2016",,,3692,"7",,,,,,,"28/06/2021",55.75,168.9,,,19.54,1.62,"Not known","Not known",,,,,,,,,,,,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"No Concerns","Yes","Not Applicable","Yes",,"No",,"HC","Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,,,,,,,,,,,,"Not known",,,,,,,,"3692 28/06/2021"
"Glasgow - RHC","United Kingdom",3692,"United Kingdom",,"17/03/2016","17/03/2009","Male",3402,,,,"Male","46 XY",,"Disorder of androgen excess","21-hydroxylase def (CYP21A)",,"25/02/2016",,,3692,"7",,,,,,,"17/01/2022",60.7,173.5,,,20.16,1.71,"Not known","Not known",,,,,,,,,,,,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"No Concerns","No","Not Applicable","Yes",,"No",,"HC","Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,,,,,,,,,,,,"Not known",,,,,,,,"3692 17/01/2022"
"Glasgow - RHC","United Kingdom",3692,"United Kingdom",,"17/03/2016","17/03/2009","Male",3402,,,,"Male","46 XY",,"Disorder of androgen excess","21-hydroxylase def (CYP21A)",,"25/02/2016",,,3692,"7",,,,,,,"01/08/2022",56.15,178.1,,,17.7,1.67,"Not known","Not known",,,,,,,,,,,,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"No Concerns","Yes","Not Applicable","Yes",,"No",,"HC","Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,,,,,,,,,,,,"Not known",,,,,,,,"3692 01/08/2022"
"Glasgow - RHC","United Kingdom",3765,"United Kingdom",,"25/06/2011","11/06/2011","Female",,,,,"Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,,,3765,"< 1 month",,,,,,,"13/06/2016",18.44,105.1,,,16.69,0.73,"Not known","Not known",,,,,,,,,,,,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"No Concerns","No","Not Applicable","Yes",,"Yes","OD","HC","Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,,,,,,,,,,,,"Not known",,,,,,,,"3765 13/06/2016"
"Glasgow - RHC","United Kingdom",3765,"United Kingdom",,"25/06/2011","11/06/2011","Female",,,,,"Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,,,3765,"< 1 month",,,,,,,"12/12/2016",18.9,107.9,,,16.23,0.75,"Not known","Not known",,,,,,,,,,,,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"No Concerns","No","Not Applicable","Yes",,"Yes","OD","HC","Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,,,,,,,,,,,,"Not known",,,,,,,,"3765 12/12/2016"
"Glasgow - RHC","United Kingdom",3765,"United Kingdom",,"25/06/2011","11/06/2011","Female",,,,,"Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,,,3765,"< 1 month",,,,,,,"12/06/2017",21.3,111.9,,,17.01,0.81,"Not known","Not known",,,,,,,,,,,,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"No Concerns","No","Not Applicable","Yes",,"Yes","OD","HC","Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,,,,,,,,,,,,"Not known",,,,,,,,"3765 12/06/2017"
"Glasgow - RHC","United Kingdom",3765,"United Kingdom",,"25/06/2011","11/06/2011","Female",,,,,"Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,,,3765,"< 1 month",,,,,,,"11/09/2017",22.55,113.1,,,17.63,0.84,"Not known","Not known",,,,,,,,,,,,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"No Concerns","Yes","Not Applicable","Yes",,"Yes","OD","HC","Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,,,,,,,,,,,,"Not known",,,,,,,,"3765 11/09/2017"
"Glasgow - RHC","United Kingdom",3765,"United Kingdom",,"25/06/2011","11/06/2011","Female",,,,,"Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,,,3765,"< 1 month",,,,,,,"09/01/2018",23.3,115.3,,,17.53,0.86,"Not known","Not known",95,59,,,,,,,,,,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"No Concerns","No","Not Applicable","Yes",,"Yes","OD","HC","Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,,,,,,,,,,,,"Not known",,,,,,,,"3765 09/01/2018"
"Glasgow - RHC","United Kingdom",3765,"United Kingdom",,"25/06/2011","11/06/2011","Female",,,,,"Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,,,3765,"< 1 month",,,,,,,"19/06/2018",24.3,118.9,,,17.19,0.9,"Not known","Not known",84,63,,,,,,,,,,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"No Concerns","Yes","Not Applicable","Yes",,"Yes","OD","HC","Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,,,,,,,,,,,,"Not known",,,,,,,,"3765 19/06/2018"
"Glasgow - RHC","United Kingdom",3765,"United Kingdom",,"25/06/2011","11/06/2011","Female",,,,,"Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,,,3765,"< 1 month",,,,,,,"09/10/2018",24.7,120,,,17.15,0.91,"Not known","Not known",102,72,,,,,,,,,,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"No Concerns","Yes","Other","Yes",,"Yes","OD","HC","Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,,,,,,,,,,,,"Not known",,,,,,,,"3765 09/10/2018"
"Glasgow - RHC","United Kingdom",3765,"United Kingdom",,"25/06/2011","11/06/2011","Female",,,,,"Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,,,3765,"< 1 month",,,,,,,"08/04/2019",28.95,124.4,,,18.71,1,"Not known","Not known",100,58,,,,,,,,,,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"No Concerns","No","Other","Yes",,"Yes","OD","HC","Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,7.4,,,,,,,,,,,,"Not known",,,,,,,,"3765 08/04/2019"
"Glasgow - RHC","United Kingdom",3766,"United Kingdom",,"23/08/2014","09/08/2014","Female",,,,,"Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,,,3766,"< 1 month",,,,,,,"13/06/2016",11.76,80,,,18.38,0.51,"Not known","Not known",,,,,,,,,,,,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"No Concerns","Yes","Not Applicable","Yes",,"Yes","OD","HC","Yes","6ml daily","Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,,,,,,,,,,,,"Not known",,,,,,,,"3766 13/06/2016"
"Glasgow - RHC","United Kingdom",3766,"United Kingdom",,"23/08/2014","09/08/2014","Female",,,,,"Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,,,3766,"< 1 month",,,,,,,"12/12/2016",13.15,84.8,,,18.29,0.56,"Not known","Not known",,,,,,,,,,,,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"No Concerns","Yes","Other","Yes",,"Yes","OD","HC","No","6ml daily","Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,,,,,,,,,,,,"Not known",,,,,,,,"3766 12/12/2016"
"Glasgow - RHC","United Kingdom",3766,"United Kingdom",,"23/08/2014","09/08/2014","Female",,,,,"Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,,,3766,"< 1 month",,,,,,,"12/06/2017",13.9,87.8,,,18.03,0.58,"Not known","Not known",,,,,,,,,,,,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"No Concerns","No","Not Applicable","Yes",,"Yes","OD","HC","No","6ml daily","Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,,,,,,,,,,,,"Not known",,,,,,,,"3766 12/06/2017"
"Glasgow - RHC","United Kingdom",3766,"United Kingdom",,"23/08/2014","09/08/2014","Female",,,,,"Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,,,3766,"< 1 month",,,,,,,"11/09/2017",14.4,91.6,,,17.16,0.61,"Not known","Not known",,,,,,,,,,,,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"No Concerns","Yes","Not Applicable","Yes",,"Yes","OD","HC","No","6ml daily","Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,,,,,,,,,,,,"Not known",,,,,,,,"3766 11/09/2017"
"Glasgow - RHC","United Kingdom",3766,"United Kingdom",,"23/08/2014","09/08/2014","Female",,,,,"Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,,,3766,"< 1 month",,,,,,,"09/01/2018",15.9,94.5,,,17.8,0.65,"Not known","Not known",89,62,,,,,,,,,,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"No Concerns","No","Not Applicable","Yes",,"Yes","OD","HC","No","6ml daily","Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,,,,,,,,,,,,"Not known",,,,,,,,"3766 09/01/2018"
"Glasgow - RHC","United Kingdom",3766,"United Kingdom",,"23/08/2014","09/08/2014","Female",,,,,"Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,,,3766,"< 1 month",,,,,,,"19/06/2018",17.18,98,,,17.89,0.68,"Not known","Not known",80,61,,,,,,,,,,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"No Concerns","No","Not Applicable","Yes",,"Yes","OD","HC","No","6ml daily","Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,,,,,,,,,,,,"Not known",,,,,,,,"3766 19/06/2018"
"Glasgow - RHC","United Kingdom",3766,"United Kingdom",,"23/08/2014","09/08/2014","Female",,,,,"Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,,,3766,"< 1 month",,,,,,,"09/10/2018",17.7,99.6,,,17.84,0.7,"Not known","Not known",110,77,,,,,,,,,,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"No Concerns","Yes","Other","Yes",,"Yes","OD","HC","No","6ml daily","Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,,,,,,,,,,,,"Not known",,,,,,,,"3766 09/10/2018"
"Glasgow - RHC","United Kingdom",3766,"United Kingdom",,"23/08/2014","09/08/2014","Female",,,,,"Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,,,3766,"< 1 month",,,,,,,"08/04/2019",20.15,107.5,,,17.44,0.78,"No","Not known",92,78,,,,,,,,,,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"No Concerns","Yes","Undertreatment","Yes",,"Yes","OD","HC","No","6ml daily","Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,,,,,,,,,,,,"Not known",,,,,,,,"3766 08/04/2019"
"Glasgow - RHC","United Kingdom",3770,"United Kingdom",,"16/05/2014","16/05/2007","Male",,,,,"Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"21/08/2015",,,3770,"7",,,,,,,"11/01/2016",34.9,142.4,,,17.21,1.17,"Not known","Not known",,,,,,,,,,,,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"No Concerns","Yes","Not Applicable","Yes",,"No",,"HC","Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,,,,,,,,,,,,"Not known",,,,,,,,"3770 11/01/2016"
"Glasgow - RHC","United Kingdom",3770,"United Kingdom",,"16/05/2014","16/05/2007","Male",,,,,"Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"21/08/2015",,,3770,"7",,,,,,,"09/05/2016",36.95,144,,,17.82,1.22,"Not known","Not known",,,"17oh progesterone  54.5 testosterone 0.9  androstenedione 5 reninen 43.1 ",,,,,,,,,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"No Concerns","No","Not Applicable","Yes",,"No",,"HC","Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"09/05/2016",13.5,,,,,,,,,,,,"Not known",,,,,,,,"3770 09/05/2016"
"Glasgow - RHC","United Kingdom",3770,"United Kingdom",,"16/05/2014","16/05/2007","Male",,,,,"Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"21/08/2015",,,3770,"7",,,,,,,"08/08/2016",38.35,144.6,,,18.34,1.24,"Not known","Not known",,,,,,,,,,,,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"No Concerns","Yes","Not Applicable","Yes",,"No",,"HC","Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,,,,,,,,,,,,"Not known",,,,,,,,"3770 08/08/2016"
"Glasgow - RHC","United Kingdom",3770,"United Kingdom",,"16/05/2014","16/05/2007","Male",,,,,"Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"21/08/2015",,,3770,"7",,,,,,,"13/03/2017",40.1,147.6,,,18.41,1.28,"Not known","Not known",,,"acth : 12 17oh progesterone 40.1  testosterone 0.9 androstenione 4.4  renine 30.5 ",,,,,,,,,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"No Concerns","No","Not Applicable","Yes",,"No",,"HC","Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,,,,,,,,,,,,"Not known",,,,,,,,"3770 13/03/2017"
"Glasgow - RHC","United Kingdom",3770,"United Kingdom",,"16/05/2014","16/05/2007","Male",,,,,"Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"21/08/2015",,,3770,"7",,,,,,,"14/08/2017",42.1,149.4,,,18.86,1.32,"Not known","Not known",,,"17oh : 59.4 testosterone 1.1 androstenedione 5.4 ",,,,,,,,,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"No Concerns","No","Not Applicable","Yes",,"No",,"HC","Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,,,,,,,,,,,,"Not known",,,,,,,,"3770 14/08/2017"
"Glasgow - RHC","United Kingdom",3770,"United Kingdom",,"16/05/2014","16/05/2007","Male",,,,,"Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"21/08/2015",,,3770,"7",,,,,,,"12/02/2018",44.9,151.2,,,19.64,1.37,"Not known","Not known",98,53,"17oh  4.2 testosyteone 0.5 androstenedione 1.5  renine 19.8 ",,,,,,,,,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"No Concerns","Yes","Other","Yes",,"No",,"HC","Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,13.5,,,,,,,,,,,,"Not known",,,,,,,,"3770 12/02/2018"
"Glasgow - RHC","United Kingdom",3770,"United Kingdom",,"16/05/2014","16/05/2007","Male",,,,,"Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"21/08/2015",,,3770,"7",,,,,,,"13/08/2018",47.55,153.1,,,20.29,1.42,"Not known","Not known",,,"17oh progesterone 5.9 testosterone 0.6 androstenedione 1.9 renine  26.5 ",,,,,,,,,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"No Concerns","No","Not Applicable","Yes",,"No",,"HC","Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,13.59,,,,,,,,,,,,"Not known",,,,,,,,"3770 13/08/2018"
"Glasgow - RHC","United Kingdom",3770,"United Kingdom",,"16/05/2014","16/05/2007","Male",,,,,"Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"21/08/2015",,,3770,"7",,,,,,,"14/10/2019",50.3,159.1,,,19.87,1.49,"Not known","Not known",100,59,"17OH PROGESTERONE  19.8 TESTOSTERONE  10.4 ANDROSTENEDIONE 4.1 RENINA 26.1 ",,,,,,,,,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"No Concerns","Yes","Undertreatment","Yes",,"No",,"HC","No",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,14.49,,,,,,,,,,,,"Not known",,,,,,,,"3770 14/10/2019"
"Glasgow - RHC","United Kingdom",3770,"United Kingdom",,"16/05/2014","16/05/2007","Male",,,,,"Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"21/08/2015",,,3770,"7",,,,,,,"29/04/2020",54,163,,,20.32,1.56,"Not known","Not known",,,"17OH PROGESTERONE 34.5 TESTOS 12.1 ANDROSTENEDIONE 5.4 RENIN 20.8 ",,,,,,,,,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"No Concerns","No","Undertreatment","Yes",,"No",,"HC","No",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,14.75,,,,,,,,,,,,"Not known",,,,,,,,"3770 29/04/2020"
"Glasgow - RHC","United Kingdom",3770,"United Kingdom",,"16/05/2014","16/05/2007","Male",,,,,"Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"21/08/2015",,,3770,"7",,,,,,,"21/12/2020",57.5,167.5,,,20.49,1.64,"Not known","Not known",,,,,,,,,,,,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"No Concerns","Yes","Undertreatment","Yes",,"No",,"HC","No",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,,,,,,,,,,,,"Not known",,,,,,,,"3770 21/12/2020"
"Glasgow - RHC","United Kingdom",3770,"United Kingdom",,"16/05/2014","16/05/2007","Male",,,,,"Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"21/08/2015",,,3770,"7",,,,,,,"28/06/2021",60.45,170.5,,,20.79,1.69,"Not known","Not known",,,"ACTH: 24 17OHPROGE: 18.1 TESTOSTERONE 14.6 ANDROSTENEDIONE 4.8 ",,,,,,,,,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"No Concerns","No","Undertreatment","Yes",,"No",,"HC","No",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,15.25,,,,,,,,,,,,"Not known",,,,,,,,"3770 28/06/2021"
"Glasgow - RHC","United Kingdom",3770,"United Kingdom",,"16/05/2014","16/05/2007","Male",,,,,"Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"21/08/2015",,,3770,"7",,,,,,,"17/01/2022",69.05,172.7,,,23.15,1.82,"Not known","Not known",,,,,,,,,,,,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"No Concerns","No","Undertreatment","Yes",,"No",,"HC","No",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,,,,,,,,,,,,"Not known",,,,,,,,"3770 17/01/2022"
"Glasgow - RHC","United Kingdom",3770,"United Kingdom",,"16/05/2014","16/05/2007","Male",,,,,"Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"21/08/2015",,,3770,"7",,,,,,,"01/08/2022",71.05,174.4,,,23.36,1.86,"Not known","Not known",,,,,,,,,,,,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Yes","2  FRACTURES ","No Concerns","No","Undertreatment","Yes",,"No",,"HC","No",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,16.7,,,,,,,,,,,,"Not known",,,,,,,,"3770 01/08/2022"
"Glasgow - RHC","United Kingdom",3770,"United Kingdom",,"16/05/2014","16/05/2007","Male",,,,,"Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"21/08/2015",,,3770,"7",,,,,,,"25/02/2019",49.35,155.6,,,20.38,1.46,"Not known","Not known",100,64,"ACTH: 4 170H PROGESTERONE 7.1  TESTOSTERONE 0.8 ANDROSTENEDIONE 2.7 ",,,,,,,,,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"No Concerns","No","Undertreatment","Yes",,"No",,"HC","No",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,,,,,,,,,,,,"Not known",,,,,,,,"3770 25/02/2019"
"Glasgow - RHC","United Kingdom",6181,"United Kingdom","Active","08/01/2013","03/01/2013","Female",1916,,"37 weeks","Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"08/01/2013",,,6181,,,"Yes",,,,,"22/07/2019",18.6,119.8,,,12.96,0.79,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Yes","Undertreatment","Yes",,"No",,,"No",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"6181 22/07/2019"
"Glasgow - RHC","United Kingdom",6181,"United Kingdom","Active","08/01/2013","03/01/2013","Female",1916,,"37 weeks","Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"08/01/2013",,,6181,,,"Yes",,,,,"23/12/2019",20.25,124.7,,,13.02,0.84,,,91,54,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No","Undertreatment","Yes",,"No",,,"No",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"6181 23/12/2019"
"Glasgow - RHC","United Kingdom",6181,"United Kingdom","Active","08/01/2013","03/01/2013","Female",1916,,"37 weeks","Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"08/01/2013",,,6181,,,"Yes",,,,,"23/11/2020",22.75,131.6,,,13.14,0.91,,,93,70,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Yes","Undertreatment","Yes",,"Yes","OD","HC","No",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"6181 23/11/2020"
"Glasgow - RHC","United Kingdom",6181,"United Kingdom","Active","08/01/2013","03/01/2013","Female",1916,,"37 weeks","Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"08/01/2013",,,6181,,,"Yes",,,,,"19/04/2021",24.5,134.7,,,13.5,0.96,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No","Undertreatment","Yes",,"Yes","OD","HC","No",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"6181 19/04/2021"
"Glasgow - RHC","United Kingdom",6181,"United Kingdom","Active","08/01/2013","03/01/2013","Female",1916,,"37 weeks","Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"08/01/2013",,,6181,,,"Yes",,,,,"05/07/2021",24.5,134.7,,,13.5,0.96,,,93,63,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No","Undertreatment","Yes",,"Yes","OD","HC","No",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"6181 05/07/2021"
"Glasgow - RHC","United Kingdom",6181,"United Kingdom","Active","08/01/2013","03/01/2013","Female",1916,,"37 weeks","Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"08/01/2013",,,6181,,,"Yes",,,,,"08/11/2021",25.9,137.1,,,13.78,0.99,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No","Undertreatment","Yes",,"Yes","OD","HC","No",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"6181 08/11/2021"
"Glasgow - RHC","United Kingdom",6181,"United Kingdom","Active","08/01/2013","03/01/2013","Female",1916,,"37 weeks","Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"08/01/2013",,,6181,,,"Yes",,,,,"09/05/2022",26.85,140,,,13.7,1.02,,,100,60,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No","Undertreatment","Yes",,"Yes","OD","HC","No",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"6181 09/05/2022"
"Glasgow - RHC","United Kingdom",6181,"United Kingdom","Active","08/01/2013","03/01/2013","Female",1916,,"37 weeks","Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"08/01/2013",,,6181,,,"Yes",,,,,"14/11/2022",29.1,141.4,,,14.55,1.07,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Yes","Undertreatment","Yes",,"Yes","OD","HC","No",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"6181 14/11/2022"
"Glasgow - RHC","United Kingdom",6181,"United Kingdom","Active","08/01/2013","03/01/2013","Female",1916,,"37 weeks","Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"08/01/2013",,,6181,,,"Yes",,,,,"08/02/2016",11.66,92.4,,,13.66,0.55,"No","No",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No Concerns","Yes","Other","Yes",,"No","OD","HC","No",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"6181 08/02/2016"
"Glasgow - RHC","United Kingdom",6181,"United Kingdom","Active","08/01/2013","03/01/2013","Female",1916,,"37 weeks","Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"08/01/2013",,,6181,,,"Yes",,,,,"11/08/2016",13.04,97.4,,,13.75,0.59,"No","No",99,62,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No","Undertreatment","Yes",,"No","OD","HC","No",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"6181 11/08/2016"
"Glasgow - RHC","United Kingdom",6181,"United Kingdom","Active","08/01/2013","03/01/2013","Female",1916,,"37 weeks","Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"08/01/2013",,,6181,,,"Yes",,,,,"08/05/2017",14.7,103.5,,,13.72,0.65,"No","No",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No","Undertreatment","Yes",,"No","OD","HC","No",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"6181 08/05/2017"
"Glasgow - RHC","United Kingdom",6181,"United Kingdom","Active","08/01/2013","03/01/2013","Female",1916,,"37 weeks","Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"08/01/2013",,,6181,,,"Yes",,,,,"08/01/2018",15.95,108.4,,,13.57,0.69,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No","Undertreatment","Yes",,"No","OD","HC","No",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"6181 08/01/2018"
"Glasgow - RHC","United Kingdom",6181,"United Kingdom","Active","08/01/2013","03/01/2013","Female",1916,,"37 weeks","Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"08/01/2013",,,6181,,,"Yes",,,,,"11/06/2018",16.5,112.3,,,13.08,0.72,"No","No",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No","Undertreatment","Yes",,"No","OD","HC","No",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"6181 11/06/2018"
"Glasgow - RHC","United Kingdom",6181,"United Kingdom","Active","08/01/2013","03/01/2013","Female",1916,,"37 weeks","Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"08/01/2013",,,6181,,,"Yes",,,,,"09/10/2018",17.46,114.9,,,13.23,0.75,"No","No",104,69,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No","Undertreatment","Yes",,"No","OD","HC","No",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"6181 09/10/2018"
"Glasgow - RHC","United Kingdom",6184,"United Kingdom","Active","25/02/2019","28/08/2009","Female",3000,,"40 weeks","Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"01/12/2018",173,176,6184,"9",,"No","late onset CAH
diagnosed through Synacthen for ?precocious puberty",,,,"09/11/2020",79.7,159.7,,,31.25,1.88,,,,,"ACTH 16 17 OH PROGESTE: 74.8 TESTSOTERENOE 2.3 ANDREOSTE NEDIRO 13.9 ",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No Concerns","No",,"Yes",,"No",,"HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"Yes","thyroxine
salbutamol inhaler",,,,,,,,,,,,,,,,,,,,"168",,"6184 09/11/2020"
"Glasgow - RHC","United Kingdom",6184,"United Kingdom","Active","25/02/2019","28/08/2009","Female",3000,,"40 weeks","Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"01/12/2018",173,176,6184,"9",,"No","late onset CAH
diagnosed through Synacthen for ?precocious puberty",,,,"25/02/2019",67.8,155.8,,,27.93,1.71,,,124,74,"17 OH 20.3 TESTSOTERONE 2.5 ANDROPSTENEDIONE 11.2  RENINE 74.5 ","4",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No Concerns","No",,"Yes",,"No",,"HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"Yes","thyroxine
salbutamol inhaler","25/02/2019",15,,,,,,,,,,,,,,,,,,"168",,"6184 25/02/2019"
"Glasgow - RHC","United Kingdom",6187,"United Kingdom","Active","11/11/2019","15/03/2015","Male",3000,,"40 weeks","Yes","Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"01/04/2015",,,6187,"< 1 month",,"No",,,,,"10/02/2020",15,104.1,,,13.84,0.66,,,,,"17 OH PROGESTEROINE 47 TSTOSTERONE 1  ANDROSTENEDIONE 4 RENINE 423.8 ",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No Concerns","Yes","Undertreatment","Yes",,"Yes","OD","HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,,7.96,,,,,,,,,,,,,,,,,,,,"6187 10/02/2020"
"Glasgow - RHC","United Kingdom",6187,"United Kingdom","Active","11/11/2019","15/03/2015","Male",3000,,"40 weeks","Yes","Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"01/04/2015",,,6187,"< 1 month",,"No",,,,,"11/05/2020",,,,,,,,,,,"17 OH PROGESTERONE  40 TESTOSTERONE 0.7 ANDROSTENE 2.8 ",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No Concerns","No","Undertreatment","Yes",,"Yes","OD","HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,,,,,,,,,,,,,,,"6187 11/05/2020"
"Glasgow - RHC","United Kingdom",6187,"United Kingdom","Active","11/11/2019","15/03/2015","Male",3000,,"40 weeks","Yes","Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"01/04/2015",,,6187,"< 1 month",,"No",,,,,"18/01/2021",,,,,,,,,,,"ACTH 97  nA 139 k 3.7   17 OH PROIGESTERINE  149  TESTO 1.4 ANDROSTENE 6.8 TRNINR  55.8 ",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No Concerns","Yes","Undertreatment","Yes",,"Yes","OD","HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,,,,,,,,,,,,,,,"6187 18/01/2021"
"Glasgow - RHC","United Kingdom",6187,"United Kingdom","Active","11/11/2019","15/03/2015","Male",3000,,"40 weeks","Yes","Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"01/04/2015",,,6187,"< 1 month",,"No",,,,,"09/08/2021",19,118,,,13.65,0.79,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No Concerns","No","Undertreatment","Yes",,"Yes","OD","HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,,,,,,,,,,,,,,,"6187 09/08/2021"
"Glasgow - RHC","United Kingdom",6187,"United Kingdom","Active","11/11/2019","15/03/2015","Male",3000,,"40 weeks","Yes","Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"01/04/2015",,,6187,"< 1 month",,"No",,,,,"08/11/2022",21.9,127.8,,,13.41,0.88,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No Concerns","Yes","Undertreatment","Yes",,"Yes","OD","HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,,,,,,,,,,,,,,,"6187 08/11/2022"
"Glasgow - RHC","United Kingdom",6187,"United Kingdom","Active","11/11/2019","15/03/2015","Male",3000,,"40 weeks","Yes","Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"01/04/2015",,,6187,"< 1 month",,"No",,,,,"11/09/2019",15.15,106,,,13.48,0.67,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No Concerns","Yes",,"Yes",,"Yes","OD","HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,,,,,,,,,,,,,,,"6187 11/09/2019"
"Glasgow - RHC","United Kingdom",6187,"United Kingdom","Active","11/11/2019","15/03/2015","Male",3000,,"40 weeks","Yes","Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"01/04/2015",,,6187,"< 1 month",,"No",,,,,"08/11/2021",19,118,,,13.65,0.79,,,,,"ACTH  27 17 OH PROGESTERONE  36.5  TESTOSTERONE 0.5 RENINE 7-.7 ",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No Concerns","Yes","Undertreatment","Yes",,"Yes","OD","HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,,,,,,,,,,,,,,,"6187 08/11/2021"
"Glasgow - RHC","United Kingdom",6187,"United Kingdom","Active","11/11/2019","15/03/2015","Male",3000,,"40 weeks","Yes","Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"01/04/2015",,,6187,"< 1 month",,"No",,,,,"08/03/2023",23.45,130.7,,,13.73,0.92,,,,,"17OH PROG 11.6 
TESTOSTER 1  ANDROSTE 2 RENINE 166 ",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No Concerns","Yes","Undertreatment","Yes",,"Yes","OD","HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,,13.68,,,,,,,,,,,,,,,,,,,,"6187 08/03/2023"
"Glasgow - RHC","United Kingdom",6187,"United Kingdom","Active","11/11/2019","15/03/2015","Male",3000,,"40 weeks","Yes","Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"01/04/2015",,,6187,"< 1 month",,"No",,,,,"09/10/2023",25.6,133.6,,,14.34,0.97,,,119,72,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No Concerns","Yes","Undertreatment","Yes",,"Yes","OD","HC","No",,"No",,"No",,"Yes",,"No",,"No",,"No",,"No",,,,,,,,,"3","1",,6,6,,,,,,,,,,"6187 09/10/2023"
"Glasgow - RHC","United Kingdom",6191,"United Kingdom","Active","03/08/2020","17/08/2014","Female",,,"40 weeks","Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"14/09/2019",157,182,6191,"6",,,,"I",,,"11/09/2020",25.25,118.6,,,17.95,0.91,,,,,"17 OH > 151  TESTSOTERONE 0.6 ANDROSTENEDION 2.3  RENINRE  71.6 ",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No Concerns","Yes","Other","Yes","For sick days- hydrocortisone 5 mg tid oral or hydrocortisone 50 mg im","No",,"HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"Yes","inhaled steroids",,7.92,,,,,,,,,,,,,,,,,,"163",,"6191 11/09/2020"
"Glasgow - RHC","United Kingdom",6191,"United Kingdom","Active","03/08/2020","17/08/2014","Female",,,"40 weeks","Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"14/09/2019",157,182,6191,"6",,,,"I",,,"30/11/2020",26.2,119.1,,,18.47,0.93,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No Concerns","Yes","Other","Yes","For sick days- hydrocortisone 5 mg tid oral or hydrocortisone 50 mg im","No",,"HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"Yes","inhaled steroids",,,,,,,,,,,,,,,,,,,,"163",,"6191 30/11/2020"
"Glasgow - RHC","United Kingdom",6191,"United Kingdom","Active","03/08/2020","17/08/2014","Female",,,"40 weeks","Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"14/09/2019",157,182,6191,"6",,,,"I",,,"12/04/2021",26.3,121.3,,,17.87,0.94,,,99,55,"ACTH 6  17 OH 17.4 TESTOSTERONE < 0.5   ANDROSTENEDIONE 1.3 ",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No Concerns","Yes","Other","Yes","For sick days- hydrocortisone 5 mg tid oral or hydrocortisone 50 mg im","No",,"HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"Yes","inhaled steroids",,,,,,,,,,,,,,,,,,,,"163",,"6191 12/04/2021"
"Glasgow - RHC","United Kingdom",6191,"United Kingdom","Active","03/08/2020","17/08/2014","Female",,,"40 weeks","Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"14/09/2019",157,182,6191,"6",,,,"I",,,"28/03/2022",28.4,125.5,,,18.03,1,,,,,"17 OH PROGE>17.8 
TESTSOTE >0.5 
ANDROSTENE 1.1 
RENINE 75.2 ",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No Concerns","Yes","Other","Yes","For sick days- hydrocortisone 5 mg tds oral or hydrocortisone 50 mg im","No",,"HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"Yes","inhaled steroids",,,,,,,,,,,,,,,,,,,,"163",,"6191 28/03/2022"
"Glasgow - RHC","United Kingdom",6191,"United Kingdom","Active","03/08/2020","17/08/2014","Female",,,"40 weeks","Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"14/09/2019",157,182,6191,"6",,,,"I",,,"27/06/2022",30.1,127.3,,,18.57,1.03,,,115,62,"17 OH 3.2 TESTSOTERONE <0.5 ANDROSTENE 0.9 RENBINE 75.2 ",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No Concerns","Yes","Other","Yes","For sick days- hydrocortisone 5 mg tds oral or hydrocortisone 50 mg im","No",,"HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"Yes","inhaled steroids",,10.6,,,,,,,,,,,,,,,,,,"163",,"6191 27/06/2022"
"Glasgow - RHC","United Kingdom",6191,"United Kingdom","Active","03/08/2020","17/08/2014","Female",,,"40 weeks","Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"14/09/2019",157,182,6191,"6",,,,"I",,,"09/01/2023",33.2,130.5,,,19.49,1.1,,,99,62,"170H : 7.8 TESTOSTERONE 0.5  ANDROSTENEDIO 1.1 ",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No Concerns","Yes","Other","Yes","For sick days- hydrocortisone 5 mg tds oral or hydrocortisone 50 mg im","No",,"HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"Yes","inhaled steroids",,10.6,,,,,,,,,,,,,,,,,,"163",,"6191 09/01/2023"
"Glasgow - RHC","United Kingdom",6191,"United Kingdom","Active","03/08/2020","17/08/2014","Female",,,"40 weeks","Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"14/09/2019",157,182,6191,"6",,,,"I",,,"03/07/2023",33.5,131.7,,,19.31,1.11,,,,,"17 OH PROGESTERON 4.3 TESTESTERONE 0.5 ANDROSTE 1 RENINE 62 ","3","2",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No Concerns","Yes","Other","Yes","For sick days- hydrocortisone 5 mg tds oral or hydrocortisone 50 mg im","No",,"HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"Yes","inhaled steroids",,10.6,,,,,,,,,,,,,,,,,,"163",,"6191 03/07/2023"
"Glasgow - RHC","United Kingdom",6763,"United Kingdom",,"08/06/2015","16/05/2007","Male",3764,,,"Yes","Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,,190.5,6763,"7",,,,"III",,,"14/10/2019",50.3,159.1,,,19.87,1.49,,,100,59,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Yes","Undertreatment","Yes",,"No",,"HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,,,,,,,,,,,,,,,"6763 14/10/2019"
"Glasgow - RHC","United Kingdom",6763,"United Kingdom",,"08/06/2015","16/05/2007","Male",3764,,,"Yes","Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,,190.5,6763,"7",,,,"III",,,"29/04/2020",54,163,,,20.32,1.56,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No Concerns","No","Undertreatment","Yes",,"No",,"HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"08/04/2020",14.75,,,,,,,,,,,,,,,,,,,,"6763 29/04/2020"
"Glasgow - RHC","United Kingdom",6763,"United Kingdom",,"08/06/2015","16/05/2007","Male",3764,,,"Yes","Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,,190.5,6763,"7",,,,"III",,,"21/12/2020",57.5,167.5,,,20.49,1.64,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No Concerns","Yes","Undertreatment","Yes",,"No",,"HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,,,,,,,,,,,,,,,"6763 21/12/2020"
"Glasgow - RHC","United Kingdom",6763,"United Kingdom",,"08/06/2015","16/05/2007","Male",3764,,,"Yes","Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,,190.5,6763,"7",,,,"III",,,"28/06/2021",60.45,170.5,,,20.79,1.69,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No Concerns","Yes","Undertreatment","Yes",,"No",,"HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"28/06/2021",15.25,,"No",,,,,,,,,,,,,,,,,,"6763 28/06/2021"
"Glasgow - RHC","United Kingdom",6763,"United Kingdom",,"08/06/2015","16/05/2007","Male",3764,,,"Yes","Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,,190.5,6763,"7",,,,"III",,,"17/01/2022",69.05,172.7,,,23.15,1.82,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No Concerns","Yes","Undertreatment","Yes",,"No",,"HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,,,,,,,,,,,,,,,"6763 17/01/2022"
"Glasgow - RHC","United Kingdom",6763,"United Kingdom",,"08/06/2015","16/05/2007","Male",3764,,,"Yes","Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,,190.5,6763,"7",,,,"III",,,"01/08/2022",71.05,174.4,,,23.36,1.86,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No Concerns","Yes","Undertreatment","Yes",,"No",,"HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,,,,,,,,,,,,,,,"6763 01/08/2022"
"Glasgow - RHC","United Kingdom",6763,"United Kingdom",,"08/06/2015","16/05/2007","Male",3764,,,"Yes","Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,,190.5,6763,"7",,,,"III",,,"21/01/2016",34.2,142.2,,,16.91,1.16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No Concerns","Yes","Undertreatment","Yes",,"No",,"HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,,,,,,,,,,,,,,,"6763 21/01/2016"
"Glasgow - RHC","United Kingdom",6763,"United Kingdom",,"08/06/2015","16/05/2007","Male",3764,,,"Yes","Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,,190.5,6763,"7",,,,"III",,,"09/05/2016",39.2,144,,,18.9,1.25,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No Concerns","Yes","Undertreatment","Yes",,"No",,"HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,,,,,,,,,,,,,,,"6763 09/05/2016"
"Glasgow - RHC","United Kingdom",6763,"United Kingdom",,"08/06/2015","16/05/2007","Male",3764,,,"Yes","Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,,190.5,6763,"7",,,,"III",,,"13/03/2017",40.1,147.6,,,18.41,1.28,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No Concerns","Yes","Undertreatment","Yes",,"No",,"HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,,,,,,,,,,,,,,,"6763 13/03/2017"
"Glasgow - RHC","United Kingdom",6763,"United Kingdom",,"08/06/2015","16/05/2007","Male",3764,,,"Yes","Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,,190.5,6763,"7",,,,"III",,,"26/07/2017",42.1,149.2,,,18.91,1.32,"No","No",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No Concerns","Yes","Undertreatment","Yes",,"No",,"HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,,,,,,,,,,,,,,,"6763 26/07/2017"
"Glasgow - RHC","United Kingdom",6763,"United Kingdom",,"08/06/2015","16/05/2007","Male",3764,,,"Yes","Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,,190.5,6763,"7",,,,"III",,,"12/02/2018",44.9,151.2,,,19.64,1.37,,,98,53,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No Concerns","Yes","Undertreatment","Yes",,"No",,"HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,,,,,,,,,,,,,,,"6763 12/02/2018"
"Glasgow - RHC","United Kingdom",6763,"United Kingdom",,"08/06/2015","16/05/2007","Male",3764,,,"Yes","Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,,190.5,6763,"7",,,,"III",,,"13/08/2018",47.5,153.1,,,20.26,1.42,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No Concerns","Yes","Undertreatment","Yes",,"No",,"HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,,13.59,"TW20",,,,,,,,,,,,,,,,,,,"6763 13/08/2018"
"Glasgow - RHC","United Kingdom",6763,"United Kingdom",,"08/06/2015","16/05/2007","Male",3764,,,"Yes","Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,,190.5,6763,"7",,,,"III",,,"25/02/2019",49.35,155.6,,,20.38,1.46,,,100,64,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No Concerns","Yes","Undertreatment","Yes",,"No",,"HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,,,,,,,,,,,,,,,"6763 25/02/2019"
"Glasgow - RHC","United Kingdom",7853,"United Kingdom","Active","27/06/2022","16/06/2012","Male",,,,"Yes","Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"12/09/2022",,,7853,"10",,"No",,,,,"27/06/2022",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No Concerns","No",,"Yes",,"No",,"HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,,,,,,,,,,,,,,,"7853 27/06/2022"
"Glasgow - RHC","United Kingdom",7853,"United Kingdom","Active","27/06/2022","16/06/2012","Male",,,,"Yes","Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"12/09/2022",,,7853,"10",,"No",,,,,"12/09/2022",34.4,146.9,,,15.94,1.18,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No Concerns","No",,"Yes",,"No",,"HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,,,,,,,,,,,,,,,"7853 12/09/2022"
"Glasgow - RHC","United Kingdom",7853,"United Kingdom","Active","27/06/2022","16/06/2012","Male",,,,"Yes","Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"12/09/2022",,,7853,"10",,"No",,,,,"13/02/2023",37.16,149,,,16.74,1.24,"No","No",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No Concerns","No",,"Yes",,"No",,"HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,,,,,,,,,,,,,,,"7853 13/02/2023"
"Leeds - LCH","United Kingdom",6809,"United Kingdom","Active","23/08/2013","16/02/2008","Male",,,,"Yes","Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"27/08/2013",,,6809,"5",,"Not known",,"Normal Male",,,"09/12/2021",53.35,171.1,,,18.22,1.59,"No","Not Applicable",,,,,,,,,,,,,,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"No",,"Some Concerns","Yes","Undertreatment","Yes",,"No",,,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,,,,,,,,,,,,,,,"6809 09/12/2021"
"Leeds - LCH","United Kingdom",6809,"United Kingdom","Active","23/08/2013","16/02/2008","Male",,,,"Yes","Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"27/08/2013",,,6809,"5",,"Not known",,"Normal Male",,,"15/07/2016",32.75,147.8,,,14.99,1.16,"No","Yes",,,,,,,,,,,,,,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"No",,"No Concerns","No","Undertreatment","Yes",,"No",,,"No",,"No",,"No",,"Yes","Decapeptyl 11.25 mg IM 10 weekly","No",,"No",,"No",,"No",,"28/04/2017",12.46,"TW20","Not Known",,,,,"2",,6,6,"Normal","No",,,,,"not_known",,,"6809 15/07/2016"
"Leeds - LCH","United Kingdom",6891,"United Kingdom","Active","04/12/2012","07/11/2012","Female",4020,,,"Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,,,6891,"< 1 month",,"No",,"II",,,"27/10/2022",37,153.7,,,15.66,1.26,"No","Not known",,,,"1","1","1",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Some Concerns","Yes","Undertreatment","Yes",,"Yes","OD",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,,,,,,,,,,,,,,,"6891 27/10/2022"
"Leeds - LCH","United Kingdom",7223,"United Kingdom","Active","22/04/2017","26/10/2016","Male",2380,,"37 weeks","Yes","Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"07/09/2018",,,7223,"2",,"No","noted general penile length","Normal Male",,,"07/10/2021",21.5,117.6,,,15.55,0.84,"No","Yes",,,,,,,,,,,,,,"No",,"No",,"No",,"No",,"No",,"No",,"Yes","on levothyroxine","No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"Not known",,"No",,"No Concerns","Yes","Undertreatment","Yes",,"No",,"HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"02/10/2020",8.52,,"Not Known",,,,,,,,,,,,,,,,,,"7223 07/10/2021"
"Leeds - LCH","United Kingdom",7223,"United Kingdom","Active","22/04/2017","26/10/2016","Male",2380,,"37 weeks","Yes","Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"07/09/2018",,,7223,"2",,"No","noted general penile length","Normal Male",,,"09/02/2023",,,,,,,"No","Yes",,,,,,,,,,,,,,"No",,"No",,"No",,"No",,"No",,"No",,"Yes","on levothyroxine","No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"Not known",,"No",,"No Concerns","Yes","Undertreatment","Yes",,"No",,"HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"02/10/2020",8.52,,"Not Known",,,,,,,,,,,,,,,,,,"7223 09/02/2023"
"Leeds - LCH","United Kingdom",7256,"United Kingdom","Active","15/06/2012","12/06/2012","Female",,,"40 weeks","Yes","Female","Not known",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"15/06/2012",,,7256,"< 1 month",,,"family history of CAH ",,,,"01/10/2020",7.4,62.7,,,18.82,0.36,"No","Yes",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No Concerns","Not known",,"Yes",,"Yes","OD","HC","Yes","4mmol QDS",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"7256 01/10/2020"
"Leeds - LCH","United Kingdom",7652,"United Kingdom","Active","18/01/2008","11/01/2008","Female",,,,"Yes","Female","Not known",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,,,7652,,,,,,,,"17/09/2021",62.7,151.1,,,27.46,1.62,"No","Not known",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No Concerns","No",,"Yes",,"Yes","OD","HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,,,,,,,,,,,,,,,"7652 17/09/2021"
"Leeds - LCH","United Kingdom",7652,"United Kingdom","Active","18/01/2008","11/01/2008","Female",,,,"Yes","Female","Not known",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,,,7652,,,,,,,,"10/06/2022",66,151.3,,,28.83,1.67,"No","Not known",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No Concerns","No",,"Yes",,"Yes","OD","HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,,,,,,,,,,,,,,,"7652 10/06/2022"
"Leeds - LCH","United Kingdom",7653,"United Kingdom","Active","16/06/2010","10/06/2010","Male",,,,"Yes","Male","Not known",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,,,7653,"< 1 month",,"Not known",,,,,"10/06/2022",47.5,155.1,,,19.75,1.43,"No","Not known",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No Concerns","No",,"Yes",,"Yes","OD","HC","No",,"No",,"No",,"Yes",,"No",,"No",,"No",,"No",,,,,,,,,"5","5","2",5,5,,,,,,,,,,"7653 10/06/2022"
"Leeds - LCH","United Kingdom",7653,"United Kingdom","Active","16/06/2010","10/06/2010","Male",,,,"Yes","Male","Not known",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,,,7653,"< 1 month",,"Not known",,,,,"17/09/2021",45.75,153.7,,,19.37,1.4,"No","Not Applicable",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No Concerns","Yes","Other","Yes",,"Yes","OD","HC","No",,"No",,"No",,"Yes",,"No",,"No",,"No",,"No",,,16.3,"TW20","No",,,,"5","5","2",5,5,,,,,,,,,,"7653 17/09/2021"
"Leeds - LCH","United Kingdom",7653,"United Kingdom","Active","16/06/2010","10/06/2010","Male",,,,"Yes","Male","Not known",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,,,7653,"< 1 month",,"Not known",,,,,"17/11/2022",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No Concerns","No",,"Yes",,"Yes","OD","HC","No",,"No",,"No",,"Yes",,"No",,"No",,"No",,"No",,,,,,,,,"5","5","2",5,5,,,,,,,,,,"7653 17/11/2022"
"Leicester - LRI","United Kingdom",7789,"United Kingdom","Active","23/01/2019","11/03/2016","Female",,,"40 weeks","Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"11/02/2019",166,175,7789,"2",,"No",,"V",,,"23/04/2023",44.2,137,,,23.55,1.3,"No","No",104,52,,"1","2","2",,,"No",,,,,"Yes",,"Yes",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No Concerns","No",,"Yes",,"No",,"HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"Yes","Anastrozole","24/04/2023",11.5,"Greulich & Pyle","No",,,,,,,,,,,,,,,,"164",,"7789 23/04/2023"
"Leicester - LRI","United Kingdom",7789,"United Kingdom","Active","23/01/2019","11/03/2016","Female",,,"40 weeks","Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"11/02/2019",166,175,7789,"2",,"No",,"V",,,"27/09/2023",45.7,140.7,,,23.08,1.34,"No","No",,,,"1","2","2",,,"No",,,,,"Yes",,"Yes",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No Concerns","No",,"Yes",,"No",,"HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"Yes","Anastrozole","24/04/2023",11.5,"Greulich & Pyle","No",,,,,,,,,,,,,,,,"164",,"7789 27/09/2023"
"Leicester - LRI","United Kingdom",7789,"United Kingdom","Active","23/01/2019","11/03/2016","Female",,,"40 weeks","Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"11/02/2019",166,175,7789,"2",,"No",,"V",,,"23/03/2022",33.5,127.8,,,20.51,1.09,"No","No",,,,"1","2","2",,,"No",,,,,"Yes",,"Yes",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No Concerns","No",,"Yes",,"No",,"HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"Yes","Anastrozole","24/04/2023",11.5,"Greulich & Pyle","No",,,,,,,,,,,,,,,,"164",,"7789 23/03/2022"
"Leicester - LRI","United Kingdom",7789,"United Kingdom","Active","23/01/2019","11/03/2016","Female",,,"40 weeks","Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"11/02/2019",166,175,7789,"2",,"No",,"V",,,"12/10/2022",38.9,131.9,,,22.36,1.19,"No","No",104,52,,"1","2","2",,,"No",,,,,"Yes",,"Yes",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No Concerns","No",,"Yes",,"No",,"HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"Yes","Anastrozole","24/04/2023",11.5,"Greulich & Pyle","No",,,,,,,,,,,,,,,,"164",,"7789 12/10/2022"
"Leicester - LRI","United Kingdom",7789,"United Kingdom","Active","23/01/2019","11/03/2016","Female",,,"40 weeks","Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"11/02/2019",166,175,7789,"2",,"No",,"V",,,"22/09/2021",31.9,123,,,21.09,1.04,"No","No",,,,"1","2","2",,,"No",,,,,"Yes",,"Yes",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No Concerns","No",,"Yes",,"No",,"HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"Yes","Anastrozole","22/09/2021",9,"Greulich & Pyle","No",,,,,,,,,,,,,,,,"164",,"7789 22/09/2021"
"Leicester - LRI","United Kingdom",7971,"United Kingdom","Active","30/08/2012","29/08/2012","Female",2340,,"38 weeks","Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"31/08/2012",,,7971,"< 1 month",,"No",,"V",,,"19/12/2022",48.3,144.8,,,23.04,1.39,"No","No",123,73,,"1","2","2","Not known",,,,,,,"Yes",,"Yes",,"No",,"No",,"No",,"No",,"No",,"Not known",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Some Concerns","Yes","Dose adjustment for size","Yes",,"Yes","OD","HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"09/09/2020",11.67,"Greulich & Pyle","Not Known",,,,,,,,,,,,,,,,,,"7971 19/12/2022"
"Leicester - LRI","United Kingdom",7971,"United Kingdom","Active","30/08/2012","29/08/2012","Female",2340,,"38 weeks","Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"31/08/2012",,,7971,"< 1 month",,"No",,"V",,,"23/03/2016",14.66,91.5,,,17.51,0.61,"No","No",90,40,,"1","2","2","Not known",,,,,,,"Yes",,"No",,"No",,"No",,"No",,"No",,"No",,"Not known",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No Concerns","No",,"Yes","HC 15.4mg/m2/day","Yes","OD","HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"09/09/2020",11.67,"Greulich & Pyle","Not Known",,,,,,,,,,,,,,,,,,"7971 23/03/2016"
"Leicester - LRI","United Kingdom",7971,"United Kingdom","Active","30/08/2012","29/08/2012","Female",2340,,"38 weeks","Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"31/08/2012",,,7971,"< 1 month",,"No",,"V",,,"29/07/2019",28.2,120.9,,,19.29,0.97,"No","No",96,76,,"1","2","2","Not known",,,,,,,"Yes",,"Yes",,"No",,"No",,"No",,"No",,"No",,"Not known",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No Concerns","No",,"Yes",,"Yes","OD","HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"09/09/2020",11.67,"Greulich & Pyle","Not Known",,,,,,,,,,,,,,,,,,"7971 29/07/2019"
"Leicester - LRI","United Kingdom",7971,"United Kingdom","Active","30/08/2012","29/08/2012","Female",2340,,"38 weeks","Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"31/08/2012",,,7971,"< 1 month",,"No",,"V",,,"29/11/2023",57.9,147.7,,,26.54,1.54,"No","No",126,78,,"2","2","2","Not known",,"No",,,,,"Yes",,"Yes",,"No",,"No",,"No",,"No",,"No",,"Not known",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Some Concerns","Yes","Dose adjustment for size","Yes",,"Yes","OD","HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"28/06/2023",13.2,"Greulich & Pyle","No",,,,,,,,,,,,,,,,,,"7971 29/11/2023"
"Leicester - LRI","United Kingdom",8754,"United Kingdom","Active","26/05/2010","08/01/2010","Female",3400,,"37 weeks","Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"19/01/2010",,,8754,"< 1 month",,"No",,"V",,,"14/06/2017",30.8,123.3,,,20.26,1.03,"No","No",,,,,,,,,,,,,,"Yes",,"Yes",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No Concerns","No",,"Yes",,"Yes","OD","HC","Yes",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,"Not Known",,,,,,,,,,,,,,,,,,"8754 14/06/2017"
"Leicester - LRI","United Kingdom",8754,"United Kingdom","Active","26/05/2010","08/01/2010","Female",3400,,"37 weeks","Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"19/01/2010",,,8754,"< 1 month",,"No",,"V",,,"23/03/2016",24.3,115,,,18.37,0.88,"No","No",,,,,,,,,,,,,,"Yes",,"Yes",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No Concerns","No",,"Yes",,"Yes","OD","HC","Yes",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,"Not Known",,,,,,,,,,,,,,,,,,"8754 23/03/2016"
"Leicester - LRI","United Kingdom",8754,"United Kingdom","Active","26/05/2010","08/01/2010","Female",3400,,"37 weeks","Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"19/01/2010",,,8754,"< 1 month",,"No",,"V",,,"24/07/2023",71.8,157.5,,,28.94,1.77,"No","No",,,,"5","5","3","Spontaneous",12,"Yes",,,,,"Yes",,"Yes",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No Concerns","No",,"Yes",,"Yes","OD","HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,"Not Known",,,,,,,,,,,,,,,,,,"8754 24/07/2023"
"Leicester - LRI","United Kingdom",8754,"United Kingdom","Active","26/05/2010","08/01/2010","Female",3400,,"37 weeks","Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"19/01/2010",,,8754,"< 1 month",,"No",,"V",,,"04/07/2022",68.3,153.8,,,28.87,1.71,"No","No",110,70,,"5","5","3","Spontaneous",12,"Yes",,,,,"Yes",,"Yes",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Some Concerns","No",,"Yes","10mg Hydrocortisone three times daily","Yes","OD","HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,"Not Known",,,,,,,,,,,,,,,,,,"8754 04/07/2022"
"Leicester - LRI","United Kingdom",8754,"United Kingdom","Active","26/05/2010","08/01/2010","Female",3400,,"37 weeks","Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"19/01/2010",,,8754,"< 1 month",,"No",,"V",,,"07/02/2024",55,158.8,,,21.81,1.56,"No","No",113,46,,"5","5","3","Spontaneous",12,"Yes",,,,,"Yes",,"Yes",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No Concerns","No",,"Yes",,"Yes","OD","HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,"Not Known",,,,,,,,,,,,,,,,,,"8754 07/02/2024"
"Leicester - LRI","United Kingdom",8756,"United Kingdom","Active","09/02/2009","06/07/2008","Female",3000,,"36 weeks","Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"04/09/2008",,,8756,"< 1 month",,"No","presented with failure to thrive - noted to have clitoromegaly on first assessment , Sodium 131, potassium 6.2 nmol/L","II",,,"24/07/2023",77.6,164.5,,,28.68,1.88,"No","No",126,60,,"5","5","3","Spontaneous",12,"Yes",,,,,,,"Yes",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No Concerns","No",,"Yes",,"Yes","OD","HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,,,,,,,,,,,,,,,"8756 24/07/2023"
"Leicester - LRI","United Kingdom",8756,"United Kingdom","Active","09/02/2009","06/07/2008","Female",3000,,"36 weeks","Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"04/09/2008",,,8756,"< 1 month",,"No","presented with failure to thrive - noted to have clitoromegaly on first assessment , Sodium 131, potassium 6.2 nmol/L","II",,,"04/07/2022",74,164,,,27.51,1.84,"No","No",110,60,,"5","5","3","Spontaneous",12,"Yes",,,,,,,"Yes",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No Concerns","No",,"Yes","Hydrocortisone tablet 10mg three times daily","Yes","OD","HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,,,,,,,,,,,,,,,"8756 04/07/2022"
"Leicester - LRI","United Kingdom",8756,"United Kingdom","Active","09/02/2009","06/07/2008","Female",3000,,"36 weeks","Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"04/09/2008",,,8756,"< 1 month",,"No","presented with failure to thrive - noted to have clitoromegaly on first assessment , Sodium 131, potassium 6.2 nmol/L","II",,,"07/02/2024",74.2,165,,,27.25,1.84,"No","No",131,67,,"5","5","3","Spontaneous",12,"Yes",,,,,,,"Yes",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No Concerns","No",,"Yes",,"Yes","OD","HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,,,,,,,,,,,,,,,"8756 07/02/2024"
"Leicester - LRI","United Kingdom",8962,"United Kingdom","Active","21/07/2008","23/11/2007","Female",,,,"Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"29/10/2008",152,165,8962,"3 months - 1 year",,"No",,"IV",,,"04/09/2023",87.9,155.5,,,36.35,1.95,"No","No",111,78,,"5","5","3","Spontaneous",14,"Yes","Not known",,,"No","Yes","EUA post surgery 13/03/2012","Yes","Genital correction surgery 09/08/2011","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Current",,"No",,"No",,"Not known",,"No",,"No",,"No",,"No",,"No Concerns","No",,"Yes",,"No",,"HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,"No",,,,,,,,,,,,,,,,"152",,"8962 04/09/2023"
"Leicester - LRI","United Kingdom",8962,"United Kingdom","Active","21/07/2008","23/11/2007","Female",,,,"Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"29/10/2008",152,165,8962,"3 months - 1 year",,"No",,"IV",,,"06/06/2022",79.1,155,,,32.92,1.85,"No","Not known",,,,"5","5","3","Spontaneous",14,"Yes","Not known",,,"No","Yes","EUA post surgery 13/03/2012","Yes","Genital correction surgery 09/08/2011","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Current",,"No",,"No",,"Not known",,"No",,"No",,"No",,"No",,"Some Concerns","No",,"Yes",,"No",,"HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"02/08/2017",11,"Greulich & Pyle","No",,,,,,,,,,,,,,,,"152",,"8962 06/06/2022"
"Leicester - LRI","United Kingdom",9546,"United Kingdom","Active","15/07/2013","20/02/2008","Male",,,,"Yes","Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"15/07/2013",161.2,185.5,9546,"5",,"No","Genital stage 4
Bone age 13 years at diagnosis when chronological age 5yrs 5 months","Normal Male",,,"04/03/2024",53.2,159.5,,,20.91,1.54,"No","Not Applicable",121,72,,,,,,,,,,,,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No Concerns","No",,"Yes",,"No",,,"No",,"No",,"No",,"Yes","2014 to July 2021 then stopped","No",,"No",,"No",,"No",,"04/03/2024",18,"Greulich & Pyle","No",,,,"5","5","3",15,15,"Normal","No","yes","No",,,"no","179.85",,"9546 04/03/2024"
"Leicester - LRI","United Kingdom",9546,"United Kingdom","Active","15/07/2013","20/02/2008","Male",,,,"Yes","Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"15/07/2013",161.2,185.5,9546,"5",,"No","Genital stage 4
Bone age 13 years at diagnosis when chronological age 5yrs 5 months","Normal Male",,,"05/09/2022",51,159,,,20.17,1.5,"No","Not Applicable",,,,,,,,,,,,,,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Some Concerns","No",,"Yes","hydrocortisone 10mg Am, 10 mg afternoon, 5 mg nocte","No",,,"No",,"No",,"No",,"Yes","2014 to July 2021 then stopped","No",,"No",,"No",,"No",,"13/09/2022",16.7,"Greulich & Pyle","No",,,,"5","5","3",15,15,"Normal","No","yes","No",,,"no","179.85",,"9546 05/09/2022"
"London - KCH","United Kingdom",9428,"United Kingdom",,,"02/12/2010","Male",,,,"Yes","Male","Not known",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,170,179.1,9428,"< 1 month",,"No",,"Normal Male",,,"12/01/2024",50,171.5,,,17,1.54,"No","Not Applicable",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No Concerns","No",,"Yes",,"Yes","OD","HC","No",,"No",,"No",,"No",,"No",,,,,,,,"15/09/2023",13.5,"Greulich & Pyle","No",,,,"4","4",,12,12,"Normal","No",,,,,,"181.05",,"9428 12/01/2024"
"London - KCH","United Kingdom",9428,"United Kingdom",,,"02/12/2010","Male",,,,"Yes","Male","Not known",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,170,179.1,9428,"< 1 month",,"No",,"Normal Male",,,"15/09/2023",48.1,166.3,,,17.39,1.49,"No","Not Applicable",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No Concerns","No",,"Yes","7.5mg morning - 5mg at lunch time and 2.5mg at bedtime","Yes","OD","HC","No",,"No",,"No",,"No",,"No",,,,,,,,"15/09/2023",13.5,"Greulich & Pyle","No",,,,"4","4",,12,12,"Normal","No",,,,,,"181.05",,"9428 15/09/2023"
"London - KCH","United Kingdom",9434,"United Kingdom","Active",,"02/06/2013","Female",,,,"Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"11/06/2013",160,185.4,9434,"< 1 month",,"No",,"II",,,"02/02/2024",47.4,152.5,,,20.38,1.42,"No","No",109,65,,"3",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Yes","Hypermobility (Ehlers Danlos syndrome - deletion/conversion of TNXB gene","No Concerns","No",,"Yes",,"Yes","BD","HC","No",,"No",,,,"No",,"No",,,,"No",,,,,,,,,,,,,,,,,,,,,,,"166.2",,"9434 02/02/2024"
"London - KCH","United Kingdom",9434,"United Kingdom","Active",,"02/06/2013","Female",,,,"Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"11/06/2013",160,185.4,9434,"< 1 month",,"No",,"II",,,"30/06/2023",41.9,148,,,19.13,1.31,"No","No",,,,"3",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Yes","Hypermobility (Ehlers Danlos syndrome - deletion/conversion of TNXB gene","No Concerns","No",,"Yes",,"Yes","BD","HC","No",,"No",,,,"No",,"No",,,,"No",,,,,,,,,,,,,,,,,,,,,,,"166.2",,"9434 30/06/2023"
"London - KCH","United Kingdom",9434,"United Kingdom","Active",,"02/06/2013","Female",,,,"Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"11/06/2013",160,185.4,9434,"< 1 month",,"No",,"II",,,"16/09/2022",37,141.5,,,18.48,1.21,"No","No",,,,"2","1","1",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Yes","Hypermobility (Ehlers Danlos syndrome - deletion/conversion of TNXB gene","No Concerns","No",,"Yes",,"Yes","BD","HC","No",,"No",,,,"No",,"No",,,,"No",,,,,,,,,,,,,,,,,,,,,,,"166.2",,"9434 16/09/2022"
"London - KCH","United Kingdom",9434,"United Kingdom","Active",,"02/06/2013","Female",,,,"Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"11/06/2013",160,185.4,9434,"< 1 month",,"No",,"II",,,"03/09/2021",33,134,,,18.38,1.11,"No","No",,,,"1","1","1",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Yes","Hypermobility (Ehlers Danlos syndrome - deletion/conversion of TNXB gene","No Concerns","No",,"Yes",,"Yes","BD","HC","No",,"No",,,,"No",,"No",,,,"No",,,,,,,,,,,,,,,,,,,,,,,"166.2",,"9434 03/09/2021"
"London - KCH","United Kingdom",9434,"United Kingdom","Active",,"02/06/2013","Female",,,,"Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"11/06/2013",160,185.4,9434,"< 1 month",,"No",,"II",,,"11/03/2022",33.9,137.4,,,17.96,1.14,"No","No",,,,"3",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Yes","Hypermobility (Ehlers Danlos syndrome - deletion/conversion of TNXB gene","No Concerns","No",,"Yes",,"Yes","BD","HC","No",,"No",,,,"No",,"No",,,,"No",,,,,,,,,,,,,,,,,,,,,,,"166.2",,"9434 11/03/2022"
"London - QMUL - Barts adults","United Kingdom",4470,"United Kingdom",,"01/01/2015","01/01/2011","Male",3040,51,"40 weeks",,"Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,,,4470,"4",,"No",,,,,"02/06/2016",28.9,129.7,,,17.18,1.02,"No","Yes",103,65,"none",,,,,,,,,,,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,,"Yes","Other","Yes",,"No",,"HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"02/06/2016",10,,"Not Known",,,,"4","1","1",2,2,,"Not known","not_known","No","No",,"no",,,"4470 02/06/2016"
"London - QMUL - Barts adults","United Kingdom",4470,"United Kingdom",,"01/01/2015","01/01/2011","Male",3040,51,"40 weeks",,"Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,,,4470,"4",,"No",,,,,"14/02/2019",44.8,148.6,,,20.29,1.36,"No","Yes",125,79,,,,,,,,,,,,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No Concerns","Yes","Dose adjustment for size",,,"No",,"HC","No",,"No",,"No",,"Yes","Decapeptyl 11.25mg x 12weeks","No",,"No",,"No",,"No",,,,,,,,,"4","2","1",6,5,,"Not known","not_known","No","No",,"no",,,"4470 14/02/2019"
"London - QMUL - Barts paeds","United Kingdom",3049,"United Kingdom",,"01/04/2015","21/01/2015","Female",1980,,"35 weeks",,"Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,,,3049,"1 - 3 months",,"No",,,,,"14/04/2016",6.85,69.8,,,14.06,0.36,"Not known","Not known",,,,,,,,,,,,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"No Concerns","No","Not Applicable","Yes",,"Yes","OD",,"Yes","5mmol/ml QDS",,,,,,,,,,,,,,,,,,"Not Known",,,,,,,,,,"Not known",,,,,,,,"3049 14/04/2016"
"London - QMUL - Barts paeds","United Kingdom",3049,"United Kingdom",,"01/04/2015","21/01/2015","Female",1980,,"35 weeks",,"Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,,,3049,"1 - 3 months",,"No",,,,,"04/10/2016",,,,,,,"Not known","Not known",,,,,,,,,,,,,,"Not known",,"Yes","7.7.2016 Vaginoplasty","Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"No Concerns","Yes","Other","Yes",,"Yes","OD","HC","Yes","5mmol/ml QDS",,,,,,,,,,,,,"Yes","Abidec 0.6ml OD
Domperidone 2mg TDS",,,,,,,,,,,,,,"Not known",,,,,,,,"3049 04/10/2016"
"London - QMUL - Barts paeds","United Kingdom",3049,"United Kingdom",,"01/04/2015","21/01/2015","Female",1980,,"35 weeks",,"Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,,,3049,"1 - 3 months",,"No",,,,,"17/01/2017",8.6,78.4,,,13.99,0.43,"Not known","Not known",90,55,,,,,,,,,,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known","Prescription lowered",,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"No Concerns","Yes","Other","Yes",,"Yes","OD","HC","Yes","5mmol/ml QDS",,,,,,,,,,,,,"Yes","Abidec 0.6ml OD
Domperidone 2mg TDS",,,,,,,,,,,,,,"Not known",,,,,,,,"3049 17/01/2017"
"London - QMUL - Barts paeds","United Kingdom",3049,"United Kingdom",,"01/04/2015","21/01/2015","Female",1980,,"35 weeks",,"Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,,,3049,"1 - 3 months",,"No",,,,,"06/04/2017",9,77.9,,,14.83,0.44,"Not known","Not known",,,,,,,,,,,,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"No Concerns","No","Not Applicable",,,"Yes","OD","HC","Yes","5mmol/ml QDS",,,,,,,,,,,,,"No","Abidec 0.6ml OD
Domperidone 2mg TDS",,,,,,,,,,,,,,"Not known",,,,,,,,"3049 06/04/2017"
"London - QMUL - Barts paeds","United Kingdom",3049,"United Kingdom",,"01/04/2015","21/01/2015","Female",1980,,"35 weeks",,"Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,,,3049,"1 - 3 months",,"No",,,,,"14/06/2018",11.7,90.2,,,14.38,0.54,"Not known","Not known",,,,,,,,,,,,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,"No","Not Applicable",,,"Yes","OD","HC","Yes","5mmol/ml QDS",,,,,,,,,,,,,"No","Abidec 0.6ml OD
Domperidone 2mg TDS",,,,,,,,,,,,,,"Not known",,,,,,,,"3049 14/06/2018"
"London - QMUL - Barts paeds","United Kingdom",3332,"United Kingdom",,"15/01/2017","01/01/2017","Female",,,"41 weeks",,"Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,,,3332,"< 1 month",,"No","Salt-losing, ambiguous genitalia, diagnosis made based on urine steroid profile soon after birth","III",,,"04/05/2017",3.42,50.6,,,13.36,0.22,"Not known","Not known",,,,,,,,,,,,,,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No Concerns","No","Not Applicable","Yes",,"Yes","OD","HC","Yes","5.233ol every 4 hours (10mml/kg/day)","No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,"Not Known",,,,,,,,,,"Not known",,,,,,,,"3332 04/05/2017"
"London - QMUL - Barts paeds","United Kingdom",3332,"United Kingdom",,"15/01/2017","01/01/2017","Female",,,"41 weeks",,"Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,,,3332,"< 1 month",,"No","Salt-losing, ambiguous genitalia, diagnosis made based on urine steroid profile soon after birth","III",,,"16/06/2017",5.01,58.5,,,14.64,0.29,"Not known","Not known",,,"Labia less rugaed, clitoromegaly",,,,,,,,,,,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No Concerns","No","Not Applicable","Yes",,"Yes","OD","HC","Yes","5.2ml every 4 hours (10mml/kg/day)","No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,,,,,,,"Not known",,,,,,,,"3332 16/06/2017"
"London - QMUL - Barts paeds","United Kingdom",9505,"United Kingdom","Active","22/10/2018","01/07/2016","Not assigned",,,"37 weeks","Not known","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,163,178,9505,"< 1 month",,"No","Mum was told might be male on prenatal scan. Presented at birth with ambiguous genitalia in Colombia. Underwent clitoral reduction surgery at 1 month of life and vaginoplasty 4 months later. ","Not Known",,,"09/01/2024",27.6,116.3,,,20.41,0.94,,"No",,,,,,,,,,,,,,,,"Yes","Clitoral reduction at 1 month of age, vaginoplasty at 5 months of age
Cystovaginosocpy done at 5 years of age ","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"Yes","Asthma","No Concerns","No",,"Yes","HC 2mg, 1.5mg, 1.5mg, 2mg (total 7mg) ","Yes","OD","HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"Yes","Salbutamol inhaler PRN 
","23/03/2023",6.8,"Radius-ulna-short bone",,,,,,,,,,,,,,,,,"(Male) 177 (Female) 164",,"9505 09/01/2024"
"Manchester - RMCH","United Kingdom",8846,"United Kingdom","Active","08/01/2006","26/12/2005","Male",2630,,"36 weeks","Yes","Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"08/01/2006",162.5,187.9,8846,"< 1 month",,"No",,"Normal Male",,,"10/05/2016",53.8,147.2,,,24.83,1.48,"No","No",,,,,,,,,,,,,,"No",,"No",,"Yes","Bilateral hydronephrosis","No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No Concerns","Yes","Undertreatment","Yes",,"Yes","OD","HC","No","2g OD","No",,"No",,"No",,"No",,"No",,"No",,"No",,"11/12/2015",13,"Greulich & Pyle",,,,,"1","2",,4,4,,"No",,,,,,"181.7",,"8846 10/05/2016"
"Manchester - RMCH","United Kingdom",8846,"United Kingdom","Active","08/01/2006","26/12/2005","Male",2630,,"36 weeks","Yes","Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"08/01/2006",162.5,187.9,8846,"< 1 month",,"No",,"Normal Male",,,"12/05/2017",54.1,151.3,,,23.63,1.51,"No","No",,,,,,,,,,,,,,"No",,"No",,"Yes","Bilateral hydronephrosis","No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No Concerns","Yes","Dose adjustment for size","Yes",,"Yes","OD","HC","No","2g OD","No",,"No",,"No",,"No",,"No",,"No",,"No",,"11/12/2015",13,"Greulich & Pyle",,,,,"1","2",,4,4,,"No",,,,,,"181.7",,"8846 12/05/2017"
"Manchester - RMCH","United Kingdom",8846,"United Kingdom","Active","08/01/2006","26/12/2005","Male",2630,,"36 weeks","Yes","Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"08/01/2006",162.5,187.9,8846,"< 1 month",,"No",,"Normal Male",,,"09/11/2018",60.25,163.2,,,22.62,1.65,"No","No",,,,,,,,,,,,,,"No",,"No",,"Yes","Bilateral hydronephrosis","No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No Concerns","No","Dose adjustment for size","Yes",,"Yes","OD","HC","No","2g OD","No",,"No",,"No",,"No",,"No",,"No",,"No",,"11/12/2015",13,"Greulich & Pyle",,,,,"4","3","2",12,12,,"No",,,,,,"181.7",,"8846 09/11/2018"
"Manchester - RMCH","United Kingdom",8846,"United Kingdom","Active","08/01/2006","26/12/2005","Male",2630,,"36 weeks","Yes","Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"08/01/2006",162.5,187.9,8846,"< 1 month",,"No",,"Normal Male",,,"08/03/2019",60.7,164.5,,,22.43,1.67,"No","No",124,70,,,,,,,,,,,,"No",,"No",,"Yes","Bilateral hydronephrosis","No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No Concerns","Yes","Undertreatment","Yes",,"Yes","OD","HC","No","2g OD","No",,"No",,"No",,"No",,"No",,"No",,"No",,"11/12/2015",13,"Greulich & Pyle",,,,,"4","3","2",12,12,,"No",,,,,,"181.7",,"8846 08/03/2019"
"Manchester - RMCH","United Kingdom",8846,"United Kingdom","Active","08/01/2006","26/12/2005","Male",2630,,"36 weeks","Yes","Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"08/01/2006",162.5,187.9,8846,"< 1 month",,"No",,"Normal Male",,,"13/11/2020",59.9,168.9,,,21,1.68,"No","No",120,75,,,,,,,,,,,,"No",,"No",,"Yes","Bilateral hydronephrosis","No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No Concerns","Yes","Dose adjustment for size","Yes",,"Yes","OD","HC","No","2g OD","No",,"No",,"No",,"No",,"No",,"No",,"No",,"11/12/2015",13,"Greulich & Pyle",,,,,"4","3","2",12,12,,"No",,,,,,"181.7",,"8846 13/11/2020"
"Manchester - RMCH","United Kingdom",8846,"United Kingdom","Active","08/01/2006","26/12/2005","Male",2630,,"36 weeks","Yes","Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"08/01/2006",162.5,187.9,8846,"< 1 month",,"No",,"Normal Male",,,"11/06/2021",73,172,,,24.68,1.87,"No","No",,,,,,,,,,,,,,"No",,"No",,"Yes","Bilateral hydronephrosis","No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No Concerns","Yes","Undertreatment","Yes",,"Yes","OD","HC","No","2g OD","No",,"No",,"No",,"No",,"No",,"No",,"No",,"11/12/2015",13,"Greulich & Pyle",,,,,"5","3","2",10,15,,"No",,,,,,"181.7",,"8846 11/06/2021"
"Manchester - RMCH","United Kingdom",8846,"United Kingdom","Active","08/01/2006","26/12/2005","Male",2630,,"36 weeks","Yes","Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"08/01/2006",162.5,187.9,8846,"< 1 month",,"No",,"Normal Male",,,"08/07/2022",78.5,173,,,26.23,1.94,"No","No",,,,,,,,,,,,,,"No",,"No",,"Yes","Bilateral hydronephrosis","No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No Concerns","Yes","Undertreatment","Yes",,"Yes","OD","HC","No","2g OD","No",,"No",,"No",,"No",,"No",,"No",,"No",,"11/12/2015",13,"Greulich & Pyle",,,,,"5","3","2",10,15,,"No",,,,,,"181.7",,"8846 08/07/2022"
"Manchester - RMCH","United Kingdom",8846,"United Kingdom","Active","08/01/2006","26/12/2005","Male",2630,,"36 weeks","Yes","Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"08/01/2006",162.5,187.9,8846,"< 1 month",,"No",,"Normal Male",,,"12/05/2023",83,171.7,,,28.15,1.99,"No","No",,,,,,,,,,,,,,"No",,"No",,"Yes","Bilateral hydronephrosis","No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No Concerns","No","Undertreatment","Yes",,"Yes","OD","HC","No","2g OD","No",,"No",,"No",,"No",,"No",,"No",,"No",,"11/12/2015",13,"Greulich & Pyle",,,,,"5","3","2",10,15,,"No",,,,,,"181.7",,"8846 12/05/2023"
"Manchester - RMCH","United Kingdom",8955,"United Kingdom","Active","18/11/2008","27/10/2008","Male",4000,,"38 weeks","Yes","Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"10/11/2008",154.9,180.3,8955,"< 1 month",,"No",,"Normal Male",,,"08/04/2016",27.3,129.2,,,16.35,0.99,"No","No",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No","Undertreatment","Yes",,"Yes","OD","HC","No","2 g added to milk and food daily","No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,"1","1","1",2,2,,,,,,,,"174.1",,"8955 08/04/2016"
"Manchester - RMCH","United Kingdom",8955,"United Kingdom","Active","18/11/2008","27/10/2008","Male",4000,,"38 weeks","Yes","Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"10/11/2008",154.9,180.3,8955,"< 1 month",,"No",,"Normal Male",,,"12/05/2017",32.55,133.33,,,18.31,1.1,"No","No",112,64,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Yes","Dose adjustment for size","Yes",,"Yes","OD","HC","No","2 g added to milk and food daily","No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,"1","1","1",2,2,,,,,,,,"174.1",,"8955 12/05/2017"
"Manchester - RMCH","United Kingdom",8955,"United Kingdom","Active","18/11/2008","27/10/2008","Male",4000,,"38 weeks","Yes","Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"10/11/2008",154.9,180.3,8955,"< 1 month",,"No",,"Normal Male",,,"09/03/2018",35.5,134.6,,,19.59,1.15,"No","No",112,65,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No","Dose adjustment for size","Yes",,"Yes","OD","HC","No","2 g added to milk and food daily","No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,"1","1","1",2,2,,,,,,,,"174.1",,"8955 09/03/2018"
"Manchester - RMCH","United Kingdom",8955,"United Kingdom","Active","18/11/2008","27/10/2008","Male",4000,,"38 weeks","Yes","Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"10/11/2008",154.9,180.3,8955,"< 1 month",,"No",,"Normal Male",,,"12/04/2019",37.4,142.5,,,18.42,1.22,"No","No",90,67,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Yes","Undertreatment","Yes",,"Yes","OD","HC","No","2 g added to milk and food daily","No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,"1","1","1",2,2,,,,,,,,"174.1",,"8955 12/04/2019"
"Manchester - RMCH","United Kingdom",8955,"United Kingdom","Active","18/11/2008","27/10/2008","Male",4000,,"38 weeks","Yes","Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"10/11/2008",154.9,180.3,8955,"< 1 month",,"No",,"Normal Male",,,"13/03/2020",41.1,145.1,,,19.52,1.29,"No","No",110,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No","Undertreatment","Yes",,"Yes","OD","HC","No","2 g added to milk and food daily","No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,"1","1","1",2,2,,,,,,,,"174.1",,"8955 13/03/2020"
"Manchester - RMCH","United Kingdom",8955,"United Kingdom","Active","18/11/2008","27/10/2008","Male",4000,,"38 weeks","Yes","Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"10/11/2008",154.9,180.3,8955,"< 1 month",,"No",,"Normal Male",,,"08/01/2021",45.4,150,,,20.18,1.38,"No","No",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No","Undertreatment","Yes",,"Yes","OD","HC","No","2 g added to milk and food daily","No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,"1","1","1",3,3,,,,,,,,"174.1",,"8955 08/01/2021"
"Manchester - RMCH","United Kingdom",8955,"United Kingdom","Active","18/11/2008","27/10/2008","Male",4000,,"38 weeks","Yes","Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"10/11/2008",154.9,180.3,8955,"< 1 month",,"No",,"Normal Male",,,"10/06/2022",53.4,159.1,,,21.1,1.54,"No","No",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No","Undertreatment","Yes",,"Yes","OD","HC","No","2 g added to milk and food daily","No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,"1","1","1",3,3,,,,,,,,"174.1",,"8955 10/06/2022"
"Manchester - RMCH","United Kingdom",8955,"United Kingdom","Active","18/11/2008","27/10/2008","Male",4000,,"38 weeks","Yes","Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"10/11/2008",154.9,180.3,8955,"< 1 month",,"No",,"Normal Male",,,"30/06/2023",53.8,165.9,,,19.55,1.57,"No","No",121,74,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Yes","Undertreatment","Yes",,"Yes","OD","HC","No","2 g added to milk and food daily","No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,"1","1","1",3,3,,,,,,,,"174.1",,"8955 30/06/2023"
"Manchester - RMCH","United Kingdom",8956,"United Kingdom","Active","31/07/2013","23/07/2013","Not assigned",4100,,"38 weeks","Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"29/07/2013",178,194,8956,"< 1 month",,"No",,"III",,,"12/02/2016",16.9,98.3,,,17.49,0.68,"No","No",,,,,,,,,,,,,,"Yes","vaginal orifice very easily seen at cystoscopy","Yes","VULVO-VAGINOPLASTY + REDUCTION CLITOROPLASTY done
","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,,"No","Undertreatment","Yes",,"Yes","OD","HC","No","3 g mixed to milk feeds","No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,,,,,,,,,,,,,"(Male) 192.5 (Female) 179.5",,"8956 12/02/2016"
"Manchester - RMCH","United Kingdom",8956,"United Kingdom","Active","31/07/2013","23/07/2013","Not assigned",4100,,"38 weeks","Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"29/07/2013",178,194,8956,"< 1 month",,"No",,"III",,,"09/06/2017",24.3,112.4,,,19.23,0.87,"No","No",85,57,,,,,,,,,,,,"Yes","vaginal orifice very easily seen at cystoscopy","Yes","VULVO-VAGINOPLASTY + REDUCTION CLITOROPLASTY done
","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,,"Yes","Undertreatment","Yes",,"Yes","OD","HC","No","3 g mixed to milk feeds","No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,,,,,,,,,,,,,"(Male) 192.5 (Female) 179.5",,"8956 09/06/2017"
"Manchester - RMCH","United Kingdom",8956,"United Kingdom","Active","31/07/2013","23/07/2013","Not assigned",4100,,"38 weeks","Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"29/07/2013",178,194,8956,"< 1 month",,"No",,"III",,,"12/01/2018",26.4,116.2,,,19.55,0.92,"No","No",,,,,,,,,,,,,,"Yes","vaginal orifice very easily seen at cystoscopy","Yes","VULVO-VAGINOPLASTY + REDUCTION CLITOROPLASTY done
","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,,"No","Dose adjustment for size","Yes",,"Yes","OD","HC","No","3 g mixed to milk feeds","No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,,,,,,,,,,,,,"(Male) 192.5 (Female) 179.5",,"8956 12/01/2018"
"Manchester - RMCH","United Kingdom",8956,"United Kingdom","Active","31/07/2013","23/07/2013","Not assigned",4100,,"38 weeks","Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"29/07/2013",178,194,8956,"< 1 month",,"No",,"III",,,"08/02/2019",28.7,125,,,18.37,1,"No","No",120,74,,,,,,,,,,,,"Yes","vaginal orifice very easily seen at cystoscopy","Yes","VULVO-VAGINOPLASTY + REDUCTION CLITOROPLASTY done
","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,,"Yes","Dose adjustment for size","Yes",,"Yes","OD","HC","No","3 g mixed to milk feeds","No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,,,,,,,,,,,,,"(Male) 192.5 (Female) 179.5",,"8956 08/02/2019"
"Manchester - RMCH","United Kingdom",8956,"United Kingdom","Active","31/07/2013","23/07/2013","Not assigned",4100,,"38 weeks","Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"29/07/2013",178,194,8956,"< 1 month",,"No",,"III",,,"11/12/2020",39.7,141.3,,,19.88,1.25,"No","No",118,57,,,,,,,,,,,,"Yes","vaginal orifice very easily seen at cystoscopy","Yes","VULVO-VAGINOPLASTY + REDUCTION CLITOROPLASTY done
","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,,"No","Dose adjustment for size","Yes",,"Yes","OD","HC","No","3 g mixed to milk feeds","No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,,,,,,,,,,,,,"(Male) 192.5 (Female) 179.5",,"8956 11/12/2020"
"Manchester - RMCH","United Kingdom",8956,"United Kingdom","Active","31/07/2013","23/07/2013","Not assigned",4100,,"38 weeks","Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"29/07/2013",178,194,8956,"< 1 month",,"No",,"III",,,"08/10/2021",43.1,148,,,19.68,1.33,"No","No",105,63,,"1","2","1",,,,,,,,"Yes","vaginal orifice very easily seen at cystoscopy","Yes","VULVO-VAGINOPLASTY + REDUCTION CLITOROPLASTY done
","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,,"Yes","Undertreatment","Yes",,"Yes","OD","HC","No","3 g mixed to milk feeds","No",,"No",,"No",,"No",,"No",,"No",,"No",,"09/06/2017",3,"Greulich & Pyle","Not Known",,,,,,,,,,,,,,,,"(Male) 192.5 (Female) 179.5",,"8956 08/10/2021"
"Manchester - RMCH","United Kingdom",8956,"United Kingdom","Active","31/07/2013","23/07/2013","Not assigned",4100,,"38 weeks","Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"29/07/2013",178,194,8956,"< 1 month",,"No",,"III",,,"08/04/2022",49.9,151,,,21.89,1.45,"No","No",,,,"1","2","1",,,,,,,,"Yes","vaginal orifice very easily seen at cystoscopy","Yes","VULVO-VAGINOPLASTY + REDUCTION CLITOROPLASTY done
","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,,"No","Undertreatment","Yes",,"Yes","OD","HC","No","3 g mixed to milk feeds","No",,"No",,"No",,"No",,"No",,"No",,"No",,"09/06/2017",3,"Greulich & Pyle","Not Known",,,,,,,,,,,,,,,,"(Male) 192.5 (Female) 179.5",,"8956 08/04/2022"
"Manchester - RMCH","United Kingdom",8956,"United Kingdom","Active","31/07/2013","23/07/2013","Not assigned",4100,,"38 weeks","Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"29/07/2013",178,194,8956,"< 1 month",,"No",,"III",,,"09/06/2023",56.5,158.5,,,22.49,1.58,"No","No",91,61,,"1","3","1",,,,,,,,"Yes","vaginal orifice very easily seen at cystoscopy","Yes","VULVO-VAGINOPLASTY + REDUCTION CLITOROPLASTY done
","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,,"Yes","Dose adjustment for size","Yes",,"Yes","OD","HC","No","3 g mixed to milk feeds","No",,"No",,"No",,"No",,"No",,"No",,"No",,"09/06/2017",3,"Greulich & Pyle","Not Known",,,,,,,,,,,,,,,,"(Male) 192.5 (Female) 179.5",,"8956 09/06/2023"
"Manchester - RMCH","United Kingdom",8958,"United Kingdom","Active","20/12/2018","20/06/2010","Female",3742,,"38 weeks","Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"20/12/2018",165.1,187.9,8958,"8",,"No",,"Normal Female",,,"20/12/2018",46.8,140.3,,,23.78,1.35,"No","No",,,,"3","3","2",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No Concerns","No",,"Yes",,"No",,,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"20/12/2018",10.5,"Greulich & Pyle","Not Known",,,,,,,,,,,,,,,,"170",,"8958 20/12/2018"
"Manchester - RMCH","United Kingdom",8958,"United Kingdom","Active","20/12/2018","20/06/2010","Female",3742,,"38 weeks","Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"20/12/2018",165.1,187.9,8958,"8",,"No",,"Normal Female",,,"14/06/2019",51.8,143.9,,,25.02,1.44,"No","No",119,68,,"3","3","2",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No Concerns","No",,"Yes",,"No",,,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,,,,,,,,,,,,,"170",,"8958 14/06/2019"
"Manchester - RMCH","United Kingdom",8958,"United Kingdom","Active","20/12/2018","20/06/2010","Female",3742,,"38 weeks","Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"20/12/2018",165.1,187.9,8958,"8",,"No",,"Normal Female",,,"30/07/2020",61,151,,,26.75,1.6,"No","No",,,,"3","3","2",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No Concerns","Yes","Overtreatment","Yes",,"No",,,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,,,,,,,,,,,,,"170",,"8958 30/07/2020"
"Manchester - RMCH","United Kingdom",8958,"United Kingdom","Active","20/12/2018","20/06/2010","Female",3742,,"38 weeks","Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"20/12/2018",165.1,187.9,8958,"8",,"No",,"Normal Female",,,"09/07/2021",67.4,159,,,26.66,1.73,"No","No",,,,"3","3","2",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No Concerns","No","Overtreatment","Yes",,"No",,,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"13/05/2022",14.8,"Greulich & Pyle","Not Known",,,,,,,,,,,,,,,,"170",,"8958 09/07/2021"
"Manchester - RMCH","United Kingdom",8958,"United Kingdom","Active","20/12/2018","20/06/2010","Female",3742,,"38 weeks","Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"20/12/2018",165.1,187.9,8958,"8",,"No",,"Normal Female",,,"13/05/2022",71.2,157.6,,,28.67,1.77,"No","No",117,67,,"3","3","2",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No Concerns","No","Overtreatment","Yes",,"No",,,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"13/05/2022",14.8,"Greulich & Pyle","Not Known",,,,,,,,,,,,,,,,"170",,"8958 13/05/2022"
"Manchester - RMCH","United Kingdom",8958,"United Kingdom","Active","20/12/2018","20/06/2010","Female",3742,,"38 weeks","Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"20/12/2018",165.1,187.9,8958,"8",,"No",,"Normal Female",,,"09/06/2023",71.2,159.4,,,28.02,1.78,"No","No",124,73,,"3","3","2",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No Concerns","No","Overtreatment","Yes",,"No",,,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"13/05/2022",14.8,"Greulich & Pyle","Not Known",,,,,,,,,,,,,,,,"170",,"8958 09/06/2023"
"Manchester - RMCH","United Kingdom",9045,"United Kingdom","Active","27/09/2013","25/09/2013","Female",,,"38 weeks","Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"27/09/2013",170,186.5,9045,"< 1 month",,"No",,"III",,,"08/07/2016",15.3,93.5,,,17.5,0.63,"No","No",,,,,,,,,,,,,,"Yes","Separate urethral and vaginal orifice. Single normal vagina with single cervix.
","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No Concerns","No",,"Yes",,"Yes","OD","HC","Yes","2g/kg/day in TDS","No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,,,,,,,,,,,,,"171.75",,"9045 08/07/2016"
"Manchester - RMCH","United Kingdom",9045,"United Kingdom","Active","27/09/2013","25/09/2013","Female",,,"38 weeks","Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"27/09/2013",170,186.5,9045,"< 1 month",,"No",,"III",,,"10/02/2017",17.2,99.9,,,17.23,0.69,"No","No",,,,,,,,,,,,,,"Yes","Separate urethral and vaginal orifice. Single normal vagina with single cervix.
","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No Concerns","No",,"Yes",,"Yes","OD","HC","Yes","2g/kg/day in TDS","No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,,,,,,,,,,,,,"171.75",,"9045 10/02/2017"
"Manchester - RMCH","United Kingdom",9045,"United Kingdom","Active","27/09/2013","25/09/2013","Female",,,"38 weeks","Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"27/09/2013",170,186.5,9045,"< 1 month",,"No",,"III",,,"13/10/2017",18.5,104.5,,,16.94,0.73,"No","No",,,,,,,,,,,,,,"Yes","Separate urethral and vaginal orifice. Single normal vagina with single cervix.
","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No Concerns","No",,"Yes",,"Yes","OD","HC","Yes","2g/kg/day in TDS","No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,,,,,,,,,,,,,"171.75",,"9045 13/10/2017"
"Manchester - RMCH","United Kingdom",9045,"United Kingdom","Active","27/09/2013","25/09/2013","Female",,,"38 weeks","Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"27/09/2013",170,186.5,9045,"< 1 month",,"No",,"III",,,"09/03/2018",20.2,107.7,,,17.41,0.78,"No","No",,,,,,,,,,,,,,"Yes","Separate urethral and vaginal orifice. Single normal vagina with single cervix.
","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No Concerns","Yes","Dose adjustment for size","Yes",,"Yes","OD","HC","Yes","2g/kg/day in TDS","No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,,,,,,,,,,,,,"171.75",,"9045 09/03/2018"
"Manchester - RMCH","United Kingdom",9045,"United Kingdom","Active","27/09/2013","25/09/2013","Female",,,"38 weeks","Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"27/09/2013",170,186.5,9045,"< 1 month",,"No",,"III",,,"14/12/2018",22.6,113.1,,,17.67,0.84,"No","No",,,,,,,,,,,,,,"Yes","Separate urethral and vaginal orifice. Single normal vagina with single cervix.
","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"Yes","no pathogenic gene identified","No",,"No Concerns","No","Dose adjustment for size","Yes",,"Yes","OD","HC","Yes","2g/kg/day in TDS","No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,,,,,,,,,,,,,"171.75",,"9045 14/12/2018"
"Manchester - RMCH","United Kingdom",9045,"United Kingdom","Active","27/09/2013","25/09/2013","Female",,,"38 weeks","Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"27/09/2013",170,186.5,9045,"< 1 month",,"No",,"III",,,"10/05/2019",24,115,,,18.15,0.88,"No","No",,,,,,,,,,,,,,"Yes","Separate urethral and vaginal orifice. Single normal vagina with single cervix.
","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"Yes","no pathogenic gene identified","No",,"No Concerns","No","Dose adjustment for size","Yes",,"Yes","OD","HC","Yes","2g/kg/day in TDS","No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,,,,,,,,,,,,,"171.75",,"9045 10/05/2019"
"Manchester - RMCH","United Kingdom",9045,"United Kingdom","Active","27/09/2013","25/09/2013","Female",,,"38 weeks","Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"27/09/2013",170,186.5,9045,"< 1 month",,"No",,"III",,,"14/02/2020",25.42,121.9,,,17.11,0.93,"No","No",,,,,,,,,,,,,,"Yes","Separate urethral and vaginal orifice. Single normal vagina with single cervix.
","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"Yes","no pathogenic gene identified","No",,"No Concerns","No","Dose adjustment for size","Yes",,"Yes","OD","HC","Yes","2g/kg/day in TDS","No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,,,,,,,,,,,,,"171.75",,"9045 14/02/2020"
"Manchester - RMCH","United Kingdom",9045,"United Kingdom","Active","27/09/2013","25/09/2013","Female",,,"38 weeks","Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"27/09/2013",170,186.5,9045,"< 1 month",,"No",,"III",,,"11/12/2020",28.4,125.8,,,17.95,1,"No","No",,,,,,,,,,,,,,"Yes","Separate urethral and vaginal orifice. Single normal vagina with single cervix.
","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"Yes","no pathogenic gene identified","No",,"No Concerns","Yes","Dose adjustment for size","Yes",,"Yes","OD","HC","Yes","2g/kg/day in TDS","No",,"No",,"No",,"No",,"No",,"No",,"No",,"12/11/2020",5.6,"Greulich & Pyle",,,,,,,,,,,,,,,,,"171.75",,"9045 11/12/2020"
"Manchester - RMCH","United Kingdom",9045,"United Kingdom","Active","27/09/2013","25/09/2013","Female",,,"38 weeks","Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"27/09/2013",170,186.5,9045,"< 1 month",,"No",,"III",,,"11/06/2021",30.6,130,,,18.11,1.05,"No","No",,,,,,,,,,,,,,"Yes","Separate urethral and vaginal orifice. Single normal vagina with single cervix.
","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"Yes","no pathogenic gene identified","No",,"No Concerns","Yes","Dose adjustment for size","Yes",,"Yes","OD","HC","Yes","2g/kg/day in TDS","No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,,,,,,,,,,,,,"171.75",,"9045 11/06/2021"
"Manchester - RMCH","United Kingdom",9045,"United Kingdom","Active","27/09/2013","25/09/2013","Female",,,"38 weeks","Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"27/09/2013",170,186.5,9045,"< 1 month",,"No",,"III",,,"10/06/2022",33.8,139.7,,,17.32,1.15,"No","No",,,,,,,,,,,,,,"Yes","Separate urethral and vaginal orifice. Single normal vagina with single cervix.
","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"Yes","no pathogenic gene identified","No",,"No Concerns","No","Dose adjustment for size","Yes",,"Yes","OD","HC","No","2g/kg/day in TDS","No",,"No",,"No",,"No",,"No",,"No",,"No",,"10/06/2022",6.7,"Greulich & Pyle","Not Known",,,,,,,,,,,,,,,,"171.75",,"9045 10/06/2022"
"Manchester - RMCH","United Kingdom",9045,"United Kingdom","Active","27/09/2013","25/09/2013","Female",,,"38 weeks","Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"27/09/2013",170,186.5,9045,"< 1 month",,"No",,"III",,,"10/03/2023",40.1,138.6,,,20.87,1.24,"No","No",,,,,,,,,,,,,,"Yes","Separate urethral and vaginal orifice. Single normal vagina with single cervix.
","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"Yes","no pathogenic gene identified","No",,"No Concerns","Yes","Dose adjustment for size","Yes",,"Yes","OD","HC","No","2g/kg/day in TDS","No",,"No",,"No",,"No",,"No",,"No",,"No",,"10/06/2022",6.7,"Greulich & Pyle","Not Known",,,,,,,,,,,,,,,,"171.75",,"9045 10/03/2023"
"Manchester - RMCH","United Kingdom",9045,"United Kingdom","Active","27/09/2013","25/09/2013","Female",,,"38 weeks","Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"27/09/2013",170,186.5,9045,"< 1 month",,"No",,"III",,,"14/07/2023",38.7,140.9,,,19.49,1.23,"No","No",117,76,,"1","1","1",,,,,,,,"Yes","Separate urethral and vaginal orifice. Single normal vagina with single cervix.
","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"Yes","no pathogenic gene identified","No",,"No Concerns","No","Dose adjustment for size","Yes",,"Yes","OD","HC","No","2g/kg/day in TDS","No",,"No",,"No",,"No",,"No",,"No",,"No",,"10/06/2022",6.7,"Greulich & Pyle","Not Known",,,,,,,,,,,,,,,,"171.75",,"9045 14/07/2023"
"Manchester - RMCH","United Kingdom",9046,"United Kingdom","Active","12/12/2014","06/12/2014","Male",,,"38 weeks","Yes","Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"09/12/2014",170,186.5,9046,"< 1 month",,"No",,"Normal Male",,,"11/03/2016",9.8,76.8,,,16.62,0.46,"No","No",,,,,,,,,,,,,,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No Concerns","Yes","Undertreatment","Yes",,"Yes","OD",,"Yes","1 g/day","No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,,,,,,,,,,,,,"184.75",,"9046 11/03/2016"
"Manchester - RMCH","United Kingdom",9046,"United Kingdom","Active","12/12/2014","06/12/2014","Male",,,"38 weeks","Yes","Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"09/12/2014",170,186.5,9046,"< 1 month",,"No",,"Normal Male",,,"14/10/2016",11.85,81.7,,,17.75,0.52,"No","No",84,44,,,,,,,,,,,,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No Concerns","Yes","Dose adjustment for size","Yes",,"Yes","OD",,"No","1 g/day","No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,,,,,,,,,,,,,"184.75",,"9046 14/10/2016"
"Manchester - RMCH","United Kingdom",9046,"United Kingdom","Active","12/12/2014","06/12/2014","Male",,,"38 weeks","Yes","Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"09/12/2014",170,186.5,9046,"< 1 month",,"No",,"Normal Male",,,"09/06/2017",13.3,91.5,,,15.89,0.58,"No","No",,,,,,,,,,,,,,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No Concerns","No","Dose adjustment for size","Yes",,"Yes","OD",,"No","1 g/day","No",,"No",,"No",,"No",,"No",,"No",,"No",,"13/10/2017",3.37,"TW20",,,,,,,,,,,,,,,,,"184.75",,"9046 09/06/2017"
"Manchester - RMCH","United Kingdom",9046,"United Kingdom","Active","12/12/2014","06/12/2014","Male",,,"38 weeks","Yes","Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"09/12/2014",170,186.5,9046,"< 1 month",,"No",,"Normal Male",,,"09/03/2018",15,95.1,,,16.59,0.63,"No","No",,,,,,,,,,,,,,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No Concerns","Yes","Overtreatment","Yes",,"Yes","OD",,"No","1 g/day","No",,"No",,"No",,"No",,"No",,"No",,"No",,"13/10/2017",3.37,"TW20",,,,,,,,,,,,,,,,,"184.75",,"9046 09/03/2018"
"Manchester - RMCH","United Kingdom",9046,"United Kingdom","Active","12/12/2014","06/12/2014","Male",,,"38 weeks","Yes","Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"09/12/2014",170,186.5,9046,"< 1 month",,"No",,"Normal Male",,,"14/12/2018",16.9,100.2,,,16.83,0.69,"No","No",77,56,,,,,,,,,,,,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No Concerns","Yes","Overtreatment","Yes",,"Yes","OD",,"No","1 g/day","No",,"No",,"No",,"No",,"No",,"No",,"No",,"13/10/2017",3.37,"TW20",,,,,,,,,,,,,,,,,"184.75",,"9046 14/12/2018"
"Manchester - RMCH","United Kingdom",9046,"United Kingdom","Active","12/12/2014","06/12/2014","Male",,,"38 weeks","Yes","Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"09/12/2014",170,186.5,9046,"< 1 month",,"No",,"Normal Male",,,"10/05/2019",17.8,103.8,,,16.52,0.72,"No","No",,,,,,,,,,,,,,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No Concerns","No","Overtreatment","Yes",,"Yes","OD",,"No","1 g/day","No",,"No",,"No",,"No",,"No",,"No",,"No",,"13/10/2017",3.37,"TW20",,,,,,,,,,,,,,,,,"184.75",,"9046 10/05/2019"
"Manchester - RMCH","United Kingdom",9046,"United Kingdom","Active","12/12/2014","06/12/2014","Male",,,"38 weeks","Yes","Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"09/12/2014",170,186.5,9046,"< 1 month",,"No",,"Normal Male",,,"27/09/2019",19.3,106.4,,,17.05,0.76,"No","No",,,,,,,,,,,,,,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No Concerns","No","Overtreatment","Yes",,"Yes","OD",,"No","1 g/day","No",,"No",,"No",,"No",,"No",,"No",,"No",,"13/10/2017",3.37,"TW20",,,,,,,,,,,,,,,,,"184.75",,"9046 27/09/2019"
"Manchester - RMCH","United Kingdom",9046,"United Kingdom","Active","12/12/2014","06/12/2014","Male",,,"38 weeks","Yes","Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"09/12/2014",170,186.5,9046,"< 1 month",,"No",,"Normal Male",,,"11/12/2020",19.7,118.7,,,13.98,0.81,"No","No",,,,,,,,,,,,,,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No Concerns","Yes","Dose adjustment for size","Yes",,"Yes","OD",,"No","1 g/day","No",,"No",,"No",,"No",,"No",,"No",,"No",,"11/12/2020",5.2,"TW20",,,,,,,,,,,,,,,,,"184.75",,"9046 11/12/2020"
"Manchester - RMCH","United Kingdom",9046,"United Kingdom","Active","12/12/2014","06/12/2014","Male",,,"38 weeks","Yes","Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"09/12/2014",170,186.5,9046,"< 1 month",,"No",,"Normal Male",,,"10/12/2021",21.5,119,,,15.18,0.84,"No","No",,,,,,,,,,,,,,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No Concerns","No","Dose adjustment for size","Yes",,"Yes","OD",,"No","1 g/day","No",,"No",,"No",,"No",,"No",,"No",,"No",,"10/12/2021",6.3,"TW20",,,,,,,,,,,,,,,,,"184.75",,"9046 10/12/2021"
"Manchester - RMCH","United Kingdom",9046,"United Kingdom","Active","12/12/2014","06/12/2014","Male",,,"38 weeks","Yes","Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"09/12/2014",170,186.5,9046,"< 1 month",,"No",,"Normal Male",,,"10/06/2022",22.9,124.6,,,14.75,0.89,"No","No",,,,,,,,,,,,,,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No Concerns","No","Dose adjustment for size","Yes",,"Yes","OD",,"No","1 g/day","No",,"No",,"No",,"No",,"No",,"No",,"No",,"10/12/2021",6.3,"TW20",,,,,,,,,,,,,,,,,"184.75",,"9046 10/06/2022"
"Manchester - RMCH","United Kingdom",9046,"United Kingdom","Active","12/12/2014","06/12/2014","Male",,,"38 weeks","Yes","Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"09/12/2014",170,186.5,9046,"< 1 month",,"No",,"Normal Male",,,"10/03/2023",25.3,127.7,,,15.51,0.95,"No","No",120,84,,,,,,,,,,,,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No Concerns","No","Dose adjustment for size","Yes",,"Yes","OD",,"No","1 g/day","No",,"No",,"No",,"No",,"No",,"No",,"No",,"10/12/2021",6.3,"TW20",,,,,,,,,,,,,,,,,"184.75",,"9046 10/03/2023"
"Manchester - RMCH","United Kingdom",9046,"United Kingdom","Active","12/12/2014","06/12/2014","Male",,,"38 weeks","Yes","Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"09/12/2014",170,186.5,9046,"< 1 month",,"No",,"Normal Male",,,"14/07/2023",25.2,129.8,,,14.96,0.95,"No","No",123,86,,,,,,,,,,,,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No Concerns","No","Dose adjustment for size","Yes",,"Yes","OD",,"No","1 g/day","No",,"No",,"No",,"No",,"No",,"No",,"No",,"10/12/2021",6.3,"TW20",,,,,"1","1","1",2,2,,,,,,,,"184.75",,"9046 14/07/2023"
"Manchester - RMCH","United Kingdom",9047,"United Kingdom","Active","04/03/2021","07/12/2016","Male",,,,"Yes","Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"04/03/2021",,,9047,"5",,"No",,"Normal Male",,,"12/03/2021",21.6,116,,,16.05,0.83,"No","Yes",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No",,"Yes",,"No",,"HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,"2","3","2",,,,"No",,,,,,,,"9047 12/03/2021"
"Manchester - RMCH","United Kingdom",9047,"United Kingdom","Active","04/03/2021","07/12/2016","Male",,,,"Yes","Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"04/03/2021",,,9047,"5",,"No",,"Normal Male",,,"12/11/2021",22.9,120,,,15.9,0.87,"No","No",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No",,"Yes",,"No",,"HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,"2","2","2",,,,"No",,,,,,,,"9047 12/11/2021"
"Manchester - RMCH","United Kingdom",9047,"United Kingdom","Active","04/03/2021","07/12/2016","Male",,,,"Yes","Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"04/03/2021",,,9047,"5",,"No",,"Normal Male",,,"13/05/2022",24.2,128,,,14.77,0.93,"No","No",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No",,"Yes",,"No",,"HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,"2","2","2",2,2,,"No",,,,,,,,"9047 13/05/2022"
"Manchester - RMCH","United Kingdom",9047,"United Kingdom","Active","04/03/2021","07/12/2016","Male",,,,"Yes","Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"04/03/2021",,,9047,"5",,"No",,"Normal Male",,,"09/12/2022",24.5,125.6,,,15.53,0.92,"No","No",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Yes","Dose adjustment for size","Yes",,"No",,"HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,"2","2","2",2,2,,"No",,,,,,,,"9047 09/12/2022"
"Manchester - RMCH","United Kingdom",9047,"United Kingdom","Active","04/03/2021","07/12/2016","Male",,,,"Yes","Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"04/03/2021",,,9047,"5",,"No",,"Normal Male",,,"09/06/2023",26.6,127.1,,,16.47,0.97,"No","No",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No","Dose adjustment for size","Yes",,"No",,"HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"09/06/2023",11.55,"TW20",,,,,"2","2","2",2,2,,"No",,,,,,,,"9047 09/06/2023"
"Manchester - RMCH","United Kingdom",9048,"United Kingdom","Active","10/11/2006","18/10/2006","Female",,,,"Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"10/11/2006",,,9048,"< 1 month",,"Yes",,"II",,,"09/12/2016",45.5,145.6,,,21.46,1.36,"No","No",,,,,"2","2",,,,,,,,"Yes","Clitoris not particularly enlarged.Urethral and vaginal orifices present quite at the back of perineum with a small vaginal opening","Yes","vulvoplasty done. No clitoroplasty","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No Concerns","Yes","Undertreatment","Yes",,"Yes","OD","HC","No","3 g daily","No",,"No",,"No",,"No",,"No",,"No",,"No",,"10/02/2012",8,"Greulich & Pyle","No",,,,,,,,,,,,,,,,,,"9048 09/12/2016"
"Manchester - RMCH","United Kingdom",9048,"United Kingdom","Active","10/11/2006","18/10/2006","Female",,,,"Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"10/11/2006",,,9048,"< 1 month",,"Yes",,"II",,,"13/10/2017",51.7,151.1,,,22.64,1.47,"No","No",,,,,"2","2",,,,,,,,"Yes","Clitoris not particularly enlarged.Urethral and vaginal orifices present quite at the back of perineum with a small vaginal opening","Yes","vulvoplasty done. No clitoroplasty","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No Concerns","Yes","Undertreatment","Yes",,"Yes","OD","HC","No","3 g daily","No",,"No",,"No",,"No",,"No",,"No",,"No",,"10/02/2012",8,"Greulich & Pyle","No",,,,,,,,,,,,,,,,,,"9048 13/10/2017"
"Manchester - RMCH","United Kingdom",9048,"United Kingdom","Active","10/11/2006","18/10/2006","Female",,,,"Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"10/11/2006",,,9048,"< 1 month",,"Yes",,"II",,,"14/09/2018",52,153.5,,,22.07,1.49,"No","No",110,67,,,"2","2","Spontaneous",11,"Yes",,,,,"Yes","Clitoris not particularly enlarged.Urethral and vaginal orifices present quite at the back of perineum with a small vaginal opening","Yes","vulvoplasty done. No clitoroplasty","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No Concerns","Yes","Undertreatment","Yes",,"Yes","OD","HC","No","3 g daily","No",,"No",,"No",,"No",,"No",,"No",,"No",,"10/02/2012",8,"Greulich & Pyle","No",,,,,,,,,,,,,,,,,,"9048 14/09/2018"
"Manchester - RMCH","United Kingdom",9048,"United Kingdom","Active","10/11/2006","18/10/2006","Female",,,,"Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"10/11/2006",,,9048,"< 1 month",,"Yes",,"II",,,"11/10/2019",50.2,154.9,,,20.92,1.47,"No","No",,,,,"2","2","Spontaneous",11,"Yes",,,,,"Yes","Clitoris not particularly enlarged.Urethral and vaginal orifices present quite at the back of perineum with a small vaginal opening","Yes","vulvoplasty done. No clitoroplasty","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No Concerns","No","Undertreatment","Yes",,"Yes","OD","HC","No","3 g daily","No",,"No",,"No",,"No",,"No",,"No",,"No",,"10/02/2012",8,"Greulich & Pyle","No",,,,,,,,,,,,,,,,,,"9048 11/10/2019"
"Manchester - RMCH","United Kingdom",9048,"United Kingdom","Active","10/11/2006","18/10/2006","Female",,,,"Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"10/11/2006",,,9048,"< 1 month",,"Yes",,"II",,,"12/06/2020",,,,,,,"No","No",,,,,"2","2","Spontaneous",11,"Yes",,,,,"Yes","Clitoris not particularly enlarged.Urethral and vaginal orifices present quite at the back of perineum with a small vaginal opening","Yes","vulvoplasty done. No clitoroplasty","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No Concerns","No","Undertreatment","Yes",,"Yes","OD","HC","No","3 g daily","No",,"No",,"No",,"No",,"No",,"No",,"No",,"10/02/2012",8,"Greulich & Pyle","No",,,,,,,,,,,,,,,,,,"9048 12/06/2020"
"Manchester - RMCH","United Kingdom",9048,"United Kingdom","Active","10/11/2006","18/10/2006","Female",,,,"Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"10/11/2006",,,9048,"< 1 month",,"Yes",,"II",,,"13/08/2021",49.4,157.8,,,19.84,1.47,"No","No",,,,,"2","2","Spontaneous",11,"Yes",,,,,"Yes","Clitoris not particularly enlarged.Urethral and vaginal orifices present quite at the back of perineum with a small vaginal opening","Yes","vulvoplasty done. No clitoroplasty","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No Concerns","No","Undertreatment","Yes",,"Yes","OD","HC","No","3 g daily","No",,"No",,"No",,"No",,"No",,"No",,"No",,"10/02/2012",8,"Greulich & Pyle","No",,,,,,,,,,,,,,,,,,"9048 13/08/2021"
"Manchester - RMCH","United Kingdom",9048,"United Kingdom","Active","10/11/2006","18/10/2006","Female",,,,"Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"10/11/2006",,,9048,"< 1 month",,"Yes",,"II",,,"10/06/2022",55,156.8,,,22.37,1.55,"No","No",,,,,"2","2","Spontaneous",11,"Yes",,,,,"Yes","Clitoris not particularly enlarged.Urethral and vaginal orifices present quite at the back of perineum with a small vaginal opening","Yes","vulvoplasty done. No clitoroplasty","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No Concerns","No","Undertreatment","Yes",,"Yes","OD","HC","No","3 g daily","No",,"No",,"No",,"No",,"No",,"No",,"No",,"10/02/2012",8,"Greulich & Pyle","No",,,,,,,,,,,,,,,,,,"9048 10/06/2022"
"Manchester - RMCH","United Kingdom",9048,"United Kingdom","Active","10/11/2006","18/10/2006","Female",,,,"Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"10/11/2006",,,9048,"< 1 month",,"Yes",,"II",,,"14/07/2023",58.9,157.8,,,23.65,1.61,"No","No",128,73,,,"2","2","Spontaneous",11,"Yes",,,,,"Yes","Clitoris not particularly enlarged.Urethral and vaginal orifices present quite at the back of perineum with a small vaginal opening","Yes","vulvoplasty done. No clitoroplasty","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No Concerns","Yes","Overtreatment","Yes",,"Yes","OD","HC","No","3 g daily","No",,"No",,"No",,"No",,"No",,"No",,"No",,"10/02/2012",8,"Greulich & Pyle","No",,,,,,,,,,,,,,,,,,"9048 14/07/2023"
"Manchester - RMCH","United Kingdom",9351,"United Kingdom","Active","14/08/2015","26/05/2015","Male",,,,"Yes","Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"13/06/2015",160,179,9351,"< 1 month",,"No",,"Normal Male",,,"10/06/2016",8.95,75.9,,,15.54,0.43,"No","No",,,,,,,,,,,,,,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Current",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No Concerns","No",,"Yes",,"Yes",,,"Yes"," 1 scoops of salt daily added to milk","No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,,,,,,,,,,,,,"176",,"9351 10/06/2016"
"Manchester - RMCH","United Kingdom",9351,"United Kingdom","Active","14/08/2015","26/05/2015","Male",,,,"Yes","Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"13/06/2015",160,179,9351,"< 1 month",,"No",,"Normal Male",,,"10/02/2017",11.5,81,,,17.53,0.51,"No","No",,,,,,,,,,,,,,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Current",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No Concerns","Yes","Dose adjustment for size","Yes",,"Yes",,,"Yes"," 1 scoops of salt daily added to milk","No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,,,,,,,,,,,,,"176",,"9351 10/02/2017"
"Manchester - RMCH","United Kingdom",9351,"United Kingdom","Active","14/08/2015","26/05/2015","Male",,,,"Yes","Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"13/06/2015",160,179,9351,"< 1 month",,"No",,"Normal Male",,,"12/01/2018",13.2,90.7,,,16.05,0.58,"No","No",,,,,,,,,,,,,,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Current",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No Concerns","Yes","Dose adjustment for size","Yes",,"Yes","OD",,"Yes"," 1 scoops of salt daily added to milk","No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,,,,,,,,,,,,,"176",,"9351 12/01/2018"
"Manchester - RMCH","United Kingdom",9351,"United Kingdom","Active","14/08/2015","26/05/2015","Male",,,,"Yes","Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"13/06/2015",160,179,9351,"< 1 month",,"No",,"Normal Male",,,"12/10/2018",15,96.8,,,16.01,0.64,"No","No",,,,,,,,,,,,,,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Current",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No Concerns","No","Dose adjustment for size","Yes",,"Yes","OD",,"Yes"," 1 scoops of salt daily added to milk","No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,,,,,,,,,,,,,"176",,"9351 12/10/2018"
"Manchester - RMCH","United Kingdom",9351,"United Kingdom","Active","14/08/2015","26/05/2015","Male",,,,"Yes","Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"13/06/2015",160,179,9351,"< 1 month",,"No",,"Normal Male",,,"13/01/2020",19.6,114,,,15.08,0.79,"No","No",,,,,,,,,,,,,,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Current",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No Concerns","Yes","Undertreatment","Yes",,"Yes","OD",,"Yes"," 1 scoops of salt daily added to milk","No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,,,,,,,,,,,,,"176",,"9351 13/01/2020"
"Manchester - RMCH","United Kingdom",9351,"United Kingdom","Active","14/08/2015","26/05/2015","Male",,,,"Yes","Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"13/06/2015",160,179,9351,"< 1 month",,"No",,"Normal Male",,,"17/10/2023",30,143.2,,,14.63,1.09,"No","No",91,53,,,,,,,,,,,,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Current",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No Concerns","Yes","Undertreatment","Yes",,"Yes","OD",,"Yes"," 1 scoops of salt daily added to milk","No",,"No",,"No",,"No",,"No",,"No",,"No",,"13/10/2023",10,"Greulich & Pyle",,,,,"1","1","1",,,,,,,,,,"176",,"9351 17/10/2023"
"Manchester - RMCH","United Kingdom",9354,"United Kingdom","Active","02/10/2018","18/06/2011","Female",650,,"30 weeks","No","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"02/10/2018",145.5,179.9,9354,"7",,"No",,"Normal Female",,,"30/10/2018",21.6,114.9,,,16.36,0.83,"No","No",,,,"2","2","2",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No Concerns","No",,"Yes",,"No",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"156.2",,"9354 30/10/2018"
"Manchester - RMCH","United Kingdom",9354,"United Kingdom","Active","02/10/2018","18/06/2011","Female",650,,"30 weeks","No","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"02/10/2018",145.5,179.9,9354,"7",,"No",,"Normal Female",,,"14/06/2019",20.98,119,,,14.82,0.83,"No","No",,,,"2","2","2",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No Concerns","No",,"Yes",,"No",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"156.2",,"9354 14/06/2019"
"Manchester - RMCH","United Kingdom",9354,"United Kingdom","Active","02/10/2018","18/06/2011","Female",650,,"30 weeks","No","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"02/10/2018",145.5,179.9,9354,"7",,"No",,"Normal Female",,,"03/01/2020",26.48,124.5,,,17.08,0.96,"No","No",,,,"2","3","2",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No Concerns","No",,"Yes",,"No",,"HC","No",,"No",,"No",,"Yes","Zoladex LA 10.8 mg subcutaneous injection every 12 weeks","No",,"No",,"No",,"No",,,,,,,,,,,,,,,,,,,,,"156.2",,"9354 03/01/2020"
"Manchester - RMCH","United Kingdom",9354,"United Kingdom","Active","02/10/2018","18/06/2011","Female",650,,"30 weeks","No","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"02/10/2018",145.5,179.9,9354,"7",,"No",,"Normal Female",,,"12/02/2021",32.4,132.8,,,18.37,1.09,"No","No",,,,"2","3","2",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No Concerns","No",,"Yes",,"No",,"HC","No",,"No",,"No",,"Yes","Zoladex LA 10.8 mg subcutaneous injection every 12 weeks","No",,"No",,"No",,"No",,,,,,,,,,,,,,,,,,,,,"156.2",,"9354 12/02/2021"
"Manchester - RMCH","United Kingdom",9354,"United Kingdom","Active","02/10/2018","18/06/2011","Female",650,,"30 weeks","No","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"02/10/2018",145.5,179.9,9354,"7",,"No",,"Normal Female",,,"11/03/2022",36.5,133.7,,,20.42,1.16,"No","No",88,56,,"2","3","2",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No Concerns","Yes","Dose adjustment for size","Yes",,"No",,"HC","No",,"No",,"No",,"No","Zoladex LA 10.8 mg subcutaneous injection every 12 weeks","No",,"No",,"No",,"No",,,,,,,,,,,,,,,,,,,,,"156.2",,"9354 11/03/2022"
"Manchester - RMCH","United Kingdom",9354,"United Kingdom","Active","02/10/2018","18/06/2011","Female",650,,"30 weeks","No","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"02/10/2018",145.5,179.9,9354,"7",,"No",,"Normal Female",,,"13/10/2023",42,137,,,22.38,1.26,"No","No",,,,"4","3","2","Spontaneous",12,"Not known",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No Concerns","No","Dose adjustment for size","Yes",,"No",,"HC","No",,"No",,"No",,"No","Zoladex LA 10.8 mg subcutaneous injection every 12 weeks","No",,"No",,"No",,"No",,,,,,,,,,,,,,,,,,,,,"156.2",,"9354 13/10/2023"
"Manchester - RMCH","United Kingdom",9355,"United Kingdom","Active","04/11/2013","05/10/2013","Male",3700,,"42 weeks","Yes","Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"04/11/2013",167.4,177.8,9355,"< 1 month",,"No",,"Normal Male",,,"08/04/2016",12.95,86.8,,,17.19,0.56,"No","No",64,50,,,,,,,,,,,,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No Concerns","Yes","Undertreatment","Yes",,"Yes","OD","HC","Yes","2 g/day added to milk","No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,,,,,,,,,,,,,"179.1",,"9355 08/04/2016"
"Manchester - RMCH","United Kingdom",9355,"United Kingdom","Active","04/11/2013","05/10/2013","Male",3700,,"42 weeks","Yes","Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"04/11/2013",167.4,177.8,9355,"< 1 month",,"No",,"Normal Male",,,"14/07/2017",17,97.2,,,17.99,0.68,"No","No",,,,,,,,,,,,,,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No Concerns","Yes","Undertreatment","Yes",,"Yes","OD","HC","Yes","2 g/day added to milk","No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,,,,,,,,,,,,,"179.1",,"9355 14/07/2017"
"Manchester - RMCH","United Kingdom",9355,"United Kingdom","Active","04/11/2013","05/10/2013","Male",3700,,"42 weeks","Yes","Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"04/11/2013",167.4,177.8,9355,"< 1 month",,"No",,"Normal Male",,,"09/02/2018",19.8,101.7,,,19.14,0.75,"No","No",94,49,,,,,,,,,,,,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No Concerns","Yes","Undertreatment","Yes",,"Yes","OD","HC","No","2 g/day added to milk","No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,,,,,,,,,,,,,"179.1",,"9355 09/02/2018"
"Manchester - RMCH","United Kingdom",9355,"United Kingdom","Active","04/11/2013","05/10/2013","Male",3700,,"42 weeks","Yes","Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"04/11/2013",167.4,177.8,9355,"< 1 month",,"No",,"Normal Male",,,"08/11/2019",26,116.4,,,19.19,0.92,"No","No",97,88,,,,,,,,,,,,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No Concerns","Yes","Undertreatment","Yes",,"Yes","OD","HC","No","2 g/day added to milk","No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,,,,,,,,,,,,,"179.1",,"9355 08/11/2019"
"Manchester - RMCH","United Kingdom",9355,"United Kingdom","Active","04/11/2013","05/10/2013","Male",3700,,"42 weeks","Yes","Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"04/11/2013",167.4,177.8,9355,"< 1 month",,"No",,"Normal Male",,,"13/11/2020",30.9,127,,,19.16,1.04,"No","No",,,,,,,,,,,,,,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No Concerns","No","Undertreatment","Yes",,"Yes","OD","HC","No","2 g/day added to milk","No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,,,,,,,,,,,,,"179.1",,"9355 13/11/2020"
"Manchester - RMCH","United Kingdom",9355,"United Kingdom","Active","04/11/2013","05/10/2013","Male",3700,,"42 weeks","Yes","Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"04/11/2013",167.4,177.8,9355,"< 1 month",,"No",,"Normal Male",,,"08/10/2021",36,133.9,,,20.08,1.16,"No","No",97,58,,,,,,,,,,,,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No Concerns","No","Undertreatment","Yes",,"Yes","OD","HC","No","2 g/day added to milk","No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,"1","2","1",2,2,,,,,,,,"179.1",,"9355 08/10/2021"
"Manchester - RMCH","United Kingdom",9355,"United Kingdom","Active","04/11/2013","05/10/2013","Male",3700,,"42 weeks","Yes","Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"04/11/2013",167.4,177.8,9355,"< 1 month",,"No",,"Normal Male",,,"11/03/2022",38.6,135.6,,,20.99,1.21,"No","No",112,60,,,,,,,,,,,,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No Concerns","No","Undertreatment","Yes",,"Yes","OD","HC","No","2 g/day added to milk","No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,"1","2","1",2,2,,,,,,,,"179.1",,"9355 11/03/2022"
"Manchester - RMCH","United Kingdom",9355,"United Kingdom","Active","04/11/2013","05/10/2013","Male",3700,,"42 weeks","Yes","Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"04/11/2013",167.4,177.8,9355,"< 1 month",,"No",,"Normal Male",,,"13/01/2023",45.5,143.4,,,22.13,1.35,"No","No",111,65,,,,,,,,,,,,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No Concerns","No","Undertreatment","Yes",,"Yes","OD","HC","No","2 g/day added to milk","No",,"No",,"Yes","Decapeptyl Sr 22.5 mg started in September 2022 after positive GnRH stim test","No",,"No",,"No",,"No",,,,,,,,,"1","2","1",4,3,,,,,,,,"179.1",,"9355 13/01/2023"
"Manchester - RMCH","United Kingdom",9355,"United Kingdom","Active","04/11/2013","05/10/2013","Male",3700,,"42 weeks","Yes","Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"04/11/2013",167.4,177.8,9355,"< 1 month",,"No",,"Normal Male",,,"08/12/2023",57.9,148.2,,,26.36,1.54,"No","No",109,63,,,,,,,,,,,,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No Concerns","Yes","Dose adjustment for size","Yes",,"Yes","OD","HC","No","2 g/day added to milk","No",,"No",,"Yes","Decapeptyl Sr 22.5 mg started in September 2022 after positive GnRH stim test","No",,"No",,"No",,"No",,,,,,,,,"1","2","1",4,3,,,,,,,,"179.1",,"9355 08/12/2023"
"Manchester - RMCH","United Kingdom",9356,"United Kingdom","Active","17/06/2011","07/06/2011","Female",3510,,"39 weeks","Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"07/06/2011",162.6,174,9356,"< 1 month",,"No",,"I",,,"08/01/2016",16.55,100.1,,,16.52,0.68,"No","No",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No","Overtreatment","Yes",,"Yes","OD","HC","Yes","Salt 2g via a salt pot added to four feeds through the day","No",,"No",,"No",,"No",,"No",,"No",,"No",,"08/01/2016",2.5,"Greulich & Pyle",,,,,,,,,,,,,,,,,"161.8",,"9356 08/01/2016"
"Manchester - RMCH","United Kingdom",9356,"United Kingdom","Active","17/06/2011","07/06/2011","Female",3510,,"39 weeks","Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"07/06/2011",162.6,174,9356,"< 1 month",,"No",,"I",,,"08/12/2017",23.1,115.2,,,17.41,0.86,"No","No",98,60,,"1","1","1",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Yes","Dose adjustment for size","Yes",,"Yes","OD","HC","Yes","Salt 2g via a salt pot added to four feeds through the day","No",,"No",,"No",,"No",,"No",,"No",,"No",,"08/01/2016",2.5,"Greulich & Pyle",,,,,,,,,,,,,,,,,"161.8",,"9356 08/12/2017"
"Manchester - RMCH","United Kingdom",9356,"United Kingdom","Active","17/06/2011","07/06/2011","Female",3510,,"39 weeks","Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"07/06/2011",162.6,174,9356,"< 1 month",,"No",,"I",,,"13/04/2018",23.1,116.3,,,17.08,0.86,"No","No",,,,"1","1","1",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No","Dose adjustment for size","Yes",,"Yes","OD","HC","No","Salt 2g via a salt pot added to four feeds through the day","No",,"No",,"No",,"No",,"No",,"No",,"No",,"08/01/2016",2.5,"Greulich & Pyle",,,,,,,,,,,,,,,,,"161.8",,"9356 13/04/2018"
"Manchester - RMCH","United Kingdom",9356,"United Kingdom","Active","17/06/2011","07/06/2011","Female",3510,,"39 weeks","Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"07/06/2011",162.6,174,9356,"< 1 month",,"No",,"I",,,"10/05/2019",26.8,121.6,,,18.12,0.95,"No","No",109,60,,"1","1","1",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Yes","Undertreatment","Yes",,"Yes","OD","HC","No","Salt 2g via a salt pot added to four feeds through the day","No",,"No",,"No",,"No",,"No",,"No",,"No",,"08/01/2016",2.5,"Greulich & Pyle",,,,,,,,,,,,,,,,,"161.8",,"9356 10/05/2019"
"Manchester - RMCH","United Kingdom",9356,"United Kingdom","Active","17/06/2011","07/06/2011","Female",3510,,"39 weeks","Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"07/06/2011",162.6,174,9356,"< 1 month",,"No",,"I",,,"13/03/2020",32.2,125.9,,,20.31,1.06,"No","No",,,,"1","1","1",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No","Undertreatment","Yes",,"Yes","OD","HC","No","Salt 2g via a salt pot added to four feeds through the day","No",,"No",,"No",,"No",,"No",,"No",,"No",,"08/01/2016",2.5,"Greulich & Pyle",,,,,,,,,,,,,,,,,"161.8",,"9356 13/03/2020"
"Manchester - RMCH","United Kingdom",9356,"United Kingdom","Active","17/06/2011","07/06/2011","Female",3510,,"39 weeks","Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"07/06/2011",162.6,174,9356,"< 1 month",,"No",,"I",,,"08/01/2021",36,133.7,,,20.14,1.16,"No","No",,,,"1","2","1",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Yes","Dose adjustment for size","Yes",,"Yes","OD","HC","No","Salt 2g via a salt pot added to four feeds through the day","No",,"No",,"No",,"No",,"No",,"No",,"No",,"08/01/2016",2.5,"Greulich & Pyle",,,,,,,,,,,,,,,,,"161.8",,"9356 08/01/2021"
"Manchester - RMCH","United Kingdom",9356,"United Kingdom","Active","17/06/2011","07/06/2011","Female",3510,,"39 weeks","Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"07/06/2011",162.6,174,9356,"< 1 month",,"No",,"I",,,"13/05/2022",47.6,143.4,,,23.15,1.38,"No","No",124,97,,"1","2","1",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Yes","Dose adjustment for size","Yes",,"Yes","OD","HC","No","Salt 2g via a salt pot added to four feeds through the day","No",,"No",,"No",,"No",,"No",,"No",,"No",,"13/05/2022",11.7,"Greulich & Pyle",,,,,,,,,,,,,,,,,"161.8",,"9356 13/05/2022"
"Manchester - RMCH","United Kingdom",9356,"United Kingdom","Active","17/06/2011","07/06/2011","Female",3510,,"39 weeks","Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"07/06/2011",162.6,174,9356,"< 1 month",,"No",,"I",,,"08/12/2023",56.6,150.1,,,25.12,1.54,"No","No",,,,"2","2","1",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No","Dose adjustment for size","Yes",,"Yes","OD","HC","No","Salt 2g via a salt pot added to four feeds through the day","No",,"No",,"No",,"No",,"No",,"No",,"No",,"13/05/2022",11.7,"Greulich & Pyle",,,,,,,,,,,,,,,,,"161.8",,"9356 08/12/2023"
"Nottingham - NUH","United Kingdom",3637,"United Kingdom","Active","22/12/2006","15/12/2006","Male",3120,48,"40 weeks","Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"28/12/2006",,,3637,"< 1 month",,"No",,"IV",,,"30/08/2018",70.1,159.3,,,27.62,1.76,"No","No",,,,"3","4","3",,,"No",,,,,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Some Concerns","Yes",,"Yes",,"Yes","OD","HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"31/08/2017",14.6,"Greulich & Pyle","No",,,,,,,,,,,,,,,,,,"3637 30/08/2018"
"Nottingham - NUH","United Kingdom",3637,"United Kingdom","Active","22/12/2006","15/12/2006","Male",3120,48,"40 weeks","Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"28/12/2006",,,3637,"< 1 month",,"No",,"IV",,,"31/01/2019",74.8,159.7,,,29.33,1.82,"No","No",122,70,,"3","4","3",,,"No",,,,,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Some Concerns","Yes","Other","Yes",,"Yes","OD","Other","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"31/08/2017",14.6,"Greulich & Pyle","No",,,,,,,,,,,,,,,,,,"3637 31/01/2019"
"Nottingham - NUH","United Kingdom",3637,"United Kingdom","Active","22/12/2006","15/12/2006","Male",3120,48,"40 weeks","Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"28/12/2006",,,3637,"< 1 month",,"No",,"IV",,,"30/05/2019",79.65,159.7,,,31.23,1.88,"No","No",118,77,,"3","4","3","Spontaneous",12,"No",,,,,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Some Concerns","Yes","Other","Yes",,"Yes","OD","Other","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"31/08/2017",14.6,"Greulich & Pyle","No",,,,,,,,,,,,,,,,,,"3637 30/05/2019"
"Nottingham - NUH","United Kingdom",3637,"United Kingdom","Active","22/12/2006","15/12/2006","Male",3120,48,"40 weeks","Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"28/12/2006",,,3637,"< 1 month",,"No",,"IV",,,"22/12/2019",82.55,159.9,,,32.29,1.91,"No","No",121,74,,"3","4","3","Spontaneous",12,"No",,,,,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Some Concerns","No","Other","Yes","Remains on Pred 5mg am, H/C 5mg in evening","Yes","OD","Other","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"31/08/2017",14.6,"Greulich & Pyle","No",,,,,,,,,,,,,,,,,,"3637 22/12/2019"
"Nottingham - NUH","United Kingdom",3637,"United Kingdom","Active","22/12/2006","15/12/2006","Male",3120,48,"40 weeks","Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"28/12/2006",,,3637,"< 1 month",,"No",,"IV",,,"03/07/2020",,,,,,,"Not known","Yes",,,"Telephone consultation due to COVID","3","4","3","Spontaneous",12,"No",,,,,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Some Concerns","No","Other","Yes","Remains on Pred 5mg am, H/C 5mg in evening","Yes","OD","Other","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"31/08/2017",14.6,"Greulich & Pyle","No",,,,,,,,,,,,,,,,,,"3637 03/07/2020"
"Nottingham - NUH","United Kingdom",3637,"United Kingdom","Active","22/12/2006","15/12/2006","Male",3120,48,"40 weeks","Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"28/12/2006",,,3637,"< 1 month",,"No",,"IV",,,"30/07/2020",84.7,159.9,,,33.13,1.94,"No","Yes",128,75,,"3","4","3","Spontaneous",12,"No",,,,,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Some Concerns","No","Other","Yes","Remains on Pred 5mg am, H/C 5mg in evening","Yes","OD","Other","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"31/08/2017",14.6,"Greulich & Pyle","No",,,,,,,,,,,,,,,,,,"3637 30/07/2020"
"Nottingham - NUH","United Kingdom",3637,"United Kingdom","Active","22/12/2006","15/12/2006","Male",3120,48,"40 weeks","Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"28/12/2006",,,3637,"< 1 month",,"No",,"IV",,,"18/11/2020",79.4,,,,,,,,,,,"3","4","3","Spontaneous",12,"No",,,,,"Yes","8.5cm urogenital sinus and 3cm urethra found on cystovaginoscopy","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Some Concerns","No","Other","Yes","Hydrocortisone ","Yes","OD","HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"31/08/2017",14.6,"Greulich & Pyle","No",,,,,,,,,,,,,,,,,,"3637 18/11/2020"
"Nottingham - NUH","United Kingdom",3637,"United Kingdom","Active","22/12/2006","15/12/2006","Male",3120,48,"40 weeks","Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"28/12/2006",,,3637,"< 1 month",,"No",,"IV",,,"29/04/2021",77.1,160.3,,,30,1.85,"No","Yes",123,71,,"4","4","3","Spontaneous",12,"No",,,,,"Yes","8.5cm urogenital sinus and 3cm urethra found on cystovaginoscopy","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Some Concerns","Yes","Undertreatment","Yes","Hydrocortisone doses increased and changed to QDS regimen","Yes","OD","HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"31/08/2017",14.6,"Greulich & Pyle","No",,,,,,,,,,,,,,,,,,"3637 29/04/2021"
"Nottingham - NUH","United Kingdom",3637,"United Kingdom","Active","22/12/2006","15/12/2006","Male",3120,48,"40 weeks","Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"28/12/2006",,,3637,"< 1 month",,"No",,"IV",,,"26/08/2020",,,,,,,"No","Yes",96,54,"Admitted for 24 hour cortisol and 17 OHP day curve - demonstrated pred and h/c combination not adequately suppressing 17 OHP.","3","4","3","Spontaneous",12,"No",,,,,"Yes","8.5cm urogenital sinus and 3cm urethra found on cystovaginoscopy","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Some Concerns","Yes","Undertreatment","Yes","Switched back to hydrocortisone TDS (previously on prednisolone in morning, H/C in evening)","Yes","OD","HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"31/08/2017",14.6,"Greulich & Pyle","No",,,,,,,,,,,,,,,,,,"3637 26/08/2020"
"Nottingham - NUH","United Kingdom",3637,"United Kingdom","Active","22/12/2006","15/12/2006","Male",3120,48,"40 weeks","Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"28/12/2006",,,3637,"< 1 month",,"No",,"IV",,,"30/09/2021",,,,,,,,"Yes",,,"Virtual consultation as patient had COVID. H/C doses adjusted based on 17 OHP saliva profile","4","4","3","Spontaneous",12,"No",,,,,"Yes","8.5cm urogenital sinus and 3cm urethra found on cystovaginoscopy","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Some Concerns","Yes","Undertreatment","Yes","Hydrocortisone doses increased and changed to QDS regimen - 10mg/10mg/5mg/5mg = 15.6mg/m2/day","Yes","OD","HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"31/08/2017",14.6,"Greulich & Pyle","No",,,,,,,,,,,,,,,,,,"3637 30/09/2021"
"Nottingham - NUH","United Kingdom",3637,"United Kingdom","Active","22/12/2006","15/12/2006","Male",3120,48,"40 weeks","Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"28/12/2006",,,3637,"< 1 month",,"No",,"IV",,,"30/12/2021",85.1,160.2,,,33.16,1.95,"No","Yes",136,69,"17-OHP saliva profile and blood tests collected after 2 weeks high dose (20mg QDS) hydrocortisone dosing at home.","4","4","3","Spontaneous",12,"No",,,,,"Yes","8.5cm urogenital sinus and 3cm urethra found on cystovaginoscopy","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Some Concerns","No","Undertreatment","Yes","Hydrocortisone doses QDS regimen - 10mg/10mg/5mg/5mg = 15.6mg/m2/day","Yes","OD","HC","No",,"Yes","To start Rigevidon COCP","No",,"No",,"No",,"No",,"No",,"No",,"31/08/2017",14.6,"Greulich & Pyle","No",,,,,,,,,,,,,,,,,,"3637 30/12/2021"
"Nottingham - NUH","United Kingdom",3637,"United Kingdom","Active","22/12/2006","15/12/2006","Male",3120,48,"40 weeks","Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"28/12/2006",,,3637,"< 1 month",,"No",,"IV",,,"13/05/2022",87.85,160.7,,,34.02,1.98,"No","No",119,59,,"4","4","3","Spontaneous",12,"No",,,,,"Yes","8.5cm urogenital sinus and 3cm urethra found on cystovaginoscopy","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No Concerns","Yes","Undertreatment","Yes","Changed to Efmody in Feb 2022","Yes","OD","HC","No",,"Yes","Remains on Rigevidon COCP","No",,"No",,"No",,"No",,"No",,"No",,"31/08/2017",14.6,"Greulich & Pyle","No",,,,,,,,,,,,,,,,,,"3637 13/05/2022"
"Nottingham - NUH","United Kingdom",3637,"United Kingdom","Active","22/12/2006","15/12/2006","Male",3120,48,"40 weeks","Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"28/12/2006",,,3637,"< 1 month",,"No",,"IV",,,"29/09/2022",88.5,161,,,34.14,1.99,"No","No",132,66,"Started to have cyclical bleeding since August 2022. Ultrasound showed small collection of blood in uterus and vagina. Plan to monitor with 3 monthly scans","4","4","3","Spontaneous",12,"Yes",,,,,"Yes","8.5cm urogenital sinus and 3cm urethra found on cystovaginoscopy","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No Concerns","Yes","Overtreatment","Yes","Changed to Efmody in Feb 2022","Yes","OD","HC","No",,"No","Remains on Rigevidon COCP","No",,"No",,"No",,"No",,"No",,"Yes","Rigevidon stopped at this appointment","31/08/2017",14.6,"Greulich & Pyle","No",,,,,,,,,,,,,,,,,,"3637 29/09/2022"
"Nottingham - NUH","United Kingdom",3637,"United Kingdom","Active","22/12/2006","15/12/2006","Male",3120,48,"40 weeks","Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"28/12/2006",,,3637,"< 1 month",,"No",,"IV",,,"30/03/2023",85.9,159.8,,,33.64,1.95,"No","No",120,63,,"4","4","3","Spontaneous",12,"Yes","Not known",,,,"Yes","8.5cm urogenital sinus and 3cm urethra found on cystovaginoscopy","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No Concerns","No","Overtreatment","Yes","On Efmody 10mg BD ","Yes","OD","HC","No",,"No","Remains on Rigevidon COCP","No",,"No",,"No",,"No",,"No",,"No","Rigevidon stopped at this appointment","31/08/2017",14.6,"Greulich & Pyle","No",,,,,,,,,,,,,,,,,,"3637 30/03/2023"
"Nottingham - NUH","United Kingdom",7510,"United Kingdom","Active","30/12/2018","30/12/2018","Not assigned",3720,49,"40 weeks","Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"02/01/2019",,,7510,"< 1 month",,"No",,"IV",,,"31/01/2019",4.35,54.4,,,14.7,0.26,"No","Yes",,,,,,,,,,,,,,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Current",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No Concerns","No",,"Yes","Alkindi 2mg am, 1mg afternoon, 1mg evening","Yes","OD","HC","Yes","Sodium chloride 7 mmol QDS","No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,,,,,,,,,,,,,,,"7510 31/01/2019"
"Nottingham - NUH","United Kingdom",7510,"United Kingdom","Active","30/12/2018","30/12/2018","Not assigned",3720,49,"40 weeks","Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"02/01/2019",,,7510,"< 1 month",,"No",,"IV",,,"08/03/2019",5.75,59,,,16.52,0.31,,,,,,,,,,,,,,,,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Current",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No Concerns","No",,"Yes","Alkindi 2mg am, 1mg afternoon, 1mg evening","Yes","OD","HC","Yes","Sodium chloride 7 mmol QDS","No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,,,,,,,,,,,,,,,"7510 08/03/2019"
"Nottingham - NUH","United Kingdom",7510,"United Kingdom","Active","30/12/2018","30/12/2018","Not assigned",3720,49,"40 weeks","Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"02/01/2019",,,7510,"< 1 month",,"No",,"IV",,,"30/06/2022",16.78,98.3,,,17.37,0.68,,,,,,,,,,,,,,,,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Current",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No Concerns","No",,"Yes","Alkindi 2mg am, 1mg afternoon, 1mg evening","Yes","OD","HC","Yes","Sodium chloride 7 mmol QDS","No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,,,,,,,,,,,,,,,"7510 30/06/2022"
"Nottingham - NUH","United Kingdom",7510,"United Kingdom","Active","30/12/2018","30/12/2018","Not assigned",3720,49,"40 weeks","Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"02/01/2019",,,7510,"< 1 month",,"No",,"IV",,,"14/11/2019",9.25,71.5,,,18.09,0.43,,,,,,,,,,,,,,,,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Current",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No Concerns","No",,"Yes","Alkindi 2mg am, 1mg afternoon, 1mg evening","Yes","OD","HC","Yes","Sodium chloride 7 mmol QDS","No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,,,,,,,,,,,,,,,"7510 14/11/2019"
"Nottingham - NUH","United Kingdom",7510,"United Kingdom","Active","30/12/2018","30/12/2018","Not assigned",3720,49,"40 weeks","Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"02/01/2019",,,7510,"< 1 month",,"No",,"IV",,,"30/06/2020",11.15,77.4,,,18.61,0.49,,,,,,,,,,,,,,,,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Current",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No Concerns","No",,"Yes","Alkindi 2mg am, 1mg afternoon, 1mg evening","Yes","OD","HC","Yes","Sodium chloride 7 mmol QDS","No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,,,,,,,,,,,,,,,"7510 30/06/2020"
"Nottingham - NUH","United Kingdom",7510,"United Kingdom","Active","30/12/2018","30/12/2018","Not assigned",3720,49,"40 weeks","Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"02/01/2019",,,7510,"< 1 month",,"No",,"IV",,,"23/08/2021",13.62,90.7,,,16.56,0.59,,,,,,,,,,,,,,,,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Current",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No Concerns","No",,"Yes","Alkindi 2mg am, 1mg afternoon, 1mg evening","Yes","OD","HC","Yes","Sodium chloride 7 mmol QDS","No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,,,,,,,,,,,,,,,"7510 23/08/2021"
"Nottingham - NUH","United Kingdom",7510,"United Kingdom","Active","30/12/2018","30/12/2018","Not assigned",3720,49,"40 weeks","Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"02/01/2019",,,7510,"< 1 month",,"No",,"IV",,,"16/12/2021",15.3,93,,,17.69,0.63,,,,,,,,,,,,,,,,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Current",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No Concerns","No",,"Yes","Alkindi 2mg am, 1mg afternoon, 1mg evening","Yes","OD","HC","Yes","Sodium chloride 7 mmol QDS","No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,,,,,,,,,,,,,,,"7510 16/12/2021"
"Nottingham - NUH","United Kingdom",7510,"United Kingdom","Active","30/12/2018","30/12/2018","Not assigned",3720,49,"40 weeks","Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"02/01/2019",,,7510,"< 1 month",,"No",,"IV",,,"30/06/2023",19.8,106,,,17.62,0.76,,,,,,,,,,,,,,,,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Current",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No Concerns","No",,"Yes","Alkindi 2mg am, 1mg afternoon, 1mg evening","Yes","OD","HC","Yes","Sodium chloride 7 mmol QDS","No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,,,,,,,,,,,,,,,"7510 30/06/2023"
"Nottingham - NUH","United Kingdom",7510,"United Kingdom","Active","30/12/2018","30/12/2018","Not assigned",3720,49,"40 weeks","Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"02/01/2019",,,7510,"< 1 month",,"No",,"IV",,,"07/11/2023",20.4,109.3,,,17.08,0.79,,,,,,,,,,,,,,,,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Current",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Some Concerns","Yes","Dose adjustment for size","Yes","Alkindi 4mg am, 4mg afternoon, 3mg evening","Yes","OD","HC","No","Sodium chloride 7 mmol QDS","No",,"No",,"No",,"No",,"No",,"No",,"No",,"07/11/2023",6.9,"Greulich & Pyle","No",,,,,,,,,,,,,,,,,,"7510 07/11/2023"
"Oxford - CH","United Kingdom",9081,"United Kingdom","Active","26/08/2021","08/07/2005","Female",,,,"Yes","Female","Presumed XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,,,9081,,,"Not known",,"Not Known",,,"12/10/2023",,,,,,,"No","No",,,,"Not known","Not known","Not known","Not known",,"Not known","Not known",,,"No","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No Concerns","No",,"Yes",,"No",,"HC","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,"No",,,,,,,,,,,,,,,,,,"9081 12/10/2023"
"Sheffield - SCH","United Kingdom",2678,"United Kingdom","Active","15/01/2011","01/01/2011","Female",3685,,,"Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"16/03/2011",160.8,183,2678,"< 1 month",,"No",,,,,"13/04/2016",19.2,109.6,,,15.98,0.76,"No","Yes",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No Concerns","Yes","Overtreatment","Yes","9.81mg/m2/day","Yes","OD","HC","No","NaCl 0.6 ml BD",,,,,,,,,,,,,,,"26/08/2016",6.29,"TW20","No",,,,,,,,,,,,,,,,"165.4",,"2678 13/04/2016"
"Sheffield - SCH","United Kingdom",2678,"United Kingdom","Active","15/01/2011","01/01/2011","Female",3685,,,"Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"16/03/2011",160.8,183,2678,"< 1 month",,"No",,,,,"09/12/2016",23,113.4,,,17.89,0.85,"No","Yes",,,,"2","1","1",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No Concerns","No","Overtreatment","Yes","9.81mg/m2/day","Yes","OD","HC","No","NaCl 0.6 ml BD",,,,,,,,,,,,,,,"16/08/2016",5.9,"Greulich & Pyle","No",,,,,,,,,,,,,,,,"165.4",,"2678 09/12/2016"
"Sheffield - SCH","United Kingdom",2678,"United Kingdom","Active","15/01/2011","01/01/2011","Female",3685,,,"Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"16/03/2011",160.8,183,2678,"< 1 month",,"No",,,,,"14/07/2017",25.4,119.5,,,17.79,0.92,"No","Yes",,,,"1","1","1",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No Concerns","Yes","Dose adjustment for size","Yes","9.8mg/m2/day","Yes","OD","HC","No","NaCl 0.6 ml BD",,,,,,,,,,,,,,,"16/08/2016",5.9,"Greulich & Pyle","No",,,,,,,,,,,,,,,,"165.4",,"2678 14/07/2017"
"Sheffield - SCH","United Kingdom",2678,"United Kingdom","Active","15/01/2011","01/01/2011","Female",3685,,,"Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"16/03/2011",160.8,183,2678,"< 1 month",,"No",,,,,"27/07/2018",29.2,124.7,,,18.78,1.01,"No","Yes",,,,"1","1","1",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No Concerns","Yes","Dose adjustment for size","Yes","9.9mg/m2/day","Yes","OD","HC","No","NaCl 0.6 ml BD",,,,,,,,,,,,,,,"16/08/2016",5.9,"Greulich & Pyle","No",,,,,,,,,,,,,,,,"165.4",,"2678 27/07/2018"
"Sheffield - SCH","United Kingdom",2678,"United Kingdom","Active","15/01/2011","01/01/2011","Female",3685,,,"Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"16/03/2011",160.8,183,2678,"< 1 month",,"No",,,,,"01/07/2019",35.4,130.1,,,20.91,1.13,"No","Yes",110,61,,"1","1","1",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No Concerns","No","Dose adjustment for size","Yes","8.7mg/m2/day","Yes","OD","HC","No","NaCl 0.6 ml BD",,,,,,,,,,,,,,,"01/07/2019",6.74,"Greulich & Pyle","No",,,,,,,,,,,,,,,,"165.4",,"2678 01/07/2019"
"Sheffield - SCH","United Kingdom",2678,"United Kingdom","Active","15/01/2011","01/01/2011","Female",3685,,,"Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"16/03/2011",160.8,183,2678,"< 1 month",,"No",,,,,"09/11/2020",42.8,138,,,22.47,1.28,"No","Yes",,,,"1","1","1",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No Concerns","Yes","Dose adjustment for size","Yes","9.37mg/m2/day","Yes","OD","HC","No","NaCl 0.6 ml BD",,,,,,,,,,,,,,,"10/08/2020",8.32,"Greulich & Pyle","No",,,,,,,,,,,,,,,,"165.4",,"2678 09/11/2020"
"Sheffield - SCH","United Kingdom",2678,"United Kingdom","Active","15/01/2011","01/01/2011","Female",3685,,,"Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"16/03/2011",160.8,183,2678,"< 1 month",,"No",,,,,"16/08/2021",44.6,145.2,,,21.15,1.34,"No","Yes",,,,"1","1","1",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No Concerns","Yes","Dose adjustment for size","Yes","10.44mg/m2/day","Yes","OD","HC","No","NaCl 0.6 ml BD",,,,,,,,,,,,,,,"16/08/2021",10.49,"Greulich & Pyle","No",,,,,,,,,,,,,,,,"165.4",,"2678 16/08/2021"
"Sheffield - SCH","United Kingdom",2678,"United Kingdom","Active","15/01/2011","01/01/2011","Female",3685,,,"Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"16/03/2011",160.8,183,2678,"< 1 month",,"No",,,,,"13/06/2022",45,150.3,,,19.92,1.37,"No","Yes",,,,"1","1","1",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No Concerns","No","Dose adjustment for size","Yes","10.2mg/m2/day","Yes","OD","HC","No","NaCl 0.6 ml BD",,,,,,,,,,,,,,,"13/06/2022",11.54,"TW20","No",,,,,,,,,,,,,,,,"165.4",,"2678 13/06/2022"
"Sheffield - SCH","United Kingdom",2678,"United Kingdom","Active","15/01/2011","01/01/2011","Female",3685,,,"Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"16/03/2011",160.8,183,2678,"< 1 month",,"No",,,,,"07/02/2022",42.8,147.6,,,19.65,1.32,"No","Yes",,,,"1","1","1",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No Concerns","No","Dose adjustment for size","Yes","10.57mg/m^2/day","Yes","OD","HC","No","NaCl 0.6 ml BD",,,,,,,,,,,,,,,"13/06/2022",11.54,"TW20","No",,,,,,,,,,,,,,,,"165.4",,"2678 07/02/2022"
"Sheffield - SCH","United Kingdom",2678,"United Kingdom","Active","15/01/2011","01/01/2011","Female",3685,,,"Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"16/03/2011",160.8,183,2678,"< 1 month",,"No",,,,,"20/09/2022",45.8,151.6,,,19.93,1.39,"No","Yes",122,70,,"1","1","1",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No Concerns","No","Dose adjustment for size","Yes","10.1mg/m2/day","Yes","OD","HC","No","NaCl 0.6 ml BD",,,,,,,,,,,,,,,"13/06/2022",11.54,"TW20","No",,,,,,,,,,,,,,,,"165.4",,"2678 20/09/2022"
"Sheffield - SCH","United Kingdom",2679,"United Kingdom","Active","13/08/2014","01/08/2014","Male",,,"40 weeks","Yes","Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"13/08/2014",160.8,183,2679,"< 1 month",,"No",,"Normal Male",,,"28/04/2016",13.6,89.6,,,16.94,0.58,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No Concerns","Yes","Undertreatment","Yes","12.89mg/m2/day","Yes","OD","HC","No","NaCl 20mmol x 4/day",,,,,,,,,,,,,,,"01/02/2016",2.89,"TW20","No",,,,"Not known",,,,,,,,,,,,"178.4",,"2679 28/04/2016"
"Sheffield - SCH","United Kingdom",2679,"United Kingdom","Active","13/08/2014","01/08/2014","Male",,,"40 weeks","Yes","Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"13/08/2014",160.8,183,2679,"< 1 month",,"No",,"Normal Male",,,"31/03/2017",16.4,98.1,,,17.04,0.67,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No Concerns","Yes","Undertreatment","Yes","11.22mg/m2/day","Yes","OD","HC","No","NaCl 20mmol x 4/day",,,,,,,,,,,,,,,"01/02/2016",4.5,"TW20","No",,,,"Not known",,,,,,,,,,,,"178.4",,"2679 31/03/2017"
"Sheffield - SCH","United Kingdom",2679,"United Kingdom","Active","13/08/2014","01/08/2014","Male",,,"40 weeks","Yes","Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"13/08/2014",160.8,183,2679,"< 1 month",,"No",,"Normal Male",,,"12/01/2018",18.2,105.7,,,16.29,0.73,,,110,53,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No Concerns","Yes","Dose adjustment for size","Yes","10.6mg/m2/day","Yes","OD","HC","No","NaCl 20mmol x 4/day",,,,,,,,,,,,,,,"23/04/2018",4.1,"Greulich & Pyle","No",,,,"Not known",,,,,,,,,,,,"178.4",,"2679 12/01/2018"
"Sheffield - SCH","United Kingdom",2679,"United Kingdom","Active","13/08/2014","01/08/2014","Male",,,"40 weeks","Yes","Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"13/08/2014",160.8,183,2679,"< 1 month",,"No",,"Normal Male",,,"30/01/2019",21.2,114.7,,,16.11,0.82,,,100,52,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No Concerns","No","Dose adjustment for size","Yes","12.7mg/m2/day","Yes","OD","HC","No","NaCl 20mmol x 4/day",,,,,,,,,,,,,,,"07/10/2019",5.25,"Greulich & Pyle","No",,,,"Not known",,,,,,,,,,,,"178.4",,"2679 30/01/2019"
"Sheffield - SCH","United Kingdom",2679,"United Kingdom","Active","13/08/2014","01/08/2014","Male",,,"40 weeks","Yes","Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"13/08/2014",160.8,183,2679,"< 1 month",,"No",,"Normal Male",,,"24/02/2020",25.2,122.8,,,16.71,0.93,,,104,62,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No Concerns","No","Dose adjustment for size","Yes","10.79mg/m2/day","Yes","OD","HC","No","NaCl 20mmol x 4/day",,,,,,,,,,,,,,,"10/08/2020",5.94,"Greulich & Pyle","No",,,,"Not known",,,,,,,,,,,,"178.4",,"2679 24/02/2020"
"Sheffield - SCH","United Kingdom",2679,"United Kingdom","Active","13/08/2014","01/08/2014","Male",,,"40 weeks","Yes","Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"13/08/2014",160.8,183,2679,"< 1 month",,"No",,"Normal Male",,,"12/02/2021",27.6,130.5,,,16.21,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No Concerns","Yes","Dose adjustment for size","Yes","11.99mg/m2/day","Yes","OD","HC","No","NaCl 20mmol x 4/day",,,,,,,,,,,,,,,"10/08/2021",7.53,"Greulich & Pyle","No",,,,"Not known",,,,,,,,,,,,"178.4",,"2679 12/02/2021"
"Sheffield - SCH","United Kingdom",2679,"United Kingdom","Active","13/08/2014","01/08/2014","Male",,,"40 weeks","Yes","Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"13/08/2014",160.8,183,2679,"< 1 month",,"No",,"Normal Male",,,"01/02/2016",13.2,84.1,,,18.66,0.56,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No Concerns","Yes","Dose adjustment for size","Yes","11.99mg/m2/day","Yes","OD","HC","No","NaCl 20mmol x 4/day",,,,,,,,,,,,,,,"01/02/2016",2.89,"TW20","No",,,,"Not known",,,,,,,,,,,,"178.4",,"2679 01/02/2016"
"Sheffield - SCH","United Kingdom",2679,"United Kingdom","Active","13/08/2014","01/08/2014","Male",,,"40 weeks","Yes","Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"13/08/2014",160.8,183,2679,"< 1 month",,"No",,"Normal Male",,,"08/07/2016",14.4,90.3,,,17.66,0.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No Concerns","Yes","Dose adjustment for size","Yes","11.99mg/m2/day","Yes","OD","HC","No","NaCl 20mmol x 4/day",,,,,,,,,,,,,,,"10/08/2021",7.53,"Greulich & Pyle","No",,,,"Not known",,,,,,,,,,,,"178.4",,"2679 08/07/2016"
"Sheffield - SCH","United Kingdom",2679,"United Kingdom","Active","13/08/2014","01/08/2014","Male",,,"40 weeks","Yes","Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"13/08/2014",160.8,183,2679,"< 1 month",,"No",,"Normal Male",,,"16/09/2016",15,93,,,17.34,0.62,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No Concerns","Yes","Dose adjustment for size","Yes","11.99mg/m2/day","Yes","OD","HC","No","NaCl 20mmol x 4/day",,,,,,,,,,,,,,,"10/08/2021",7.53,"Greulich & Pyle","No",,,,"Not known",,,,,,,,,,,,"178.4",,"2679 16/09/2016"
"Sheffield - SCH","United Kingdom",2679,"United Kingdom","Active","13/08/2014","01/08/2014","Male",,,"40 weeks","Yes","Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"13/08/2014",160.8,183,2679,"< 1 month",,"No",,"Normal Male",,,"09/12/2016",15.6,95.1,,,17.25,0.64,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No Concerns","Yes","Dose adjustment for size","Yes","11.99mg/m2/day","Yes","OD","HC","No","NaCl 20mmol x 4/day",,,,,,,,,,,,,,,"10/08/2021",7.53,"Greulich & Pyle","No",,,,"Not known",,,,,,,,,,,,"178.4",,"2679 09/12/2016"
"Sheffield - SCH","United Kingdom",2679,"United Kingdom","Active","13/08/2014","01/08/2014","Male",,,"40 weeks","Yes","Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"13/08/2014",160.8,183,2679,"< 1 month",,"No",,"Normal Male",,,"14/07/2017",17.6,100.7,,,17.36,0.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No Concerns","Yes","Dose adjustment for size","Yes","12.88mg/m2/day","Yes","OD","HC","No","NaCl 20mmol x 4/day",,,,,,,,,,,,,,,"10/08/2021",7.53,"Greulich & Pyle","No",,,,"Not known",,,,,,,,,,,,"178.4",,"2679 14/07/2017"
"Sheffield - SCH","United Kingdom",2679,"United Kingdom","Active","13/08/2014","01/08/2014","Male",,,"40 weeks","Yes","Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"13/08/2014",160.8,183,2679,"< 1 month",,"No",,"Normal Male",,,"13/10/2017",17.6,103.1,,,16.56,0.71,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No Concerns","Yes","Dose adjustment for size","Yes","10.92mg/m2/day","Yes","OD","HC","No","NaCl 20mmol x 4/day",,,,,,,,,,,,,,,"10/08/2021",7.53,"Greulich & Pyle","No",,,,"Not known",,,,,,,,,,,,"178.4",,"2679 13/10/2017"
"Sheffield - SCH","United Kingdom",2679,"United Kingdom","Active","13/08/2014","01/08/2014","Male",,,"40 weeks","Yes","Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"13/08/2014",160.8,183,2679,"< 1 month",,"No",,"Normal Male",,,"27/04/2018",18.8,107.6,,,16.24,0.75,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No Concerns","Yes","Dose adjustment for size","Yes","11.01mg/m2/day","Yes","OD","HC","No","NaCl 20mmol x 4/day",,,,,,,,,,,,,,,"10/08/2021",7.53,"Greulich & Pyle","No",,,,"Not known",,,,,,,,,,,,"178.4",,"2679 27/04/2018"
"Sheffield - SCH","United Kingdom",2679,"United Kingdom","Active","13/08/2014","01/08/2014","Male",,,"40 weeks","Yes","Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"13/08/2014",160.8,183,2679,"< 1 month",,"No",,"Normal Male",,,"27/07/2018",20.4,110.6,,,16.68,0.79,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No Concerns","Yes","Dose adjustment for size","Yes","12.63mg/m2/day","Yes","OD","HC","No","NaCl 20mmol x 4/day",,,,,,,,,,,,,,,"10/08/2021",7.53,"Greulich & Pyle","No",,,,"Not known",,,,,,,,,,,,"178.4",,"2679 27/07/2018"
"Sheffield - SCH","United Kingdom",2679,"United Kingdom","Active","13/08/2014","01/08/2014","Male",,,"40 weeks","Yes","Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"13/08/2014",160.8,183,2679,"< 1 month",,"No",,"Normal Male",,,"12/11/2018",20.8,112.1,,,16.55,0.8,,,91,50,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No Concerns","Yes","Dose adjustment for size","Yes",,"Yes","OD","HC","No","NaCl 20mmol x 4/day",,,,,,,,,,,,,,,"23/04/2018",4.35,"TW20","No",,,,"Not known",,,,,,,,,,,,"178.4",,"2679 12/11/2018"
"Sheffield - SCH","United Kingdom",2679,"United Kingdom","Active","13/08/2014","01/08/2014","Male",,,"40 weeks","Yes","Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"13/08/2014",160.8,183,2679,"< 1 month",,"No",,"Normal Male",,,"01/07/2019",22.2,117.06,,,16.2,0.85,,,92,56,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No Concerns","Yes","Dose adjustment for size","Yes","11.7mg/m2/day","Yes","OD","HC","No","NaCl 20mmol x 4/day",,,,,,,,,,,,,,,"10/08/2021",7.53,"Greulich & Pyle","No",,,,"Not known",,,,,,,,,,,,"178.4",,"2679 01/07/2019"
"Sheffield - SCH","United Kingdom",2679,"United Kingdom","Active","13/08/2014","01/08/2014","Male",,,"40 weeks","Yes","Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"13/08/2014",160.8,183,2679,"< 1 month",,"No",,"Normal Male",,,"07/05/2019",22.6,116.2,,,16.74,0.85,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No Concerns","Yes","Dose adjustment for size","Yes","11.71mg/m2/day","Yes","OD","HC","No","NaCl 20mmol x 4/day",,,,,,,,,,,,,,,"10/08/2021",7.53,"Greulich & Pyle","No",,,,"Not known",,,,,,,,,,,,"178.4",,"2679 07/05/2019"
"Sheffield - SCH","United Kingdom",2679,"United Kingdom","Active","13/08/2014","01/08/2014","Male",,,"40 weeks","Yes","Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"13/08/2014",160.8,183,2679,"< 1 month",,"No",,"Normal Male",,,"07/10/2019",23.4,120.3,,,16.17,0.88,,,96,56,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No Concerns","Yes","Dose adjustment for size","Yes","11.31mg/m2/day","Yes","OD","HC","No","NaCl 20mmol x 4/day",,,,,,,,,,,,,,,"10/08/2021",7.53,"Greulich & Pyle","No",,,,"Not known",,,,,,,,,,,,"178.4",,"2679 07/10/2019"
"Sheffield - SCH","United Kingdom",2679,"United Kingdom","Active","13/08/2014","01/08/2014","Male",,,"40 weeks","Yes","Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"13/08/2014",160.8,183,2679,"< 1 month",,"No",,"Normal Male",,,"14/05/2020",25.8,125.6,,,16.35,0.95,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No Concerns","Yes","Undertreatment","Yes","12.65mg/m2/day","Yes","OD","HC","No","NaCl 20mmol x 4/day",,,,,,,,,,,,,,,"10/08/2021",7.53,"Greulich & Pyle","No",,,,"Not known",,,,,,,,,,,,"178.4",,"2679 14/05/2020"
"Sheffield - SCH","United Kingdom",2679,"United Kingdom","Active","13/08/2014","01/08/2014","Male",,,"40 weeks","Yes","Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"13/08/2014",160.8,183,2679,"< 1 month",,"No",,"Normal Male",,,"09/11/2020",27.2,128,,,16.6,0.98,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No Concerns","Yes","Dose adjustment for size","Yes","12.2mg/m2/day","Yes","OD","HC","No","NaCl 20mmol x 4/day",,,,,,,,,,,,,,,"10/08/2021",7.53,"Greulich & Pyle","No",,,,"Not known",,,,,,,,,,,,"178.4",,"2679 09/11/2020"
"Sheffield - SCH","United Kingdom",2679,"United Kingdom","Active","13/08/2014","01/08/2014","Male",,,"40 weeks","Yes","Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"13/08/2014",160.8,183,2679,"< 1 month",,"No",,"Normal Male",,,"14/05/2021",28.2,132.8,,,15.99,1.02,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No Concerns","Yes","Dose adjustment for size","Yes","11.77mg/m2/day","Yes","OD","HC","No","NaCl 20mmol x 4/day",,,,,,,,,,,,,,,"10/08/2021",7.53,"Greulich & Pyle","No",,,,"Not known",,,,,,,,,,,,"178.4",,"2679 14/05/2021"
"Sheffield - SCH","United Kingdom",2679,"United Kingdom","Active","13/08/2014","01/08/2014","Male",,,"40 weeks","Yes","Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"13/08/2014",160.8,183,2679,"< 1 month",,"No",,"Normal Male",,,"16/08/2021",29.2,134.5,,,16.14,1.04,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No Concerns","Yes","Undertreatment","Yes","12.45mg/m2/day","Yes","OD","HC","No","NaCl 20mmol x 4/day",,,,,,,,,,,,,,,"16/08/2021",7.97,"TW20","No",,,,"Not known",,,,,,,,,,,,"178.4",,"2679 16/08/2021"
"Sheffield - SCH","United Kingdom",2679,"United Kingdom","Active","13/08/2014","01/08/2014","Male",,,"40 weeks","Yes","Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"13/08/2014",160.8,183,2679,"< 1 month",,"No",,"Normal Male",,,"13/06/2022",33.4,140.2,,,16.99,1.14,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No Concerns","Yes","Dose adjustment for size","Yes","14.04mg/m^2/day","Yes","OD","HC","No","NaCl 20mmol x 4/day",,,,,,,,,,,,,,,"13/06/2022",8.33,"TW20","No",,,,"Not known",,,,,,,,,,,,"178.4",,"2679 13/06/2022"
"Sheffield - SCH","United Kingdom",2679,"United Kingdom","Active","13/08/2014","01/08/2014","Male",,,"40 weeks","Yes","Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"13/08/2014",160.8,183,2679,"< 1 month",,"No",,"Normal Male",,,"20/09/2022",33,140.7,,,16.67,1.14,,,108,62,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No Concerns","No","Dose adjustment for size","Yes","11.52mg/m^2/day","Yes","OD","HC","No","NaCl 20mmol x 4/day",,,,,,,,,,,,,,,"13/06/2022",8.33,"TW20","No",,,,"Not known",,,,,,,,,,,,"178.4",,"2679 20/09/2022"
"Sheffield - SCH","United Kingdom",3710,"United Kingdom",,"05/03/2007","12/02/2007","Male",3978,,"40 weeks","Yes","Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"13/03/2007",168.5,189.6,3710,"< 1 month",,"No","Presented at 3 weeks of age with salt wasting crisis, commenced on replacement treatment with hydrocortisone, fludrocortisone and sodium chloride immediately after diagnosis.","Normal Male",,,"30/03/2016",35.8,147.4,,,16.48,1.21,"No","Not Applicable",98,57,,,,,,,,,,,,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"Yes","Autistic spectrum disorder","No",,"Yes","UTI on initial presentation","No Concerns","Yes","Undertreatment","Yes",,"Yes","OD","HC","No","30% sodium chloride 1.5ml TDS","No",,"No",,"No",,"No",,"No",,"No",,"No",,"20/07/2016",12,"TW20","Not Known",,,,,"1","1",2,2,,"No","not_applicable","Not Applicable","Not Applicable",,,"185.55",,"3710 30/03/2016"
"Sheffield - SCH","United Kingdom",3710,"United Kingdom",,"05/03/2007","12/02/2007","Male",3978,,"40 weeks","Yes","Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"13/03/2007",168.5,189.6,3710,"< 1 month",,"No","Presented at 3 weeks of age with salt wasting crisis, commenced on replacement treatment with hydrocortisone, fludrocortisone and sodium chloride immediately after diagnosis.","Normal Male",,,"06/03/2017",42.4,153.9,,,17.9,1.35,"No","Not Applicable",,,,,,,,,,,,,,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"Yes","Autistic spectrum disorder","No",,"Yes","UTI on initial presentation","No Concerns","No","Not Applicable","Yes","14.88mg/msq/day","Yes","OD","HC","No","30% sodium chloride 1.5ml TDS","No",,"No",,"No",,"No",,"No",,"No",,"No",,"18/08/2017",13,"TW20","Not Known",,,,"2","2","1",2,2,,"No","not_applicable","Not Applicable","Not Applicable",,,"185.55",,"3710 06/03/2017"
"Sheffield - SCH","United Kingdom",3710,"United Kingdom",,"05/03/2007","12/02/2007","Male",3978,,"40 weeks","Yes","Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"13/03/2007",168.5,189.6,3710,"< 1 month",,"No","Presented at 3 weeks of age with salt wasting crisis, commenced on replacement treatment with hydrocortisone, fludrocortisone and sodium chloride immediately after diagnosis.","Normal Male",,,"30/05/2018",48.6,162.8,,,18.34,1.48,"No","Not Applicable",96,50,,,,,,,,,,,,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No","129.98mcg/msq/day","Never",,"No",,"No",,"No",,"No",,"Yes","Autistic spectrum disorder","No",,"Yes","Motor coordination problems","No Concerns","Yes","Undertreatment","Yes",,"Yes","OD","HC","No","30% sodium chloride 1.5ml TDS","No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,"2","2","1",2,2,,"No","not_applicable","Not Applicable","Not Applicable",,,"185.55",,"3710 30/05/2018"
"Sheffield - SCH","United Kingdom",3710,"United Kingdom",,"05/03/2007","12/02/2007","Male",3978,,"40 weeks","Yes","Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"13/03/2007",168.5,189.6,3710,"< 1 month",,"No","Presented at 3 weeks of age with salt wasting crisis, commenced on replacement treatment with hydrocortisone, fludrocortisone and sodium chloride immediately after diagnosis.","Normal Male",,,"01/06/2022",69.8,187.2,,,19.92,1.91,"No","Not Applicable",115,62,,,,,,,,,,,,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No","129.98mcg/msq/day","Never",,"No",,"No",,"No",,"No",,"Yes","Autistic spectrum disorder","No",,"Yes","Motor coordination problems","No Concerns","No","Undertreatment","Yes","13.8mg/m^2/day","Yes","OD","HC","No","30% sodium chloride 1.5ml TDS","No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,"2","2","1",2,2,,"No","not_applicable","Not Applicable","Not Applicable",,,"185.55",,"3710 01/06/2022"
"Sheffield - SCH","United Kingdom",3711,"United Kingdom",,"15/01/2016","01/01/2016","Female",4050,,"41 weeks","Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,165.45,175.45,3711,"< 1 month",,"No","Started on treatment with hydrocortisone, fludrocortisone and sodium chloride from the first week of life.","III",,,"29/07/2016",4.04,,,,,,"No","Yes",,,,,,,,,,,,,,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No Concerns","No","Not Applicable","Yes","0.7mg qds (10.73mg/m2/day)","Yes","OD","HC","Yes","NaCl 5.85% 4mls qds","No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,"Not Known",,,,,,,,,,"Not known",,,,,,"163.95",,"3711 29/07/2016"
"Sheffield - SCH","United Kingdom",3711,"United Kingdom",,"15/01/2016","01/01/2016","Female",4050,,"41 weeks","Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,165.45,175.45,3711,"< 1 month",,"No","Started on treatment with hydrocortisone, fludrocortisone and sodium chloride from the first week of life.","III",,,"20/02/2017",9.05,70.5,,,18.21,0.42,"No","Yes",,,,,,,,,,,,,,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No Concerns","Yes","Dose adjustment for size","Yes",,"No","OD","HC","Yes","NaCl 3.3mmol/kg/day","No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,,,,,,,"Not known",,,,,,"163.95",,"3711 20/02/2017"
"Sheffield - SCH","United Kingdom",3711,"United Kingdom",,"15/01/2016","01/01/2016","Female",4050,,"41 weeks","Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,165.45,175.45,3711,"< 1 month",,"No","Started on treatment with hydrocortisone, fludrocortisone and sodium chloride from the first week of life.","III",,,"22/09/2017",11.45,78.8,,,18.44,0.5,"No","Yes",,,,,,,,,,,,,,"Yes","common channel with a single opening","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No Concerns","Yes","Not Applicable","Yes",,"Yes","OD","HC","Yes","NaCl 10ml tds","No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,,,,,,,"Not known",,,,,,"163.95",,"3711 22/09/2017"
"Sheffield - SCH","United Kingdom",3711,"United Kingdom",,"15/01/2016","01/01/2016","Female",4050,,"41 weeks","Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,165.45,175.45,3711,"< 1 month",,"No","Started on treatment with hydrocortisone, fludrocortisone and sodium chloride from the first week of life.","III",,,"27/07/2018",14.8,90.2,,,18.19,0.61,"No","Yes",,,,,,,,,,,,,,"Yes","common channel with a single opening","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No Concerns","Yes","Dose adjustment for size","Yes","plus one evening dose 0.5mg","Yes","OD","HC","Yes","NaCl 3ml tds","No",,"No",,"No",,"No",,"No",,"No",,"No",,"27/07/2018",1,"Greulich & Pyle","No",,,,,,,,,,"Not known",,,,,,"163.95",,"3711 27/07/2018"
"Sheffield - SCH","United Kingdom",3711,"United Kingdom",,"15/01/2016","01/01/2016","Female",4050,,"41 weeks","Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,165.45,175.45,3711,"< 1 month",,"No","Started on treatment with hydrocortisone, fludrocortisone and sodium chloride from the first week of life.","III",,,"12/03/2018",16,95.8,,,17.43,0.65,"No","Yes",95,66,,,,,,,,,,,,"Yes","common channel with a single opening","Yes","26/11/2018","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No Concerns","Yes","Dose adjustment for size","Yes",,"Yes","OD","HC","No","NaCl 3ml tds","No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,,,,,,,"Not known",,,,,,"163.95",,"3711 12/03/2018"
"Sheffield - SCH","United Kingdom",3711,"United Kingdom",,"15/01/2016","01/01/2016","Female",4050,,"41 weeks","Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,165.45,175.45,3711,"< 1 month",,"No","Started on treatment with hydrocortisone, fludrocortisone and sodium chloride from the first week of life.","III",,,"03/06/2019",16.4,97.6,,,17.22,0.67,"No","Yes",108,64,,,,,,,,,,,,"Yes","common channel with a single opening","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No Concerns","No","Not Applicable","Yes","11.9mg/m2/day","Yes","OD","HC","No","NaCl 3ml tds","No",,"No",,"No",,"No",,"No",,"No",,"No",,"03/06/2019",3,"TW20","No",,,,,,,,,,"Not known",,,,,,"163.95",,"3711 03/06/2019"
"Sheffield - SCH","United Kingdom",3711,"United Kingdom",,"15/01/2016","01/01/2016","Female",4050,,"41 weeks","Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,165.45,175.45,3711,"< 1 month",,"No","Started on treatment with hydrocortisone, fludrocortisone and sodium chloride from the first week of life.","III",,,"25/07/2022",30.8,125.1,,,19.68,1.03,"No","Yes",,,,,,,,,,,,,,"Yes","common channel with a single opening","No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"Never",,"No",,"No",,"No",,"No",,"No",,"No",,"No",,"No Concerns","No","Not Applicable","Yes","13.53mg/m2/day","Yes","OD","HC","No","NaCl 3ml tds","No",,"No",,"No",,"No",,"No",,"No",,"No",,"25/07/2021",6.48,"TW20","No",,,,,,,,,,"Not known",,,,,,"163.95",,"3711 25/07/2022"
"Sheffield - SCH","United Kingdom",3713,"United Kingdom","Active","07/11/2016","30/11/2008","Female",3000,,"40 weeks","Yes","Female","Presumed XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"01/01/2009",,,3713,"< 1 month",,"Not known","Ambiguous genitalia","Not Known",,,"07/11/2016",35.3,131.6,,,20.38,1.14,,,,,,"3","2",,,,,,,,,,,"Yes","Feminising genitoplasty 26/7/09",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Yes","Undertreatment","Yes",,"Yes","OD","HC",,,,,,,,,,,,,,,,,"14/11/2016",11.5,"Greulich & Pyle","Not Known",,,,,,,,,,,,,,,,,,"3713 07/11/2016"
"Sheffield - SCH","United Kingdom",3713,"United Kingdom","Active","07/11/2016","30/11/2008","Female",3000,,"40 weeks","Yes","Female","Presumed XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"01/01/2009",,,3713,"< 1 month",,"Not known","Ambiguous genitalia","Not Known",,,"20/03/2017",38.8,138.8,,,20.14,1.22,,,,,,"3","2",,,,,,,,,,,"Yes","Feminising genitoplasty 26/7/09",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Yes","Undertreatment","Yes",,"Yes","OD","HC",,,,,,,"Yes","Decapeptyl 8 weekly",,,,,,,,,"14/11/2016",11.5,"Greulich & Pyle","Not Known",,,,,,,,,,,,,,,,,,"3713 20/03/2017"
"Sheffield - SCH","United Kingdom",3713,"United Kingdom","Active","07/11/2016","30/11/2008","Female",3000,,"40 weeks","Yes","Female","Presumed XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"01/01/2009",,,3713,"< 1 month",,"Not known","Ambiguous genitalia","Not Known",,,"06/01/2017",36.8,133.7,,,20.59,1.17,,,,,"Normal anteverted prepubertal uterus.  The uterus measures 2 x 1.1 x 1.2cm with a volume
of 1.4ml and a volume of 2ml including the cervix.
The right ovary measures 2.5 x 0.9 x 1.6cm with a volume of 1.8ml.
The left ovary measures 1.9 x 0.6 x1.2cm with a volume of 0.8ml.
Normal bladder outline with a volume of 273ml.
Loaded rectum with a transverse measurement of 2.6cm.

","3","2",,,,,,,,,,,"Yes","Feminising genitoplasty 26/7/09",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Yes","Undertreatment","Yes","Treatment changed from 5 - 5 - 5 so total daily dose the same","Yes","OD","HC",,,,,,,"Yes","Decapeptyl 8 weekly",,,,,,,,,"14/11/2016",11.5,"Greulich & Pyle","Not Known",,,,,,,,,,,,,,,,,,"3713 06/01/2017"
"Sheffield - SCH","United Kingdom",3713,"United Kingdom","Active","07/11/2016","30/11/2008","Female",3000,,"40 weeks","Yes","Female","Presumed XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"01/01/2009",,,3713,"< 1 month",,"Not known","Ambiguous genitalia","Not Known",,,"18/06/2018",45.5,143,,,22.25,1.34,,,111,63,,"3","2",,,,,,,,,,,"Yes","Feminising genitoplasty 26/7/09",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No","Undertreatment","Yes",,"Yes","OD","HC",,,,,,,"Yes","Decapeptyl 8 weekly",,,,,,,,,"14/11/2016",11.5,"Greulich & Pyle","Not Known",,,,,,,,,,,,,,,,,,"3713 18/06/2018"
"Sheffield - SCH","United Kingdom",3713,"United Kingdom","Active","07/11/2016","30/11/2008","Female",3000,,"40 weeks","Yes","Female","Presumed XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"01/01/2009",,,3713,"< 1 month",,"Not known","Ambiguous genitalia","Not Known",,,"22/10/2018",46.2,145.2,,,21.91,1.37,,,102,66,,"3","2",,,,,,,,,,,"Yes","Feminising genitoplasty 26/7/09",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No","Undertreatment","Yes",,"Yes","OD","HC",,,,,,,"Yes","Decapeptyl 8 weekly",,,,,,,,,"22/10/2018",13,"Greulich & Pyle","Not Known",,,,,,,,,,,,,,,,,,"3713 22/10/2018"
"Sheffield - SCH","United Kingdom",3713,"United Kingdom","Active","07/11/2016","30/11/2008","Female",3000,,"40 weeks","Yes","Female","Presumed XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"01/01/2009",,,3713,"< 1 month",,"Not known","Ambiguous genitalia","Not Known",,,"23/09/2019",49.8,148,,,22.74,1.43,,,115,59,,"3","2",,,,,,,,,,,"Yes","Feminising genitoplasty 26/7/09",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No","Undertreatment","Yes",,"Yes","OD","HC",,,,,,,"Yes","Decapeptyl 8 weekly",,,,,,,,,"23/09/2019",13.8,"Greulich & Pyle","Not Known",,,,,,,,,,,,,,,,,,"3713 23/09/2019"
"Sheffield - SCH","United Kingdom",3713,"United Kingdom","Active","07/11/2016","30/11/2008","Female",3000,,"40 weeks","Yes","Female","Presumed XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"01/01/2009",,,3713,"< 1 month",,"Not known","Ambiguous genitalia","Not Known",,,"13/12/2019",51.2,148.9,,,23.09,1.46,,,,,,"3","2",,,,,,,,,,,"Yes","Feminising genitoplasty 26/7/09",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No","Undertreatment","Yes","12.2","Yes","OD","HC",,,,,,,"Yes","Decapeptyl 8 weekly",,,,,,,,,"23/09/2019",13.8,"Greulich & Pyle","Not Known",,,,,,,,,,,,,,,,,,"3713 13/12/2019"
"Sheffield - SCH","United Kingdom",4511,"United Kingdom",,"23/07/2005","06/07/2005","Male",3232,,"42 weeks","Yes","Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"26/07/2005",161.6,176.8,4511,"< 1 month",,"No","Had a hypoglycaemic seizure prior to this on day 2, but diagnosis not suspected at this point. ","Normal Male",,,"16/03/2016",28.8,132,,,16.53,1.03,,,99,56,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No Concerns","No","Other","Yes",,"Yes","OD","HC","No","2ml of 30% NaCl twice daily",,,,,,,,,,,,,"No","On IV Antibiotics due to acute presentation","16/03/2016",8.99,"TW20",,,,,,,,,,,,,,,,,"175.7",,"4511 16/03/2016"
"Sheffield - SCH","United Kingdom",4511,"United Kingdom",,"23/07/2005","06/07/2005","Male",3232,,"42 weeks","Yes","Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"26/07/2005",161.6,176.8,4511,"< 1 month",,"No","Had a hypoglycaemic seizure prior to this on day 2, but diagnosis not suspected at this point. ","Normal Male",,,"29/03/2017",34.8,137.8,,,18.33,1.15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No Concerns","Yes","Other","Yes",,"Yes","OD","HC","No","2ml of 30% NaCl twice daily",,,,,,,,,,,,,"No","On IV Antibiotics due to acute presentation","29/03/2017",9.3,"TW20",,,,,"3","1",,8,8,,,,,,,,"175.7",,"4511 29/03/2017"
"Sheffield - SCH","United Kingdom",4511,"United Kingdom",,"23/07/2005","06/07/2005","Male",3232,,"42 weeks","Yes","Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"26/07/2005",161.6,176.8,4511,"< 1 month",,"No","Had a hypoglycaemic seizure prior to this on day 2, but diagnosis not suspected at this point. ","Normal Male",,,"05/03/2018",35.2,146.6,,,16.38,1.2,,,114,64,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No Concerns","No","Other","Yes",,"Yes","OD","HC","No","2ml of 30% NaCl twice daily",,,,,,,,,,,,,"No","On IV Antibiotics due to acute presentation","29/03/2017",9.3,"TW20",,,,,"3","1",,8,8,,,,,,,,"175.7",,"4511 05/03/2018"
"Sheffield - SCH","United Kingdom",4511,"United Kingdom",,"23/07/2005","06/07/2005","Male",3232,,"42 weeks","Yes","Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"26/07/2005",161.6,176.8,4511,"< 1 month",,"No","Had a hypoglycaemic seizure prior to this on day 2, but diagnosis not suspected at this point. ","Normal Male",,,"29/05/2019",41.8,159.5,,,16.43,1.36,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No Concerns","Yes","Undertreatment","Yes",,"Yes","OD","HC","No","2ml of 30% NaCl twice daily",,,,,,,,,,,,,"No","On IV Antibiotics due to acute presentation","29/03/2017",13.16,"TW20",,,,,"3","1",,8,8,,,,,,,,"175.7",,"4511 29/05/2019"
"Sheffield - SCH","United Kingdom",4511,"United Kingdom",,"23/07/2005","06/07/2005","Male",3232,,"42 weeks","Yes","Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"26/07/2005",161.6,176.8,4511,"< 1 month",,"No","Had a hypoglycaemic seizure prior to this on day 2, but diagnosis not suspected at this point. ","Normal Male",,,"29/07/2020",48.9,167.2,,,17.49,1.51,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No Concerns","Yes","Undertreatment","Yes",,"Yes","OD","HC","No","2ml of 30% NaCl twice daily",,,,,,,,,,,,,"No","On IV Antibiotics due to acute presentation","29/03/2017",13.16,"TW20",,,,,"3","1",,8,8,,,,,,,,"175.7",,"4511 29/07/2020"
"Sheffield - SCH","United Kingdom",4511,"United Kingdom",,"23/07/2005","06/07/2005","Male",3232,,"42 weeks","Yes","Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"26/07/2005",161.6,176.8,4511,"< 1 month",,"No","Had a hypoglycaemic seizure prior to this on day 2, but diagnosis not suspected at this point. ","Normal Male",,,"31/08/2022",52.1,169.8,,,18.07,1.57,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Some Concerns","No","Undertreatment","Yes","15.4mg/m^2/day
At some times it is a struggle for mum to encourage him to take his tablets","Yes","OD","HC","No","2ml of 30% NaCl twice daily",,,,,,,,,,,,,"No","On IV Antibiotics due to acute presentation","29/05/2019",13.16,"TW20","No",,,,"3","1",,8,8,,,,,,,,"175.7",,"4511 31/08/2022"
"Sheffield - SCH","United Kingdom",4513,"United Kingdom","Active","06/09/2008","05/09/2008","Female",,,,"Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"08/09/2008",171.2,178.2,4513,"< 1 month",,"No","Cliteromegaly noted after delivery","II",,,"05/08/2016",54.6,129.3,,,32.66,1.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No Concerns","No","Other","Yes","Timings not precisely specified","Yes","OD","HC","No",,,,,,,,"No",,,,,,"No",,,,,,,,,,,,,,,,,,,,,"168.2",,"4513 05/08/2016"
"Sheffield - SCH","United Kingdom",4513,"United Kingdom","Active","06/09/2008","05/09/2008","Female",,,,"Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"08/09/2008",171.2,178.2,4513,"< 1 month",,"No","Cliteromegaly noted after delivery","II",,,"03/12/2016",58.7,133,,,33.18,1.47,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No Concerns","No","Other","Yes","Timings clarified for afternoon dose, otherwise just morning and before bed","Yes","OD","HC","No",,,,,,,,"No",,,,,,"No",,,,,,,,,,,,,,,,,,,,,"168.2",,"4513 03/12/2016"
"Sheffield - SCH","United Kingdom",4513,"United Kingdom","Active","06/09/2008","05/09/2008","Female",,,,"Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"08/09/2008",171.2,178.2,4513,"< 1 month",,"No","Cliteromegaly noted after delivery","II",,,"07/08/2017",65.4,141.2,,,32.8,1.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No Concerns","No","Other","Yes","Timings clarified for afternoon dose, otherwise just morning and before bed","Yes","OD","HC","No",,,,,,,,"No",,,,,,"No",,,,,,,,,,,,,,,,,,,,,"168.2",,"4513 07/08/2017"
"Sheffield - SCH","United Kingdom",4513,"United Kingdom","Active","06/09/2008","05/09/2008","Female",,,,"Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"08/09/2008",171.2,178.2,4513,"< 1 month",,"No","Cliteromegaly noted after delivery","II",,,"22/09/2017",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No Concerns","No","Other","Yes","Timings clarified for afternoon dose, otherwise just morning and before bed","Yes","OD","HC","No",,,,,,,,"No",,,,,,"No",,,,,,,,,,,,,,,,,,,,,"168.2",,"4513 22/09/2017"
"Sheffield - SCH","United Kingdom",4513,"United Kingdom","Active","06/09/2008","05/09/2008","Female",,,,"Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"08/09/2008",171.2,178.2,4513,"< 1 month",,"No","Cliteromegaly noted after delivery","II",,,"13/11/2017",65,144.8,,,31,1.62,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Some Concerns","Yes","Undertreatment","Yes",,"Yes","OD","HC","No",,,,,,,,"No",,,,,,"No",,,,,,,,,,,,,,,,,,,,,"168.2",,"4513 13/11/2017"
"Sheffield - SCH","United Kingdom",4513,"United Kingdom","Active","06/09/2008","05/09/2008","Female",,,,"Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"08/09/2008",171.2,178.2,4513,"< 1 month",,"No","Cliteromegaly noted after delivery","II",,,"27/11/2017",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Some Concerns","Yes","Undertreatment","Yes","Timings for afternoon and evening are precise","Yes","OD","HC","No",,,,,,,,"No",,,,,,"No",,,,,,,,,,,,,,,,,,,,,"168.2",,"4513 27/11/2017"
"Sheffield - SCH","United Kingdom",4513,"United Kingdom","Active","06/09/2008","05/09/2008","Female",,,,"Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"08/09/2008",171.2,178.2,4513,"< 1 month",,"No","Cliteromegaly noted after delivery","II",,,"08/01/2018",64.4,146,,,30.21,1.62,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Some Concerns","Yes","Undertreatment","Yes","Timings for afternoon and evening are precise","Yes","OD","HC","No",,,,,,,,"No",,,,,,"No",,"08/01/2018",10.49,"TW20",,,,,,,,,,,,,,,,,"168.2",,"4513 08/01/2018"
"Sheffield - SCH","United Kingdom",4513,"United Kingdom","Active","06/09/2008","05/09/2008","Female",,,,"Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"08/09/2008",171.2,178.2,4513,"< 1 month",,"No","Cliteromegaly noted after delivery","II",,,"09/04/2018",69.2,147.2,,,31.94,1.68,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Some Concerns","No","Undertreatment","Yes","Timings for afternoon and evening have not been noted as having changed","Yes","OD","HC","No",,,,,,,,"No",,,,,,"No",,"08/01/2018",10.49,"TW20",,,,,,,,,,,,,,,,,"168.2",,"4513 09/04/2018"
"Sheffield - SCH","United Kingdom",4513,"United Kingdom","Active","06/09/2008","05/09/2008","Female",,,,"Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"08/09/2008",171.2,178.2,4513,"< 1 month",,"No","Cliteromegaly noted after delivery","II",,,"02/09/2018",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Some Concerns","Yes","Undertreatment","Yes","Changed on basis of blood tests taken on 9/4/18","Yes","OD","HC","No",,,,,,,,"No",,,,,,"No",,"08/01/2018",10.49,"TW20",,,,,,,,,,,,,,,,,"168.2",,"4513 02/09/2018"
"Sheffield - SCH","United Kingdom",4513,"United Kingdom","Active","06/09/2008","05/09/2008","Female",,,,"Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"08/09/2008",171.2,178.2,4513,"< 1 month",,"No","Cliteromegaly noted after delivery","II",,,"09/07/2018",71.8,148.8,,,32.43,1.72,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Some Concerns","No","Undertreatment","Yes",,"Yes","OD","HC","No",,,,,,,,"No",,,,,,"No",,"08/01/2018",10.49,"TW20",,,,,,,,,,,,,,,,,"168.2",,"4513 09/07/2018"
"Sheffield - SCH","United Kingdom",4513,"United Kingdom","Active","06/09/2008","05/09/2008","Female",,,,"Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"08/09/2008",171.2,178.2,4513,"< 1 month",,"No","Cliteromegaly noted after delivery","II",,,"01/10/2018",73.4,149.7,,,32.75,1.75,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Some Concerns","No","Undertreatment","Yes",,"Yes","OD","HC","No",,,,,,,,"No",,,,,,"No",,"08/01/2018",10.49,"TW20",,,,,,,,,,,,,,,,,"168.2",,"4513 01/10/2018"
"Sheffield - SCH","United Kingdom",4513,"United Kingdom","Active","06/09/2008","05/09/2008","Female",,,,"Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"08/09/2008",171.2,178.2,4513,"< 1 month",,"No","Cliteromegaly noted after delivery","II",,,"09/11/2018",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Some Concerns","No","Undertreatment","Yes",,"Yes","OD","HC","No",,,,,,,,"No",,,,,,"No",,"08/01/2018",10.49,"TW20",,,,,,,,,,,,,,,,,"168.2",,"4513 09/11/2018"
"Sheffield - SCH","United Kingdom",4513,"United Kingdom","Active","06/09/2008","05/09/2008","Female",,,,"Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"08/09/2008",171.2,178.2,4513,"< 1 month",,"No","Cliteromegaly noted after delivery","II",,,"21/12/2018",77.2,151.2,,,33.77,1.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Some Concerns","No","Undertreatment","Yes","Timings confirmed explicitly","Yes","OD","HC","No",,,,,,,,"No",,,,,,"No",,"08/01/2018",10.49,"TW20",,,,,,,,,,,,,,,,,"168.2",,"4513 21/12/2018"
"Sheffield - SCH","United Kingdom",4513,"United Kingdom","Active","06/09/2008","05/09/2008","Female",,,,"Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"08/09/2008",171.2,178.2,4513,"< 1 month",,"No","Cliteromegaly noted after delivery","II",,,"11/03/2019",78.4,152.4,,,33.76,1.82,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Some Concerns","No","Undertreatment","Yes","Timings confirmed explicitly","Yes","OD","HC","No",,,,,,,,"No",,,,,,"No",,"11/03/2018",11.14,"TW20",,,,,,,,,,,,,,,,,"168.2",,"4513 11/03/2019"
"Sheffield - SCH","United Kingdom",4513,"United Kingdom","Active","06/09/2008","05/09/2008","Female",,,,"Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"08/09/2008",171.2,178.2,4513,"< 1 month",,"No","Cliteromegaly noted after delivery","II",,,"24/06/2019",80,154,,,33.73,1.85,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Some Concerns","No","Undertreatment","Yes"," ","Yes","OD","HC","No",,,,,,,,"No",,,,,,"No",,"11/03/2018",11.14,"TW20",,,,,,,,,,,,,,,,,"168.2",,"4513 24/06/2019"
"Sheffield - SCH","United Kingdom",4513,"United Kingdom","Active","06/09/2008","05/09/2008","Female",,,,"Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"08/09/2008",171.2,178.2,4513,"< 1 month",,"No","Cliteromegaly noted after delivery","II",,,"10/10/2019",78,154.6,,,32.63,1.83,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Some Concerns","No","Undertreatment","Yes"," ","Yes","OD","HC","No",,,,,,,,"No",,,,,,"No",,"11/03/2018",11.14,"TW20",,,,,,,,,,,,,,,,,"168.2",,"4513 10/10/2019"
"Sheffield - SCH","United Kingdom",4513,"United Kingdom","Active","06/09/2008","05/09/2008","Female",,,,"Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"08/09/2008",171.2,178.2,4513,"< 1 month",,"No","Cliteromegaly noted after delivery","II",,,"24/02/2020",78.4,157.1,,,31.77,1.85,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Some Concerns","No","Undertreatment","Yes"," ","Yes","OD","HC","No",,,,,,,,"No",,,,,,"No",,"11/03/2018",11.14,"TW20",,,,,,,,,,,,,,,,,"168.2",,"4513 24/02/2020"
"Sheffield - SCH","United Kingdom",4513,"United Kingdom","Active","06/09/2008","05/09/2008","Female",,,,"Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"08/09/2008",171.2,178.2,4513,"< 1 month",,"No","Cliteromegaly noted after delivery","II",,,"13/11/2020",71.2,159.8,,,27.88,1.78,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Some Concerns","Yes","Undertreatment","Yes"," ","Yes","OD","HC","No",,,,,,,,"No",,,,,,"No",,"29/09/2020",13.97,"TW20",,,,,,,,,,,,,,,,,"168.2",,"4513 13/11/2020"
"Sheffield - SCH","United Kingdom",4513,"United Kingdom","Active","06/09/2008","05/09/2008","Female",,,,"Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"08/09/2008",171.2,178.2,4513,"< 1 month",,"No","Cliteromegaly noted after delivery","II",,,"14/01/2021",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Some Concerns","Yes","Undertreatment","Yes"," ","Yes","OD","HC","No",,,,,,,,"No",,,,,,"No",,"29/09/2020",13.97,"TW20",,,,,,,,,,,,,,,,,"168.2",,"4513 14/01/2021"
"Sheffield - SCH","United Kingdom",4513,"United Kingdom","Active","06/09/2008","05/09/2008","Female",,,,"Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"08/09/2008",171.2,178.2,4513,"< 1 month",,"No","Cliteromegaly noted after delivery","II",,,"04/05/2021",74.6,162.1,,,28.39,1.83,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Some Concerns","No","Undertreatment","Yes"," ","Yes","OD","HC","No",,,,,,,,"No",,,,,,"No",,"23/04/2021",14.15,"TW20",,,,,,,,,,,,,,,,,"168.2",,"4513 04/05/2021"
"Sheffield - SCH","United Kingdom",4513,"United Kingdom","Active","06/09/2008","05/09/2008","Female",,,,"Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"08/09/2008",171.2,178.2,4513,"< 1 month",,"No","Cliteromegaly noted after delivery","II",,,"06/06/2022",91.6,164,,,34.06,2.04,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Some Concerns","No","Undertreatment","Yes"," ","Yes","OD","HC","No",,,,,,,,"No",,,,,,"No",,"06/06/2022",14.74,"TW20",,,,,,,,,,,,,,,,,"168.2",,"4513 06/06/2022"
"Sheffield - SCH","United Kingdom",4513,"United Kingdom","Active","06/09/2008","05/09/2008","Female",,,,"Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"08/09/2008",171.2,178.2,4513,"< 1 month",,"No","Cliteromegaly noted after delivery","II",,,"01/11/2021",83.2,163.2,,,31.24,1.94,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Some Concerns","No","Undertreatment","Yes"," ","Yes","OD","HC","No",,,,,,,,"No",,,,,,"No",,"06/06/2022",14.74,"TW20",,,,,,,,,,,,,,,,,"168.2",,"4513 01/11/2021"
"Sheffield - SCH","United Kingdom",4514,"United Kingdom",,"18/08/2008","28/03/2005","Male",,,,"Yes","Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"21/08/2009",,,4514,"3",,"No","Presented with increased pubic hair, acne, tall stature and frequent chest infections with slow recovery. Mother worried about acne and tall stature for nearly 1 year before diagnosis. Normal male genitalia with low testicular volume (3ml on right, 2ml on left).",,,,"20/04/2022",76.1,181,,,23.23,1.96,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No Concerns","Yes","Dose adjustment for size","Yes",,"Yes","OD","HC",,,,,,,,,,,,,,,,,"29/11/2017",14.5,"TW20","No",,,,"3","2",,3,3,,"Not known",,,,,,,,"4514 20/04/2022"
"Sheffield - SCH","United Kingdom",4514,"United Kingdom",,"18/08/2008","28/03/2005","Male",,,,"Yes","Male","46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"21/08/2009",,,4514,"3",,"No","Presented with increased pubic hair, acne, tall stature and frequent chest infections with slow recovery. Mother worried about acne and tall stature for nearly 1 year before diagnosis. Normal male genitalia with low testicular volume (3ml on right, 2ml on left).",,,,"29/11/2017",72.6,168.7,,,25.51,1.84,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No Concerns","No","Dose adjustment for size","Yes",,"Yes","OD","HC",,,,,,,"Yes","Decapeptyl 11.25mg every 6 weeks",,,,,,,,,"29/11/2017",14.4,"TW20",,,,,"3","2",,3,3,,"Not known",,,,,,,,"4514 29/11/2017"
"Sheffield - SCH","United Kingdom",6750,"United Kingdom","Active","28/10/2014","20/10/2014","Female",3880,,"40 weeks","Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"19/02/2015",166,182,6750,"< 1 month",,"No",,"III",,,"22/06/2016",7.9,70.4,,,15.94,0.39,,,115,52,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No Concerns","No",,"Yes","hydrocortisone 1.9mg TDS","Yes","OD","HC","Yes","30%NaCl 1ml QDS","No",,"No",,"No",,"No",,"No",,"No",,"No",,,,,,,,,,,,,,,,,,,,,"167.5",,"6750 22/06/2016"
"Sheffield - SCH","United Kingdom",6750,"United Kingdom","Active","28/10/2014","20/10/2014","Female",3880,,"40 weeks","Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"19/02/2015",166,182,6750,"< 1 month",,"No",,"III",,,"05/06/2017",11.2,85.9,,,15.18,0.52,"No","Yes",102,56,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No Concerns","No",,"Yes","hydrocortisone 2.1mg TDS
(12mg/m2/day)","Yes","OD","HC","No","30%NaCl 1ml QDS","No",,"No",,"No",,"No",,"No",,"No",,"No",,"06/03/2017",2.5,"TW20",,,,,,,,,,,,,,,,,"167.5",,"6750 05/06/2017"
"Sheffield - SCH","United Kingdom",6750,"United Kingdom","Active","28/10/2014","20/10/2014","Female",3880,,"40 weeks","Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"19/02/2015",166,182,6750,"< 1 month",,"No",,"III",,,"18/06/2018",30.4,96.7,,,32.51,0.9,"No","Yes",107,59,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No Concerns","No",,"Yes","hydrocortisone (10mg/m2/day)","Yes","OD","HC","No","30%NaCl 1ml QDS","No",,"No",,"No",,"No",,"No",,"No",,"No",,"18/06/2018",,,,,,,,,,,,,,,,,,,"167.5",,"6750 18/06/2018"
"Sheffield - SCH","United Kingdom",6750,"United Kingdom","Active","28/10/2014","20/10/2014","Female",3880,,"40 weeks","Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"19/02/2015",166,182,6750,"< 1 month",,"No",,"III",,,"03/06/2019",15,103,,,14.14,0.66,"No","Yes",97,62,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No Concerns","No",,"Yes","hydrocortisone (12.2mg/m2/day)","Yes","OD","HC","No","30%NaCl 1ml QDS","No",,"No",,"No",,"No",,"No",,"No",,"No",,"05/06/2019",4.62,"Greulich & Pyle",,,,,,,,,,,,,,,,,"167.5",,"6750 03/06/2019"
"Sheffield - SCH","United Kingdom",6750,"United Kingdom","Active","28/10/2014","20/10/2014","Female",3880,,"40 weeks","Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"19/02/2015",166,182,6750,"< 1 month",,"No",,"III",,,"09/11/2020",19.2,113.2,,,14.98,0.78,"No","Yes",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No Concerns","No",,"Yes","hydrocortisone (11.5mg/m2/day)
4mg - 2mg - 5mg (evening dose increased from 2m due to raised 17OHP)","Yes","OD","HC","No","30%NaCl 1ml QDS","No",,"No",,"No",,"No",,"No",,"No",,"No",,"20/03/2020",5.17,"Greulich & Pyle","No",,,,,,,,,,,,,,,,"167.5",,"6750 09/11/2020"
"Sheffield - SCH","United Kingdom",6750,"United Kingdom","Active","28/10/2014","20/10/2014","Female",3880,,"40 weeks","Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"19/02/2015",166,182,6750,"< 1 month",,"No",,"III",,,"16/08/2021",22.4,121.9,,,15.07,0.87,"No","No",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No Concerns","No",,"Yes","hydrocortisone (14.9mg/m2/day)
","Yes","OD","HC","No","30%NaCl 1ml QDS","No",,"No",,"No",,"No",,"No",,"No",,"No",,"16/08/2021",7.37,"Greulich & Pyle","No",,,,,,,,,,,,,,,,"167.5",,"6750 16/08/2021"
"Sheffield - SCH","United Kingdom",6750,"United Kingdom","Active","28/10/2014","20/10/2014","Female",3880,,"40 weeks","Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"19/02/2015",166,182,6750,"< 1 month",,"No",,"III",,,"14/01/2022",22.6,125.1,,,14.44,0.89,"No","Yes",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No Concerns","Yes","Undertreatment","Yes","hydrocortisone (14.9mg/m2/day)
","Yes","OD","HC","No","30%NaCl 1ml QDS","No",,"No",,"No",,"No",,"No",,"No",,"No",,"16/08/2021",7.37,"Greulich & Pyle","No",,,,,,,,,,,,,,,,"167.5",,"6750 14/01/2022"
"Sheffield - SCH","United Kingdom",6750,"United Kingdom","Active","28/10/2014","20/10/2014","Female",3880,,"40 weeks","Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"19/02/2015",166,182,6750,"< 1 month",,"No",,"III",,,"25/07/2022",24,127.5,,,14.76,0.92,"No","Yes",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No Concerns","No","Undertreatment","Yes","hydrocortisone (14.1mg/m2/day)
","Yes","OD","HC","No","30%NaCl 1ml QDS","No",,"No",,"No",,"No",,"No",,"No",,"No",,"25/07/2022",8.62,"TW20","No",,,,,,,,,,,,,,,,"167.5",,"6750 25/07/2022"
"Sheffield - SCH","United Kingdom",8348,"United Kingdom","Active","08/07/2016","01/07/2016","Female",,,,"Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"01/07/2016",166,187,8348,"< 1 month",,"No",,"III",,,"08/07/2016",3.78,52.6,,,13.66,0.24,"No","Yes",101,72,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No Concerns","Not known",,"Yes","Hydrocortisone 1 mg QDS","Yes","OD","HC","Yes","NaCl 3% 1 ml QDS",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"170",,"8348 08/07/2016"
"Sheffield - SCH","United Kingdom",8348,"United Kingdom","Active","08/07/2016","01/07/2016","Female",,,,"Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"01/07/2016",166,187,8348,"< 1 month",,"No",,"III",,,"05/10/2016",5.94,61.1,,,15.91,0.32,"No","Yes",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No Concerns","No",,"Yes",,"Yes","OD","HC","Yes","NaCl 3% 1 ml QDS",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"170",,"8348 05/10/2016"
"Sheffield - SCH","United Kingdom",8348,"United Kingdom","Active","08/07/2016","01/07/2016","Female",,,,"Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"01/07/2016",166,187,8348,"< 1 month",,"No",,"III",,,"09/12/2016",6.97,66.8,,,15.62,0.36,"No","Yes",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No Concerns","No",,"Yes",,"Yes","OD","HC","Yes","NaCl 3% 1 mmol QDS",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"170",,"8348 09/12/2016"
"Sheffield - SCH","United Kingdom",8348,"United Kingdom","Active","08/07/2016","01/07/2016","Female",,,,"Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"01/07/2016",166,187,8348,"< 1 month",,"No",,"III",,,"17/03/2017",7.85,70.8,,,15.66,0.39,"No","Yes",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No Concerns","No",,"Yes","Hydrocortisone 1.6 mg TDS","Yes","OD","HC","Yes","NaCl 3% 1 mmol QDS",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"170",,"8348 17/03/2017"
"Sheffield - SCH","United Kingdom",8348,"United Kingdom","Active","08/07/2016","01/07/2016","Female",,,,"Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"01/07/2016",166,187,8348,"< 1 month",,"No",,"III",,,"17/07/2017",8.2,72.1,,,15.77,0.41,"No","Yes",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No Concerns","No",,"Yes","Hydrocortisone 1.6 mg TDS","Yes","OD","HC","Yes","NaCl 3% 2 mmol QDS",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"170",,"8348 17/07/2017"
"Sheffield - SCH","United Kingdom",8348,"United Kingdom","Active","08/07/2016","01/07/2016","Female",,,,"Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"01/07/2016",166,187,8348,"< 1 month",,"No",,"III",,,"23/04/2018",10.8,83.8,,,15.38,0.5,"No","Yes",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No Concerns","Yes","Dose adjustment for size","Yes",,"Yes","OD","HC","Yes","NaCl 3% 10 mmol QDS",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"170",,"8348 23/04/2018"
"Sheffield - SCH","United Kingdom",8348,"United Kingdom","Active","08/07/2016","01/07/2016","Female",,,,"Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"01/07/2016",166,187,8348,"< 1 month",,"No",,"III",,,"11/03/2019",13.4,94,,,15.17,0.59,"No","Yes",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No Concerns","No","Other","Yes",,"Yes","OD","HC","Yes","NaCl 3% 10 mmol QDS",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"170",,"8348 11/03/2019"
"Sheffield - SCH","United Kingdom",8348,"United Kingdom","Active","08/07/2016","01/07/2016","Female",,,,"Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"01/07/2016",166,187,8348,"< 1 month",,"No",,"III",,,"30/07/2020",15.2,103,,,14.33,0.66,"No","Yes",113,62,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No Concerns","No","Other","Yes",,"Yes","OD","HC","No","NaCl 3% 10 mmol QDS",,,,,,,,,,,,,,,"20/03/2020",3.54,"Greulich & Pyle",,,,,,,,,,,,,,,,,"170",,"8348 30/07/2020"
"Sheffield - SCH","United Kingdom",8348,"United Kingdom","Active","08/07/2016","01/07/2016","Female",,,,"Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"01/07/2016",166,187,8348,"< 1 month",,"No",,"III",,,"19/07/2021",18,112.4,,,14.25,0.75,"No","Yes",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No Concerns","Yes","Dose adjustment for size","Yes",,"Yes","OD","HC","No","NaCl 3% 10 mmol QDS",,,,,,,,,,,,,,,"09/04/2021",4.9,"Greulich & Pyle",,,,,,,,,,,,,,,,,"170",,"8348 19/07/2021"
"Sheffield - SCH","United Kingdom",8348,"United Kingdom","Active","08/07/2016","01/07/2016","Female",,,,"Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"01/07/2016",166,187,8348,"< 1 month",,"No",,"III",,,"25/07/2022",20.8,118.8,,,14.74,0.83,"No","Yes",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No Concerns","Yes","Dose adjustment for size","Yes",,"Yes","OD","HC","No","NaCl 3% 10 mmol QDS",,,,,,,,,,,,,,,"10/01/2022",5.86,"Greulich & Pyle",,,,,,,,,,,,,,,,,"170",,"8348 25/07/2022"
"Southampton - UHS","United Kingdom",3439,"United Kingdom","Active","08/07/2016","12/08/2014","Female",2770,,"36 weeks","Yes","Female","Other",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,173.7,182.88,3439,"2",,"No",,"Normal Female",,,"15/09/2016",16.6,97.9,,,17.32,0.67,,"Yes",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Yes",,"Yes",,"No",,,,,,,,,,,,,,,,,,"hydrocortisone 7.50 QID",,,,,,,,,,,,,,,,,,,,"171.79",,"3439 15/09/2016"
"Southampton - UHS","United Kingdom",3439,"United Kingdom","Active","08/07/2016","12/08/2014","Female",2770,,"36 weeks","Yes","Female","Other",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,173.7,182.88,3439,"2",,"No",,"Normal Female",,,"15/12/2016",,,,,,,,"Yes",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Yes","Undertreatment","Yes",,"No",,,,,,,,,,,,,,,,,,"hydrocortisone 11.25 QID",,,,,,,,,,,,,,,,,,,,"171.79",,"3439 15/12/2016"
"Southampton - UHS","United Kingdom",3439,"United Kingdom","Active","08/07/2016","12/08/2014","Female",2770,,"36 weeks","Yes","Female","Other",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,173.7,182.88,3439,"2",,"No",,"Normal Female",,,"29/11/2017",20.5,108.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No",,,,,,,,,,,,,,,,,,,,,,"hydrocortisone 11.25 QID",,,,,,,,,,,,,,,,,,,,"171.79",,"3439 29/11/2017"
"Southampton - UHS","United Kingdom",3439,"United Kingdom","Active","08/07/2016","12/08/2014","Female",2770,,"36 weeks","Yes","Female","Other",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,173.7,182.88,3439,"2",,"No",,"Normal Female",,,"23/11/2022",,,,,,,,,,,,,,,,,,,,,,,,"Yes","feminising genitoplasty (clitorial recession and labioplasty) -9/1/2018",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No",,,,,,,,,,,,,,,,,,,,,,"hydrocortisone 11.25 QID",,,,,,,,,,,,,,,,,,,,"171.79",,"3439 23/11/2022"
"Southampton - UHS","United Kingdom",3439,"United Kingdom","Active","08/07/2016","12/08/2014","Female",2770,,"36 weeks","Yes","Female","Other",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,173.7,182.88,3439,"2",,"No",,"Normal Female",,,"17/08/2018",22.7,114.5,,,17.31,0.85,,,,,,,,,,,,,,,,,,"Yes","feminising genitoplasty (clitorial recession and labioplasty) -9/1/2018",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No",,,,,,,"No",,,,,,,,,,,,,,,"hydrocortisone 11.25 QID",,,,,,,,,,,,,,,,,,,,"171.79",,"3439 17/08/2018"
"Southampton - UHS","United Kingdom",3439,"United Kingdom","Active","08/07/2016","12/08/2014","Female",2770,,"36 weeks","Yes","Female","Other",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,173.7,182.88,3439,"2",,"No",,"Normal Female",,,"15/01/2021",27.64,124.5,,,17.83,0.98,,,,,,,,,,,,,,,,,,"Yes","feminising genitoplasty (clitorial recession and labioplasty) -9/1/2018",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Yes","Dose adjustment for size","Yes",,,,,,,,,,,,,,,,,,,,"hydrocortisone 11.25 QID",,,,,,,,,,,,,,,,,,,,"171.79",,"3439 15/01/2021"
"Southampton - UHS","United Kingdom",3439,"United Kingdom","Active","08/07/2016","12/08/2014","Female",2770,,"36 weeks","Yes","Female","Other",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,173.7,182.88,3439,"2",,"No",,"Normal Female",,,"07/01/2022",32.5,130.3,,,19.14,1.08,,"Yes",,,,,,,,,,,,,,,,"Yes","feminising genitoplasty (clitorial recession and labioplasty) -9/1/2018",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No",,,,,,,,,,,,,,,,,,,,,,"hydrocortisone 11.25 QID",,,,,,,,,,,,,,,,,,,,"171.79",,"3439 07/01/2022"
"Southampton - UHS","United Kingdom",3439,"United Kingdom","Active","08/07/2016","12/08/2014","Female",2770,,"36 weeks","Yes","Female","Other",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,173.7,182.88,3439,"2",,"No",,"Normal Female",,,"21/06/2017",19.1,106,,,17,0.75,,,,,,,,,,,,,,,,,,"Yes","feminising genitoplasty (clitorial recession and labioplasty) -9/1/2018",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No","Dose adjustment for size",,,"No",,,,,,,,,,,,,,,,,,"hydrocortisone 11.25 QID",,,,,,,,,,,,,,,,,,,,"171.79",,"3439 21/06/2017"
"Southampton - UHS","United Kingdom",3439,"United Kingdom","Active","08/07/2016","12/08/2014","Female",2770,,"36 weeks","Yes","Female","Other",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,173.7,182.88,3439,"2",,"No",,"Normal Female",,,"27/12/2019",,,,,,,,,,,,,,,,,,,,,,,,"Yes","feminising genitoplasty (clitorial recession and labioplasty) -9/1/2018",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Yes",,"Yes",,"No",,,,,,,,,,,,,,,,,,"hydrocortisone 11.25 QID",,,,,,,,,,,,,,,,,,,,"171.79",,"3439 27/12/2019"
"Southampton - UHS","United Kingdom",3439,"United Kingdom","Active","08/07/2016","12/08/2014","Female",2770,,"36 weeks","Yes","Female","Other",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,173.7,182.88,3439,"2",,"No",,"Normal Female",,,"15/07/2016",,,,,,,,,,,,,,,,,,,,,,,,"Yes","feminising genitoplasty (clitorial recession and labioplasty) -9/1/2018",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Yes",,"Yes",,,,,,,,,,,,,,,,,,,,"hydrocortisone 11.25 QID",,,,,,,,,,,,,,,,,,,,"171.79",,"3439 15/07/2016"
"Southampton - UHS","United Kingdom",3439,"United Kingdom","Active","08/07/2016","12/08/2014","Female",2770,,"36 weeks","Yes","Female","Other",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,173.7,182.88,3439,"2",,"No",,"Normal Female",,,"05/08/2020",25.8,122,,,17.33,0.94,,,96,48,,,,,,,,,,,,,,"Yes","feminising genitoplasty (clitorial recession and labioplasty) -9/1/2018",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No","Dose adjustment for size","Yes",,,,,,,,,,,,,,,,,,,,"hydrocortisone 11.25 QID",,,,,,,,,,,,,,,,,,,,"171.79",,"3439 05/08/2020"
"Southampton - UHS","United Kingdom",3439,"United Kingdom","Active","08/07/2016","12/08/2014","Female",2770,,"36 weeks","Yes","Female","Other",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,173.7,182.88,3439,"2",,"No",,"Normal Female",,,"06/01/2023",38.08,135.4,,,20.77,1.2,,,,,,,,,,,,,,,,,,"Yes","feminising genitoplasty (clitorial recession and labioplasty) -9/1/2018",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No","Dose adjustment for size","Yes",,,,,,,,,,,,,,,,,,,,"hydrocortisone 11.25 QID",,,,,,,,,,,,,,,,,,,,"171.79",,"3439 06/01/2023"
"Southampton - UHS","United Kingdom",3440,"United Kingdom","Active","08/07/2016","12/08/2014","Female",2700,,"36 weeks","Yes","Female","Other",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,173.7,182.88,3440,"2",,"No",,"Normal Female",,,"17/08/2018",21.8,115,,,16.48,0.83,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No",,"Yes",,,,,,,,,,,,,,,,,,,,"hydrocortisone 15 mg/m2/day",,,,,,,,,,,,,,,,,,,,"171.79",,"3440 17/08/2018"
"Southampton - UHS","United Kingdom",3440,"United Kingdom","Active","08/07/2016","12/08/2014","Female",2700,,"36 weeks","Yes","Female","Other",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,173.7,182.88,3440,"2",,"No",,"Normal Female",,,"18/07/2016",16.3,96.2,,,17.61,0.66,,"Yes",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No",,"Yes",,"No",,,,,,,,,,,,,,,,,,"hydrocortisone 7.50",,,,,,,,,,,,,,,,,,,,"171.79",,"3440 18/07/2016"
"Southampton - UHS","United Kingdom",3440,"United Kingdom","Active","08/07/2016","12/08/2014","Female",2700,,"36 weeks","Yes","Female","Other",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,173.7,182.88,3440,"2",,"No",,"Normal Female",,,"07/01/2022",30.3,126.1,,,19.06,1.03,,"Yes",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Yes",,,,,,,,,,,,,,,,,,,,,"Yes","hydrocortisone 11.5",,,,,,,,,,,,,,,,,,,,"171.79",,"3440 07/01/2022"
"Southampton - UHS","United Kingdom",3440,"United Kingdom","Active","08/07/2016","12/08/2014","Female",2700,,"36 weeks","Yes","Female","Other",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,173.7,182.88,3440,"2",,"No",,"Normal Female",,,"15/01/2021",26.98,122.5,,,17.98,0.96,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No","Dose adjustment for size","Yes",,"No",,,,,,,,,,,,,,,,,"Yes","hydrocortisone 11.5",,,,,,,,,,,,,,,,,,,,"171.79",,"3440 15/01/2021"
"Southampton - UHS","United Kingdom",3440,"United Kingdom","Active","08/07/2016","12/08/2014","Female",2700,,"36 weeks","Yes","Female","Other",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,173.7,182.88,3440,"2",,"No",,"Normal Female",,,"29/11/2017",19.2,107.4,,,16.65,0.76,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No",,"Yes",,"No",,,,,,,,,,,,,,,,,"Yes","hydrocortisone 11.5",,,,,,,,,,,,,,,,,,,,"171.79",,"3440 29/11/2017"
"Southampton - UHS","United Kingdom",3440,"United Kingdom","Active","08/07/2016","12/08/2014","Female",2700,,"36 weeks","Yes","Female","Other",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,173.7,182.88,3440,"2",,"No",,"Normal Female",,,"28/04/2017",,,,,,,,,,,,,,,,,,,,,,"Yes","EUA + Cystovaginoscopy",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No",,"Yes",,,,,,,,,,,,,,,,,,,"Yes","hydrocortisone 11.5",,,,,,,,,,,,,,,,,,,,"171.79",,"3440 28/04/2017"
"Southampton - UHS","United Kingdom",3440,"United Kingdom","Active","08/07/2016","12/08/2014","Female",2700,,"36 weeks","Yes","Female","Other",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,173.7,182.88,3440,"2",,"No",,"Normal Female",,,"13/06/2017",18.34,104.7,,,16.73,0.73,,,92,44,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No",,"Yes",,,,,,,,,,,,,,,,,,,"Yes","hydrocortisone 11.5",,,,,,,,,,,,,,,,,,,,"171.79",,"3440 13/06/2017"
"Southampton - UHS","United Kingdom",3440,"United Kingdom","Active","08/07/2016","12/08/2014","Female",2700,,"36 weeks","Yes","Female","Other",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,173.7,182.88,3440,"2",,"No",,"Normal Female",,,"29/07/2022",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No",,"Yes",,"No",,,,,,,,,,,,,,,,,,"hydrocortisone 11.5",,,,,,,,,,,,,,,,,,,,"171.79",,"3440 29/07/2022"
"Southampton - UHS","United Kingdom",3440,"United Kingdom","Active","08/07/2016","12/08/2014","Female",2700,,"36 weeks","Yes","Female","Other",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,173.7,182.88,3440,"2",,"No",,"Normal Female",,,"28/06/2019",22.7,118.5,,,16.17,0.86,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Yes",,"Yes","mucoadhesive Corlan pellets to Alkindi hydrocortisone which comes as granules in capsules ","No",,,,,,,,,,,,,,,,,,"hydrocortisone 11.5",,,,,,,,,,,,,,,,,,,,"171.79",,"3440 28/06/2019"
"Southampton - UHS","United Kingdom",4594,"United Kingdom","Active","23/09/2015","19/09/2015","Not assigned",3254,,"41 weeks","Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,164,163.4,4594,"< 1 month",,,,"II",,,"03/02/2021",23.2,119.8,,,16.16,0.88,,,,,,,,,,,,,,,,"Yes","mild urogentital anomaly","Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,"Yes","Not Applicable","Yes",,"Yes","OD",,,,,,,,,,,,,,,,"Yes","hydrocortisone 17 mg/m2/day QID",,,,,,,,,,,,,,"Not known",,,,,,"(Male) 170.2 (Female) 157.2",,"4594 03/02/2021"
"Southampton - UHS","United Kingdom",4594,"United Kingdom","Active","23/09/2015","19/09/2015","Not assigned",3254,,"41 weeks","Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,164,163.4,4594,"< 1 month",,,,"II",,,"27/05/2022",26.4,127.3,,,16.29,0.97,,,111,63,,,,,,,,,0,,,"Yes","mild urogentital anomaly","Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,"Yes","Not Applicable","Yes",,"Yes","OD",,,,,,,,,,,,,,,,,"hydrocortisone 15.6 mg/m2/day QID","27/05/2022",11.7,"TW20",,,,,,,,,,,"Not known",,,,,,"(Male) 170.2 (Female) 157.2",,"4594 27/05/2022"
"Southampton - UHS","United Kingdom",4594,"United Kingdom","Active","23/09/2015","19/09/2015","Not assigned",3254,,"41 weeks","Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,164,163.4,4594,"< 1 month",,,,"II",,,"07/09/2017",12.85,89.2,,,16.15,0.56,,,,,,,,,,,,,0,,,"Yes","mild urogentital anomaly","Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,"Not known",,,"No","Not Applicable","Yes","8.6mg/m2/day","Yes","BD",,,,,,,,,,,,,,,,,"hydrocortisone 15.6 mg/m2/day QID","27/05/2022",11.7,"TW20",,,,,,,,,,,"Not known",,,,,,"(Male) 170.2 (Female) 157.2",,"4594 07/09/2017"
"Southampton - UHS","United Kingdom",4594,"United Kingdom","Active","23/09/2015","19/09/2015","Not assigned",3254,,"41 weeks","Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,164,163.4,4594,"< 1 month",,,,"II",,,"25/04/2023",29.9,130.3,,,17.61,1.04,,,,,,,,,,,,,,,,,"mild urogentital anomaly",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No","Not Applicable","Yes",,,"OD",,,,,,,,,,,,,,,,,"hydrocortisone 15.6 mg/m2/day QID",,,,,,,,,,,,,,"Not known",,,,,,"(Male) 170.2 (Female) 157.2",,"4594 25/04/2023"
"Southampton - UHS","United Kingdom",4594,"United Kingdom","Active","23/09/2015","19/09/2015","Not assigned",3254,,"41 weeks","Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,164,163.4,4594,"< 1 month",,,,"II",,,"27/01/2023",,,,,,,,,,,,,,,,,,,,,,,"mild urogentital anomaly",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"No","Not Applicable","Yes",,"No","OD","HC",,,,,,,,,,,,,,,"Yes",,,,,,,,,,,,,,,"Not known",,,,,,"(Male) 170.2 (Female) 157.2",,"4594 27/01/2023"
"Southampton - UHS","United Kingdom",4594,"United Kingdom","Active","23/09/2015","19/09/2015","Not assigned",3254,,"41 weeks","Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,164,163.4,4594,"< 1 month",,,,"II",,,"24/11/2022",29.6,130.2,,,17.46,1.03,,,90,60,,"1","2",,,,,,,,,,"mild urogentital anomaly",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Yes","Not Applicable",,,,"OD",,,,,,,,,,,,,,,,,"hydrocortisone 15.6 mg/m2/day QID",,11,,,,,,,,,,,,"Not known",,,,,,"(Male) 170.2 (Female) 157.2",,"4594 24/11/2022"
"Southampton - UHS","United Kingdom",4594,"United Kingdom","Active","23/09/2015","19/09/2015","Not assigned",3254,,"41 weeks","Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,164,163.4,4594,"< 1 month",,,,"II",,,"04/01/2016",7.25,59.7,,,20.34,0.35,,,,,,,,,,,,,,,,"Yes","mild urogentital anomaly","Yes","cystovaginoscopy done to assess anatomy - plan for repeat EUA and cystovaginoscopy aged 9-10",,,,,,,,,,,,,,,,,"Never",,,,,,,,,,,,,,,,,"Yes","Overtreatment","Yes",,"Yes","BD",,"Yes","30% NaCl 2 millilitres QD",,,,,,,,,,,,,,"hydrocortisone 15.6 mg/m2/day QID",,,,,,,,,,,,,,"Not known",,,,,,"(Male) 170.2 (Female) 157.2",,"4594 04/01/2016"
"Southampton - UHS","United Kingdom",4594,"United Kingdom","Active","23/09/2015","19/09/2015","Not assigned",3254,,"41 weeks","Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,164,163.4,4594,"< 1 month",,,,"II",,,"13/05/2019",17.8,105.7,,,15.93,0.72,,,,,,,,,,,,,,,,,"mild urogentital anomaly",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Yes","Not Applicable","Yes",,"Yes","BD",,,,,,,,,,,,,,,,,"hydrocortisone 15.6 mg/m2/day QID",,,,,,,,,,,,,,"Not known",,,,,,"(Male) 170.2 (Female) 157.2",,"4594 13/05/2019"
"Southampton - UHS","United Kingdom",4594,"United Kingdom","Active","23/09/2015","19/09/2015","Not assigned",3254,,"41 weeks","Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,164,163.4,4594,"< 1 month",,,,"II",,,"18/03/2020",20.2,113.8,,,15.6,0.8,,,,,,,,,,,,,,,,,"mild urogentital anomaly",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Yes","Not Applicable","Yes","15mg/m2/day","Yes","BD",,,,,,,,,,,,,,,,,"hydrocortisone 15.6 mg/m2/day QID",,,,,,,,,,,,,,"Not known",,,,,,"(Male) 170.2 (Female) 157.2",,"4594 18/03/2020"
"Southampton - UHS","United Kingdom",4594,"United Kingdom","Active","23/09/2015","19/09/2015","Not assigned",3254,,"41 weeks","Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,164,163.4,4594,"< 1 month",,,,"II",,,"02/08/2023",32.4,35.56,,,256.23,0.57,,,,,,,,,,,,,,,,,"mild urogentital anomaly",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Yes",,"Yes",,"Yes","OD",,,,,,,,,,,,,,,,"Yes","Decapeptyl 22.5 six monthly",,,,,,,,,,,,,,"Not known",,,,,,"(Male) 170.2 (Female) 157.2",,"4594 02/08/2023"
"Southampton - UHS","United Kingdom",4594,"United Kingdom","Active","23/09/2015","19/09/2015","Not assigned",3254,,"41 weeks","Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,164,163.4,4594,"< 1 month",,,,"II",,,"25/02/2019",16.9,105.1,,,15.3,0.7,,,,,,,,,,,,,,,,,"mild urogentital anomaly",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Yes",,"Yes","dose equivalent to 14mg/m2/day","Yes","BD",,,,,,,,,,,,,,,,"Yes","Decapeptyl 22.5 six monthly",,,,,,,,,,,,,,"Not known",,,,,,"(Male) 170.2 (Female) 157.2",,"4594 25/02/2019"
"Southampton - UHS","United Kingdom",4594,"United Kingdom","Active","23/09/2015","19/09/2015","Not assigned",3254,,"41 weeks","Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,164,163.4,4594,"< 1 month",,,,"II",,,"04/12/2019",19.5,110.5,,,15.97,0.77,,,,,,,,,,,,,,,,,"mild urogentital anomaly",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Yes",,"Yes","total daily dose 14.7 mg/m2/day","Yes","BD",,,,,,,,,,,,,,,,"Yes","Decapeptyl 22.5 six monthly",,,,,,,,,,,,,,"Not known",,,,,,"(Male) 170.2 (Female) 157.2",,"4594 04/12/2019"
"Southampton - UHS","United Kingdom",4594,"United Kingdom","Active","23/09/2015","19/09/2015","Not assigned",3254,,"41 weeks","Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,164,163.4,4594,"< 1 month",,,,"II",,,"19/05/2020",20.2,113.8,,,15.6,0.8,,,,,,,,,,,,,,,,,"mild urogentital anomaly",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Yes",,"Yes",,"Yes","OD",,,,,,,,,,,,,,,,"Yes","Decapeptyl 22.5 six monthly",,,,,,,,,,,,,,"Not known",,,,,,"(Male) 170.2 (Female) 157.2",,"4594 19/05/2020"
"Southampton - UHS","United Kingdom",4594,"United Kingdom","Active","23/09/2015","19/09/2015","Not assigned",3254,,"41 weeks","Yes","Female","46 XX",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,,164,163.4,4594,"< 1 month",,,,"II",,,"24/11/2020",22.2,118,,,15.94,0.85,,,,,,,,,,,,,,,,,"mild urogentital anomaly",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Yes",,"Yes","(10mg Hydrocortisone tablets)14.5mg per m2","Yes","BD",,,,,,,,,,,,,,,,"Yes","Decapeptyl 22.5 six monthly",,,,,,,,,,,,,,"Not known",,,,,,"(Male) 170.2 (Female) 157.2",,"4594 24/11/2020"
"Southampton - UHS","United Kingdom",7222,"United Kingdom","Active","01/08/2005","27/07/2005","Male",3430,,"39 weeks","Yes","Female","46 XX/46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"01/08/2005",,,7222,"< 1 month",,"No","hypoplastic pigmented scrotum with a median raphe with some evidence of rugosity. There was a 1.2cm phallus with a meatal opening at the tip. The anus was normally sited and there was no hypospadius. No palpable gonads.",,,,"29/03/2022",49.6,163.7,,,18.51,1.5,,,98,60,,,,,"Spontaneous",14,"No",,0,,"No","Yes","2014,satisfactory introitus with little urine pooling within it, some hair development within introitus","Yes","Femininsing  genitoplasty and clitoral recession(2006)",,,,,,,,,,,,,,,,,,,,,"Yes",,"Yes","long history of low mood and anxiety and has symptoms consistent with depressive episode,",,,,,,,"Yes","eating disorder (CAMHS involvement)",,"Yes",,"Yes","16.7mg/m2/day","Yes","OD",,,,,,,,,,,,,,,,"Yes","Solifenacin",,,,,,,,,,,,,,,,,,,,,,"7222 29/03/2022"
"Southampton - UHS","United Kingdom",7222,"United Kingdom","Active","01/08/2005","27/07/2005","Male",3430,,"39 weeks","Yes","Female","46 XX/46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"01/08/2005",,,7222,"< 1 month",,"No","hypoplastic pigmented scrotum with a median raphe with some evidence of rugosity. There was a 1.2cm phallus with a meatal opening at the tip. The anus was normally sited and there was no hypospadius. No palpable gonads.",,,,"07/11/2022",,,,,,,,,,,,,,,"Spontaneous",,,,0,,,"Yes","2014,satisfactory introitus with little urine pooling within it, some hair development within introitus","Yes","Femininsing  genitoplasty and clitoral recession(2006)",,,,,,,,,,,,,,,,,,,,,"Yes",,"Yes","long history of low mood and anxiety and has symptoms consistent with depressive episode,",,,,,,,"Yes","eating disorder (CAMHS involvement)","No Concerns","Yes","Overtreatment","Yes",,"Not known","OD",,,,,,,,,,,,,,,,"Yes","hydrocortisone 10 mg at 7am,5mg at midday, 2.5 mg at 4pm , 2.5 at bedtime
",,,,,,,,,,,,,,,,,,,,,,"7222 07/11/2022"
"Southampton - UHS","United Kingdom",7222,"United Kingdom","Active","01/08/2005","27/07/2005","Male",3430,,"39 weeks","Yes","Female","46 XX/46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"01/08/2005",,,7222,"< 1 month",,"No","hypoplastic pigmented scrotum with a median raphe with some evidence of rugosity. There was a 1.2cm phallus with a meatal opening at the tip. The anus was normally sited and there was no hypospadius. No palpable gonads.",,,,"04/06/2016",33.3,,,,,,,,,,,,,,"Spontaneous",,,,0,,,"Yes","2014,satisfactory introitus with little urine pooling within it, some hair development within introitus","Yes","Femininsing  genitoplasty and clitoral recession(2006)",,,,,,,,,,,,,,,,,,,,,"Yes",,"Yes","long history of low mood and anxiety and has symptoms consistent with depressive episode,",,,,,,,"Yes","eating disorder (CAMHS involvement)","Some Concerns","Yes",,"No",,,"OD",,,,,,,,,,,,,,,,"Yes","hydrocortisone 10 mg at 7am,5mg at midday, 2.5 mg at 4pm , 2.5 at bedtime
",,,,,,,,,,,,,,,,,,,,,,"7222 04/06/2016"
"Southampton - UHS","United Kingdom",7222,"United Kingdom","Active","01/08/2005","27/07/2005","Male",3430,,"39 weeks","Yes","Female","46 XX/46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"01/08/2005",,,7222,"< 1 month",,"No","hypoplastic pigmented scrotum with a median raphe with some evidence of rugosity. There was a 1.2cm phallus with a meatal opening at the tip. The anus was normally sited and there was no hypospadius. No palpable gonads.",,,,"12/12/2017",39.3,153.8,,,16.61,1.3,,,96,62,,,"2",,,,,,0,,,"Yes","2014,satisfactory introitus with little urine pooling within it, some hair development within introitus","Yes","Femininsing  genitoplasty and clitoral recession(2006)",,,,,,,,,,,,,,,,,,,,,"Yes",,"Yes","long history of low mood and anxiety and has symptoms consistent with depressive episode,",,,,,,,"Yes","eating disorder (CAMHS involvement)",,"Yes",,"Yes",,"Yes","OD",,,,,,,,,,,,,,,,"Yes","hydrocortisone sodium phosphate IM 100mg in emergency 
",,,,,,,,,,,,,,,,,,,,,,"7222 12/12/2017"
"Southampton - UHS","United Kingdom",7222,"United Kingdom","Active","01/08/2005","27/07/2005","Male",3430,,"39 weeks","Yes","Female","46 XX/46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"01/08/2005",,,7222,"< 1 month",,"No","hypoplastic pigmented scrotum with a median raphe with some evidence of rugosity. There was a 1.2cm phallus with a meatal opening at the tip. The anus was normally sited and there was no hypospadius. No palpable gonads.",,,,"03/07/2020",47.4,164.2,,,17.58,1.47,,,96,60,"Hydrocortisone 10 milligrams 6am midday, 6pm midnight at times of illness only 
Hydrocortisone 100 milligrams intramuscularly to be given at times of emergency
but remained well ",,,,"Spontaneous",,,,0,,,"Yes","2014,satisfactory introitus with little urine pooling within it, some hair development within introitus","Yes","Femininsing  genitoplasty and clitoral recession(2006)",,,,,,,,,,,,,,,,,,,,,"Yes",,"Yes","long history of low mood and anxiety and has symptoms consistent with depressive episode,",,,,,,,"Yes","eating disorder (CAMHS involvement)",,"Yes",,"Yes","Hydrocortisone 12.5 milligrams 6am, 5 milligrams 12 noon, 5 milligrams 4pm, 2.5 milligrams 9pm","Yes","OD",,,,,,,,,,,,,,,,"Yes","Solifenacin
",,,,,,,,,,,,,,,,,,,,,,"7222 03/07/2020"
"Southampton - UHS","United Kingdom",7222,"United Kingdom","Active","01/08/2005","27/07/2005","Male",3430,,"39 weeks","Yes","Female","46 XX/46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"01/08/2005",,,7222,"< 1 month",,"No","hypoplastic pigmented scrotum with a median raphe with some evidence of rugosity. There was a 1.2cm phallus with a meatal opening at the tip. The anus was normally sited and there was no hypospadius. No palpable gonads.",,,,"29/01/2020",50.3,162.7,,,19,1.51,,,95,60,,,,,"Spontaneous",,,,0,,,"Yes","2014,satisfactory introitus with little urine pooling within it, some hair development within introitus","Yes","Femininsing  genitoplasty and clitoral recession(2006)",,,,,,,,,,,,,,,,,,,,,"Yes",,"Yes","long history of low mood and anxiety and has symptoms consistent with depressive episode,",,,,,,,"Yes","eating disorder (CAMHS involvement)","Some Concerns","Yes",,"Yes","16.6mg/m2/day","Yes","OD","HC",,,,,,,,,,,,,,,"Yes","hydrocortisone 12.5 mg at 6am,5mg at midday, 5 mg at 4pm , 2.5 at bedtime
Solifenacin
",,,,,,,,,,,,,,,,,,,,,,"7222 29/01/2020"
"Southampton - UHS","United Kingdom",7222,"United Kingdom","Active","01/08/2005","27/07/2005","Male",3430,,"39 weeks","Yes","Female","46 XX/46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"01/08/2005",,,7222,"< 1 month",,"No","hypoplastic pigmented scrotum with a median raphe with some evidence of rugosity. There was a 1.2cm phallus with a meatal opening at the tip. The anus was normally sited and there was no hypospadius. No palpable gonads.",,,,"28/04/2021",44.7,163.5,,,16.72,1.42,,,90,65,,,,,"Spontaneous",,,,0,,,"Yes","2014,satisfactory introitus with little urine pooling within it, some hair development within introitus","Yes","Femininsing  genitoplasty and clitoral recession(2006)",,,,,,,,,,,,,,,,,,,,,"Yes",,"Yes","long history of low mood and anxiety and has symptoms consistent with depressive episode,",,,,,,,"Yes","eating disorder (CAMHS involvement)",,"Yes",,"Yes","hydrocortisone 10mg tab -12.5mg at 6, 5 mg at midday , 5mg at 4pm, 2.5 mg at bedtime","Yes","OD",,,,,,,,,,,,,,,,"Yes","solifenacin 
",,,,,,,,,,,,,,,,,,,,,,"7222 28/04/2021"
"Southampton - UHS","United Kingdom",7222,"United Kingdom","Active","01/08/2005","27/07/2005","Male",3430,,"39 weeks","Yes","Female","46 XX/46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"01/08/2005",,,7222,"< 1 month",,"No","hypoplastic pigmented scrotum with a median raphe with some evidence of rugosity. There was a 1.2cm phallus with a meatal opening at the tip. The anus was normally sited and there was no hypospadius. No palpable gonads.",,,,"06/03/2017",36.1,148,,,16.48,1.22,,,,,,,,,"Spontaneous",,"No",,0,,,"Yes","2014,satisfactory introitus with little urine pooling within it, some hair development within introitus","Yes","Femininsing  genitoplasty and clitoral recession(2006)",,,,,,,,,,,,,,,,,,,,,"Yes",,"Yes","long history of low mood and anxiety and has symptoms consistent with depressive episode,",,,,,,,"Yes","eating disorder (CAMHS involvement)",,"Yes",,"Yes","Hydrocortisone 10 mg 7:00 am, 5 mg mid day, 2.5 mg 4:00 pm, 2.5 mg bedtime","Yes","OD",,,,,,,,,,,,,,,,"Yes","Solifenacin 5 mg OD
",,,,,,,,,,,,,,,,,,,,,,"7222 06/03/2017"
"Southampton - UHS","United Kingdom",7222,"United Kingdom","Active","01/08/2005","27/07/2005","Male",3430,,"39 weeks","Yes","Female","46 XX/46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"01/08/2005",,,7222,"< 1 month",,"No","hypoplastic pigmented scrotum with a median raphe with some evidence of rugosity. There was a 1.2cm phallus with a meatal opening at the tip. The anus was normally sited and there was no hypospadius. No palpable gonads.",,,,"19/03/2018",40.3,155.7,,,16.62,1.32,,,90,60,,"3","4",,"Spontaneous",,"No",,0,,,"Yes","2014,satisfactory introitus with little urine pooling within it, some hair development within introitus","Yes","Femininsing  genitoplasty and clitoral recession(2006)",,,,,,,,,,,,,,,,,,,,,"Yes",,"Yes","long history of low mood and anxiety and has symptoms consistent with depressive episode,",,,,,,,"Yes","eating disorder (CAMHS involvement)",,"Yes",,"Yes","Hydrocortisone 10 mg 7:00 am, 5 mg mid day, 2.5 mg 4:00 pm, 2.5 mg bedtime","Yes","OD",,,,,,,,,,,,,,,,"Yes","Solifenacin
",,,,,,,,,,,,,,,,,,,,,,"7222 19/03/2018"
"Southampton - UHS","United Kingdom",7222,"United Kingdom","Active","01/08/2005","27/07/2005","Male",3430,,"39 weeks","Yes","Female","46 XX/46 XY",,"Congenital Adrenal Hyperplasia","21-hydroxylase def (CYP21A)",,"01/08/2005",,,7222,"< 1 month",,"No","hypoplastic pigmented scrotum with a median raphe with some evidence of rugosity. There was a 1.2cm phallus with a meatal opening at the tip. The anus was normally sited and there was no hypospadius. No palpable gonads.",,,,"23/01/2019",43.8,160,,,17.11,1.4,,,100,60,,"3","4",,"Spontaneous",,"No",,0,,,"Yes","2014,satisfactory introitus with little urine pooling within it, some hair development within introitus","Yes","Femininsing  genitoplasty and clitoral recession(2006)",,,,,,,,,,,,,,,,,,,,,"Yes",,"Yes","long history of low mood and anxiety and has symptoms consistent with depressive episode,",,,,,,,"Yes","eating disorder (CAMHS involvement)",,"Yes",,"Yes","Hydrocortisone 10 mg 7:00 am, 5 mg mid day, 2.5 mg 4:00 pm, 2.5 mg bedtime","Yes","OD",,,,,,,,,,,,,,,,"Yes","Solifenacin
",,,,,,,,,,,,,,,,,,,,,,"7222 23/01/2019"
